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Abstract
Abstract
Mouse embryonic stem cells (ES cells) are derived from the inner cell mass of 3.5
day blastocysts. ES cells remain totipotent when cultured on embryonic fibroblasts
or in the presence of Leukaemia inhibitory factor (LIF). However, under defined
culture conditions they are able to differentiate into multiple cell lineages and when
reintroduced back into a host blastocyst, possess the remarkable ability to contribute
to all adult tissues in the mouse. These unique features of ES cells allow genes to be
deleted in mice and when combined with Cre/LoxP technology provide an ideal
system for conditional deletion of genes where total 'knockout' would be lethal. One
such gene is integrin av where knockout mice die in utero or perinatally. Integrin av
has been implicated in angiogenesis and cell adhesion as well as in the phagocytosis
of dying cells by macrophages and dendritic cells, a process that is important in the
resolution of inflammation and tissue remodelling.
The main aim of this thesis was to examine the role of integrin av in phagocytosis.
To do this, two complementary approaches were used. Firstly, ES cells with
disrupted integrin av genes were differentiated into myeloid cells and the effects on
phagocytosis by DCs assessed. Secondly Cre was delivered to macrophages cultured
from integrin av targeted mice, to delete integrin av immediately prior to
phagocytosis assays.
This thesis demonstrates that macrophages can be generated from the culture of ES
cells. Although low in number these macrophages show similar morphology and
surface phentoype to bone marrow derived macrophages. Importantly, these ES
macrophages readily phagocytosed latex beads and apoptotic cells. In addition, ES
cells produced cells with a dendritic cell phenotype that were capable of apoptotic
cell phagocytosis and maturation. Generation of these myeloid cells from ES cells
was strongly dependent on serum and the parent ES cell line. Dendritic cells could
be generated from integrin av disrupted ES cells. These DCs retained the ability to
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phagocytose apoptotic cells suggesting that integrin av is not essential for this
process.
This study also investigates the properties of Cre fused to two transduction proteins.
Although Cre retained its recombinase activity as a fusion protein these were unable
to translocate into cells. However Cre could be delivered to both primary
macrophages and cultured epithelial cells using a replication deficient adenovirus
allowing deletion of the targeted genes. Intriguingly, the apoptotic cell phagocytosis
was unaffected by lack of integrin av but could no longer be inhibited by the integrin
antagonistic peptide RGD.
In conclusion, the capacity of ES cells to differentiate to myeloid cells combined
with the ability to deliver Cre to silently targeted myeloid cells provide powerful
systems for studying the role of specific genes in phagocytosis. Use of these
approaches with integrin av demonstrates that this gene is not essential for apoptotic
cell phagocytosis. However the ability of specific antagonists to inhibit phagocytosis




I hereby declare that this thesis has been composed by myself and has not been
accepted in any previous application for candidature for a higher degree. All work
presented in this thesis was, unless acknowledged, initiated and executed by myself.





I am grateful to the University of Edinburgh Medical School for the funding to
complete this project.
I would like to thank my supervisor and friend Dr Adam Lacy-Hulbert who has been
a great inspiration over the last four years and who has never stopped believing in my
ability or this project.
I would also like to thank Professor John Savill for giving me the opportunity to
work in his laboratory and for is help and guidance during the course of this work.
I must also thank Helen Taylor and Melanie Jackson for their help and guidance on
culturing and differentiating ES cells. Also a special thank you to Aili for all her
technical help in the lab.
Many thanks to past and present members of the lab especially: Murray, Shonna,
Graham and Lorna for their friendship and advice. Lynda for her enthusiasm for this
project and for always listening when things got tough, Mark for things too
numerous to mention and to Tiina who has become a very dear friend.
Special thanks goes to those very close friends who have helped me through the last
year in particular, Morag, Lizzy and Stephen for supplying numerous cups of tea and
always being at the other end of the phone. Kirsty and Jemma for never failing to
entertain me. My flatmate Fiona, for trying to understand what I have been doing for
the last few years even although she wouldn't know where to begin and last but not
least to Julie who truly understands why we do what we do.
Finally, thank you to my family and friends for their continual support and
encouragement during the last few years, for always believing in me and never








p3 Integrin p3 subunit
Ps Integrin p5 subunit
pHl Embryonic Globin
av Integrin av subunit
AdCre Adenoviral Cre
AdGFP Adenoviral Green Fluorescent Protein
ANTp Antennapedia Homeodomain
APC Allophycocyanin
BMDM Bone Marrow Derived Macrophages
BSA Bovine serum albumin
CAT Chloramphenicol acetyltransferase
cDNA Complementary Deoxyribonucleic Acid
CMFDA 5-Chloro-methyl-Fluorescein Diacetate
DC Dendritic Cell
DC av Integrin av disrupted Dendritic Cells
DIA Differentiation Inhibiting Activity






EGFP Enhanced Green Fluorescent Protein
ES cells Embryonic Stem Cells
ES M(J) Embryonic Stem Cell derived Macrophage
FBS Foetal Bovine Serum
FITC Fluorescein isothiocyanate
FSC/SSC Forward Scatter/Side Scatter
G418 Geneticin
GFP Green Fluorescent Protein
GM-CSF Granulocyte-Macrophage Colony-Stimulating Factor
GMFI Geometric Mean Fluorescence Intensity
His tag Histidine Tag






ICAMs Intracellular adhesion molecules
ICM Inner cell mass
IL- Interleukin
IPTG P-D-isopropyl-thiogalactosidase




LIF Leukaemia Inhibitory Factor
LPS Lipopolysaccharide
M-CSF Macrophage Colony-Stimulating Factor
MeC Methylcellulose
MFG-E8 Milk fat globule-EGF-factor 8
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1.1 Origin of macrophages and dendritic cells
Macrophages and dendritic cells (DCs) are highly specialised cells that are involved
in the orchestration of the immune response. Both cell types exist in un-inflamed
tissue at low frequency. However, during inflammation, monocytes, along with
other leukocytes, are recruited at high numbers, and differentiate into macrophages
and DCs. Macrophages combat infection, delete damaged or unwanted resident cells
and orchestrate the ongoing inflammatory response. Macrophages are also thought
to have an important role during the resolution of inflammation, removing dying
cells and promoting tissue repair. DCs exist in inflamed tissue as immature cells,
capable of capture of potential antigen by endocytosis and phagocytosis. DCs then
mature, and migrate to lymph nodes, where they become highly efficient antigen
presenting cells. They become less phagocytic and instead up-regulate adhesion and
costimulatory molecules, initiating immune responses to previously captured antigen
(Mellman and Steinman, 2001).
However this simple model of macrophage and DC function fails to emphasise the
enormous diversity and heterogeneitiy of these cells in vivo. Macrophages and
myeloid DCs arise from a common hematopoietic progenitor, present in foetal liver
and adult bone marrow. Both macrophages and DCs can be grown as relatively pure
and homogeneous populations from blood monocytes or bone marrow cells,
dependent on the addition of the lineage-determining cytokines macrophage colony-
stimulating factor (M-CSF), granulocyte-macrophage colony-stimulating factor
(GM-CSF) and interleukin (IL)-3. Resident macrophages and DCs often adopt
phenotypes specialised to their tissue microenvironment, such as Kupffer cells
(liver), osteoclast (bone), alveolar macrophages (lung), or Langheran's cells (skin).
Recruited monocyte phenotype is also dictated in part by the tissue, but also by the
ongoing immune response. Recruited macrophages are defined as classically
activated or alternatively activated depending on whether the conditioning immune
response is a Th-1 (IL-12 and IL-18) or Th-2 (IL-4 and IL-13) type response
respectively (Gordon, 2003). These activation states result in macrophages that
2
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express very different panels of receptors and other cell surface markers, and that
range from highly cytotoxic, inflammatory to phagocytic, reparative and anti¬
inflammatory cells. Similar differences are seen in DC phenotype, and this is further
complicated by the existence of seemingly fundamentally different DC populations,
myeloid and plasmacytoid DCs. The exact contribution of different DC precursors
(myeloid or lymphoid) to DC phenotypes and of these distinct DCs to the final
immune response is still debated (Shortman and Liu, 2002). However, this is only a
brief overview of the differentiation and activation ofmacrophages and DCs, each of
these cell types also interacts with altered host cells and the implications of this in the
immune response will now be considered.
1.2 Interactions with apoptotic cells
Apoptosis is a highly regulated form of cell death that is important in normal tissue
turnover, embryogenesis, and in the resolution of inflammation (Kerr et al., 1972). It
is characterised by a series of morphological and biochemical changes triggering
responses such as the activation of caspases, moderate increases in intracellular
calcium and reactive oxygen species and reduced glutathione. In contrast to
necrosis, apoptosis is an active process that is distinguished by nuclear condensation,
cell shrinkage and membrane blebbing (McConkey, 1998). In the latter stages of this
process, changes in the molecules on the cell surface allow their swift removal by
phagocytes thereby preventing an immune response.
Early studies showed that recognition and engulfment of apoptotic cells is not
associated with the release of pro-inflammatory mediators (Meagher et al., 1992) and
later work has emphasised that this cell clearance event acts to suppress the immune
response and increase the production of anti-inflammatory cytokines. Voll and
colleagues reported that co-culture of apoptotic cells with Lipopolysaccharide (LPS)
stimulated macrophages resulted in a decrease in production of tumour necrosis
factor alpha (TNF-a), IL-1(3 and IL-12 and an increase in the anti-inflammatory
cytokine IL-10 (Voll et al., 1997). Similar results were later presented by Fadok and
3
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co-workers who also demonstrated suppression of pro-inflammatory cytokines
(including thromboxane B2 and IL-8) although IL-10 secretion was shown to
decrease rather than increase. Production of the anti-inflammatory cytokine
transforming growth factor beta 1 (TGF-pi) was also shown to increase along with
prostaglandin E2 and platelet activating factor and inhibitor studies indicated that
these were acting in an autocrine/paracrine fashion to suppress TNF-a secretion
(Fadok et ah, 1998a). Moreover, suppression of the immune response by
macrophage secretion of TGF-pi following phagocytic clearance of apoptotic cells
has also recently been demonstrated in vivo (Huynh et ah, 2002).
Evidence is now emerging that apoptotic cell uptake can also promote an
inflammatory response. Lorimore and colleagues demonstrated that splenic
macrophages became activated following exposure of mice to ionising radiation and
that this was a consequence of the clearance of apoptotic cells rather than a direct
effect of the radiation (Lorimore et ah, 2001). In addition, apoptotic cell uptake by
macrophages stimulated with LPS has been shown to stimulate the production of
both pro and anti-inflammatory cytokines. Lucas et al. reported increased production
of TNF-a, macrophage inflammatory protein (MlP)-la and MIP-2 in the first few
hours after ingestion of apoptotic cells that was subsequently followed by an increase
in the secretion of TGF-pi that resulted in the inhibition of the TNF-a response
(Lucas et ah, 2003). A possible explanation for the apoptotic cell pro-inflammatory
effect is that the initial secretion of cytokines such as TNF-a may be an important
signal for the recruitment of greater numbers of macrophages to sites where there is a
high number of dying cells (Savill et ah, 2002).
Immature DCs, like macrophages, have been shown to be capable of ingesting
apoptotic cells. Apoptotic cell uptake results in the inhibition of LPS maturation of
DCs, generating mature DCs that have failed to up-regulate the costimulatory
molecule CD86, produce less IL-12 and are less efficient at stimulating T-cell
responses (Stuart et al., 2002). Similar to the macrophage story, ingestion of
apoptotic cells can also promote an immune response. DCs that have ingested
4
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apoptotic cells can cross-present antigen to both CD4 and CD8 T cells providing they
receive the appropriate activation signal (Albert et al., 1998a; Albert et al., 1998b).
Apoptotic cells clearly affect the response of interacting macrophages and DCs, and
appear to promote inflammation, resolution and immune tolerance. What is less
clear is the exact nature of the molecular interactions between the apoptotic cell and
phagocyte.
1.3 Phagocyte recognition mechanisms
The mechanism of phagocytosis of unwanted or dying cells remains a complicated
process in which many receptors, bridging molecules and 'eat me' markers on dying
cells are involved (Fig 1.1) (Savill et al., 2002). Of the 'eat me' signals expressed by
dying cells, phosphatidylserine (PS) is perhaps the most characterised. Exposure of
PS on the outer surface of the apoptotic cell is required for efficient recognition and
engulfment (Fadok et al., 1992). Recently, using phage display, Fadok and
colleagues cloned a gene that when expressed in lymphocytes conferred the ability to
recognise and engulf apoptotic cells, although the exact mechanism by which this
candidate PS receptor mediates recognition is as yet undefined (Fadok et al., 2000).
However, the definition of a prototypical 'eat me' signal and receptor will allow
focused studies of this mechanism of apoptotic cell recognition. The existence of
'don't eat me' signals has also been proposed, expression of the inhibitory receptor
CD31 on the surface of viable cells that normally functions as a 'move away' signal
to the phagocyte becomes disabled upon apoptosis, switching the signal to a more
adhesive one mediating phagocytosis (Brown et al., 2002). Therefore apoptotic cells
could potentially be distinguished from viable cells either by the presence or absence
of cell surface molecules. However, at present the mechanisms by which
macrophages and semi-professional phagocytes do this remains poorly understood.
In comparison, the receptors expressed by the phagocyte are more clearly defined.






















Figure 1.1: Phagocytic recognition mechanisms. Overview of the
recognition molecules, bridging molecules and the 'eat me' signals involved in
the phagocytic uptake of apoptotic cells. Taken from Savill 2002.
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amp2) and CR4 (also known as CD1 lc/CD18 and ax(32) that bind iC3b (Mevorach et
al., 1998), CD14 that interacts with intracellular adhesion molecule (ICAM)-3/CD50
(Devitt et al., 1998; Moffatt et al., 1999), the first component of complement, Clq
(Botto et al., 1998; Taylor et al., 2000), scavenger receptor A (Piatt et al., 1996),
CD36 (Ren et al., 1995) and the tyrosine kinase receptor, Mer (Scott et al., 2001)
among others (Moynault et al., 1998; Ogden et al., 2001; Oka et al., 1998).
The vitronectin receptor (VnR) or avp3 integrin (CD51/CD61) was the first of the
phagocytic receptors to be identified (Savill et al., 1990). Savill and co-workers
proposed a role for this receptor in apoptotic cell uptake when they observed that
phagocytosis was inhibited by monoclonal antibodies to the a/p subunits of the
vitronectin receptor and by the synthetic tetrapeptide RGDS. Subsequently it has
been shown that Thrombospondin 1 (TSP 1), secreted by macrophages binds to both
VnR and CD36 to form a 'molecular bridge' between the phagocyte and the
apoptotic cell to mediate uptake (Fadok et al., 1998b; Savill et al., 1992). In addition
to TSP 1 another bridging molecule for avP3 has been proposed. The milk fat
globule-EGF-factor 8 (MFG-E8) has been shown to be secreted by macrophages and
bind PS on the surface of the apoptotic cell. Once engaged by PS, MFG-E8 strongly
attaches to cells via its RGD motif, in particular through avP3 (Hanayama et al.,
2002). More recently, CD36 and avPs have also been implicated in the phagocytosis
of apoptotic cells by immature DCs suggesting that CD36 may act cooperatively
with both avP3 and avps (Albert et al., 1998a). Furthermore, avP3 has also been
implicated in DC uptake of apoptotic cells (Rubartelli et al., 1997).
However, despite the evidence that integrins are involved in phagocytosis little is





Integrins are a large family of heterodimeric transmembrane receptors that mediate
cell-cell interactions and adhesion to extracellular matrix. These surface receptors
and their ligands are involved in a wide variety of process from development,
hemostasis, immune response and leukocyte trafficking (Fig 1.2)(Hynes, 2002).
Importantly, integrins provide a transmembrane link from the extracellular
environment to the cytoskeleton that in turn, activate many intracellular signalling
pathways.
Integrins are composed of a and P subunits, that each contain a large extracellular
domain (>700 amino acids), a short transmembrane spanning domain and a
cytoplasmic domain of -20-60 amino acids (Travis et al., 2003). These receptors
mediate signalling through the cell membrane in both directions. Binding of ligands
to the extracellular domain transmits signals into the intracellular environment that
influences processes such as gene expression, cellular differentiation and cytoskeletal
organisation (outside-in signalling). Intracellular signals can also be transmitted to
the extracellular domain that results in alterations in the ligand binding affinity of the
integrin and cell adhesion (inside-out signalling). There are many different proteins
that bind to the cytoplasmic tail of the integrin subunits to mediate such changes and
are beyond the scope of this discussion (Liu et al., 2000a). However, some examples
include talin and paxillin that bind some of the (3 subunits (Horwitz et al., 1986;
Schaller et al., 1995), and calreticulin and calveolin-1 that bind a subunits (Rojiani et
al., 1991; Wary et al., 1998). Interestingly, it is not only different proteins that can
affect signalling through the integrin cytoplasmic domains but also the ligation of
other integrins, a phenomenon that has been called integrin crosstalk. In particular,
integrin crosstalk has been implicated in phagocytosis where ligation of avP3 has
been shown to inhibit the phagocytic and migratory functions of asPi through
suppression of calcium/calmodulin-dependent kinase II (Blystone et al., 1994;
Blystone et al., 1995; Blystone et al., 1999). Changes in the intracellular
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environment such as increases in calcium can affect integrin avidity, leading to
clustering of the integrin molecules on the cell surface. The multimerisation of
integrin molecules is important in strengthening the adhesive interaction between
integrins and cellular matrix or other cells. Recently it has been shown that
engagement of FcyR by IgG opsonised beads leads to an accumulation of a.Mp2 in the
phagocytic cup suggesting that integrin avidity is likely to be important in mediating
engulfment of particles and, potentially, apoptotic cells (Jongstra-Bilen et al., 2003).
At present, there are 24 distinct integrins that are composed of 8 a subunits and 18 P
subunits that can be divided into sub-families according to ligand specificity (Fig
1.2)(Hynes, 2002). The P2 integrins are specifically expressed on leukocytes and
mediate binding to endothelial adhesion molecules such as intracellular adhesion
molecules (ICAMs) and vascular adhesion molecules (VCAMs). The P2 integrin
associates with four different a subunits, o.l (CD 11 a, lymphocyte function-
associated antigen-1), ocm (CDlib, Mac-1), ax (CD 11c) and ao- In addition to
binding ICAMs and VCAMs, aMp2 also binds fibrinogen and inactivated
complement (iC3b) and axP2 to type 1 collagen and iC3b (Bouvard et ah, 2001).
The pi family of integrins is expressed on a wide variety of tissues and involved in
many biological processes that range from hematopoiesis, differentiation and
migration to tumorigenesis. The Pi subunit associates with the greatest number of a
subunits, binding ai-10 and av but this is further complicated by the existence of
alternatively spliced pi subunits (A-D). Various extracellular matrix components are
ligands for the pi family of integrins including collagen (ai,a2), laminins (ai, a2, a3,
a6, a7, ac>), fibronectin (a3, a4, as, av) and vitronectin (av) (Brakebusch et ah,
1997).
The most promiscuous a subunit is integrin av as it binds five different P subunits:













Figure 1.2: Integrin receptors. A) Integrins and their ligands are involved in
a wide variety of cellular processes. B) Integrins are composed of a and (3
subunits that from 24 distinct integrins that can be sub-divided according to
their ligand specificity. Taken from Hynes 2002.
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as fibronectin, vitronectin and thrombospondin except for ocvp8 that doesn't bind
vitronectin and avP6 that also binds tenascin-C. The av integrins are expressed on
many different cell types including platelets that also specifically express aIIbP3
(Ginsberg et ah, 1987), macrophages (Savill et ah, 1990), neural cells (Delannet et
ah, 1994), osteoclasts (Vaananen and Horton, 1995) and epithelial cells (Huang et
ah, 1996) and as a result have been implicated in processes such as phagocytosis
(Savill et ah, 1990), angiogenesis (Brooks et ah, 1994), survival (Montgomery et ah,
1994), metastasis (Yun et ah, 1996), wound healing (Clark et ah, 1996) and
migration (Klemke et ah, 1994). As would be expected, due to the diversity of tissue
expression and functions of av integrins the knockout mouse is embryonic lethal
(Bader et ah, 1998). Mice lacking av integrins die, either as a result of pericardial
edema between El0-12 or perinatally from intestinal and intracranial haemorrhaging.
Although the mutation was lethal development was shown to proceed almost
normally in particular vasculogenesis and angiogeneisis continued (Bader et ah,
1998). The phenotype of mice lacking integrin av has hindered further investigation
of the role that these integrins may play in phagocytosis. In the absence of adult
mice lacking integrin av, work undertaken in collaboration with Dr Adam Lacy-
Hulbert has examined the role of P3 and P5 in apoptotic cell phagocytosis by bone
marrow derived macrophages (BMDM). Interestingly, in mice lacking P3, the levels
of phagocytosis were similar to control but no longer inhibitable by the antagonistic
peptide RGDS. In contrast, phagocytosis was inhibited by RGDS in mice lacking P5
(Fig 1.3). Much of the work to date has relied upon the use of blocking antibodies,
peptides, ligand binding and gain of function experiments to determine integrin
involvement in phagocytosis. These experiments highlight the requirement for
macrophages deficient in integrin av in order to gain further insight into the role of
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Figure 1.3: Phagocytosis of apoptotic cells by p3"/_ and p57- deficient
macrophages. RGD inhibits phagocytosis of apoptotic cells in p5"A deficient
macrophages but has no effect in macrophages lacking integrin p3~/~. Data
provided by Dr Adam Lacy-Hulbert.
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1.5 Knockout studies for phagocytic receptors
The majority of genes involved in apoptotic cell clearance in vertebrates have been
defined using specific inhibitors (sugars, RGDS, PS) or antibodies (such as the
blocking antibody 61D3 (Flora and Gregory, 1994) later confirmed to bind CD 14
(Devitt et ah, 1998). However, the role of these receptors has not necessarily been
verified by other methods. Gain-of-function experiments show that expression of
CD36, PSR or avPs can confer increased apoptotic cell phagocytosis ability in 'non¬
professional' phagocytes (Albert et ah, 2000; Fadok et ah, 2000; Ren et ah, 1995),
strongly suggesting that these genes have a direct role in phagocytosis. Knockout, or
'loss-of-function' experiments have also been fruitful. Many knockout mice strains
lacking apoptotic cell receptors have been generated, but clear defects in apoptotic
cell clearance have been reported only in Mer"7" (Scott et ah, 2001), ABC1"7"
(Moynault et ah, 1998), Clq"7" (Taylor et ah, 2000) and CD14"7" (Chris Gregory,
personal communication). Macrophages from mice deficient in SRA (Piatt et ah,
2000) and CD36 (A Lacy-Hulbert, personal communication) show no defect in
apoptotic cell phagocytosis. Real-time PCR data from our laboratory (provided by
Ailiang Zhang) has shown that in the absence of CD36, resident macrophages have
increased expression of integrin P5 messenger RNA (mRNA) and that inflammatory
macrophages (CD36"7"), similar to the SRA"7" macrophages have higher expression of
integrin P3 mRNA relative to BMDM (Fig 1.4). These observations that other
compensatory phagocytic receptors are upregulated in the absence ofCD36 and SRA
and may explain why no apoptotic cell defect is observed in these mice. Furthermore
in integrin P3""/CD91" deficient mice, CD36 appears to be upregulated on smooth
muscle cells and is suppressed by retroviral reconstitution of P3 (Weng et ah, 2003)
indicating that these receptors are compensating in the absence of one another.
More striking is the observation that many of these knockout mice show little or no
ill effect from defective apoptotic cell clearance. Development is generally normal,
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Figure 1.4: Receptor expression in CD36 '" and SRA /_ macrophages.
Phagocytic receptor expression profiles for macrophages from CD36 and




Mer_/" mice show an over-responsive immune system, and develop autoimmunity, but
it is unclear whether this is due to a defect in apoptotic cell clearance or a lack of the
strong anti-inflammatory signalling through the Tyro-Axl-Mer kinase family. One of
the better- characterised knockouts is the Clq" mouse. These mice show defective
apoptotic cell clearance in inflamed sites, and develop autoimmunity with persistence
of apoptotic cells in the kidney. However, autoimmunity only develops on
susceptible backgrounds, suggesting that other factors play a role.
Normal apoptotic cell clearance in mice deficient in SRA and CD36, despite the
evidence for the involvement of these molecules by antibodies, inhibitors or
transfection experiments emphasises the need for knockout experiments to
complement other studies. How can this be done for genes that have many roles in
the organism, and result in lethal phenotypes when deleted? This thesis explores two
strategies to study these genes in in vitro experiments:
1. To generate macrophages/DCs from genetically altered stem cells.
2. To conditionally delete genes in mature macrophages.
1.6 Embryonic Stem cells
The unique properties of Embryonic Stem (ES) cells have made them invaluable in
understanding how genes function in vivo. They can be maintained as totipotent cells
in culture, and genetic alterations readily carried out by homologous recombination.
Modified cells can then be differentiated in vitro, or re-introduced into blastocysts
contributing to all adult tissues. They therefore provide an excellent system for
deleting genes and studying the consequences in isolated cell types or the whole
animal.
ES cells were first isolated in 1981 (Evans and Kaufman, 1981; Martin, 1981) and
the methods used to derive these pluripotent cells, to date, remain relatively
unchanged (Robertson, 1987). Pre-implantation blastocysts are plated intact onto a
feeder layer and several days later the inner cell mass (ICM) cells disaggregated and
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plated onto fresh feeder layers. These cells then give rise to colonies of
undifferentiated cells and various differentiated cell types. The undifferentiated
colonies can be picked, dissociated and expanded in culture to generate continuous
ES cell lines. The pluripotency of these cells was confirmed by their ability to
differentiate into various cell types when cultured in the absence of feeder layers and
to form teratomas when re-introduced into mice (Evans and Kaufman, 1981). More
recently, it has been shown that ES cells originate from the epiblast or primitive
ectoderm. Isolation of early epiblasts yielded ES cells at higher frequency than
culture of intact blastocysts and allowed the derivation of ES cell lines not only from
the 129 strain of mice but also from non-permissive strains such as CBA (Brook and
Gardner, 1997). Perhaps one of the most remarkable features of ES cells is that after
long-term culture and manipulation in vitro, they remain capable of contributing to
the germ line following their incorporation into chimeric mice (Bradley et ah, 1984).
1.7 Self-renewal of ES cells
ES cells can be routinely expanded in culture to generate relatively homogeneous
populations of undifferentiated cells and unlike other primary cells they appear to be
immortal showing no signs of crisis or senescence (Smith, 2001). Co-culture of ES
cells with a feeder layer was initially thought to be essential for the maintenance of
undifferentiated ES cells. Subsequently, it was discovered that conditioned media
from buffalo rat liver cells containing a factor with differentiation-inhibiting activity
(DIA) could be substituted for feeder cells (Smith and Hooper, 1987). Fractionation
of this conditioned media identified the cytokine Leukaemia Inhibitory Factor (LIF)
to be sufficient for the inhibition of ES cell differentiation (Smith et ah, 1988a;
Williams et al., 1988). In addition, feeder layers also express LIF that is produced in
response to paracrine signalling from co-cultured ES cells (Rathjen et ah, 1990). LIF
supports self-renewal of ES cells by engaging the heterodimeric receptor complex
that consists of the LIF receptor and the ubiquitous receptor gpl30 (Davis et al.,
1993; Yoshida et al., 1994). Signalling through this complex activates Janus
associated tyrosine kinases (JAK) that phosphorylate and bind proteins containing
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Src homology 2 (SH2) domains (Burdon et al., 2002). The signal transducer and
activator of transcription (STAT) factors bind the phosphorylated JAK kinases and it
has been shown that activation of STAT 3 in this way is essential for the self-renewal
of ES cells (Niwa et ah, 1998).
Oct-3/4 has also been shown to play an important role in self-renewal and in the
differentiation and de-differentiation of ES cells (Niwa et al., 2000). Oct-3/4 is a
member of the POU family of transcription factors and is expressed by pluripotent
cells during embryogenesis and also by ES cells (Pesce et al., 1999). Manipulation
of this transcription factor in ES cells showed that a reduction in Oct-3/4 expression
caused ES cells to de-differentiate towards trophectoderm and overexpression
towards differentiation to the endoderm and mesoderm lineages. It has been
proposed that in part, Oct-3/4 may act as a 'gatekeeper' that prevents de-
differentiation of ES cells to trophectoderm thereby maintaining the pluripotency of
the ES cells (Niwa et al., 2000). In the same study it was also found that cells
expressing the Oct-3/4 transgene were dependent on LIF and upon withdrawl of the
cytokine differentiated in the normal manner. Therefore it has been suggested that
both intrinsic expression of Oct-3/4 and the activation of STAT 3 by LIF are required
to maintain the pluripotent ES phenotype (Smith, 2001).
Just recently, a third factor involved in the pluripotency of ES cells has been
described (Chambers et al., 2003; Mitsui et al., 2003). The homeoprotein, Nanog,
was identified through functional library screening and digital differential display
comparing EST libraries from mouse ES cell and various somatic tissues. Deletion
of Nanog resulted in the loss of pluripotency in ES cells and in the ICM (Mitsui et
al., 2003) and seems to maintain pluripotency independently of LIF/gpl30
(Chambers et al., 2003). Identification of the interactions of this homeoprotein with




1.8 ES cell differentiation
ES cells spontaneously differentiate in the absence of LIF and upon the removal of
feeder support (Evans and Kaufman, 1981; Martin, 1981; Robertson, 1987). Cystic
embryoid bodies (EBs) are formed and differentiation closely mimics that of the
developing embryo where heart and blood cell-containing structures similar to the
visceral yolk sac develop (Doetschman et al., 1985). When left in culture for longer
(> 12 days) further differentiation occurs, leading to the formation of mesoderm
derivatives (Robertson, 1987). In addition, ES cell differentiation can also be
induced using retinoic acid and 3-methoxybenzamide (Smith, 1991) and it appears to
possibly play a role in biasing differentiation towards cells of the neuronal lineage
(Bain et ah, 1995; Strubing et ah, 1995).
Many different cell lineages have been produced using various methods of
differentiation, some of which are summarised in table 1.1. At present there is no
way to generate pure populations of a specific cell type through the differentiation of
ES cells although several approaches have been used to enrich for the cell type of
choice. Perhaps, one of the most widely used approaches is to culture the
differentiated cells in cytokines appropriate for the cell type of interest. Wiles and
Keller were the first to describe the defined culture conditions that allowed the
differentiation of ES cells to hematopoietic cells (Wiles and Keller, 1991). Using the
appropriate culture conditions it was demonstrated that hematopoietic cells could be
enriched for and expanded in culture for a period of weeks. This method has been
used extensively to generate cells of the hematopoietic system either by inducing EB
formation in methylcellulose or suspension culture (Fairchild et al., 2000; Tsai et al.,
2000; Wiles and Keller, 1991).
A second method that has been used successfully for the generation of myeloid cells,
other than macrophages, is to differentiate ES cell upon a stromal cell layer either in
the presence or absence of cytokines (Nakano et al., 1994; Potocnik et al., 1997). In
particular, this approach has been used to generate lymphoid precursors that can give
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rise to B cells and more recently has been used to generate dendritic cells (Senju et
al., 2003).
Table 1: Summary of cell types differentiated from ES cells.





Yolk sac endoderm Suspension (Doetschman et al., 1985)
Yolk sac mesoderm Suspension (Doetschman et al., 1985)
Definitive hematopoietic Methylcellulose + cytokines (Wiles and Keller, 1991)
Lymphoid Stromal layer (Nakano et al., 1994)
Lymphoid precursor Suspension (Potocnik et al., 1997)
Dendritic cell Suspension + cytokines (Fairchild et al., 2000)
Dendritic cell Stromal + cytokines (Senju et al., 2003)
Endothelial cell Plated on collagen (Yamashita et al., 2000)
Cardiomyocyte Hanging Drop (Maltsev et al., 1993)
Adipocyte Suspension + retinoic acid (Dani et al., 1997)
Neuronal Suspension + retinoic acid (Bain et al., 1995; Strubinget al., 1995)
Oligondendrocyte Suspension + cytokines (Liu et al., 2000b)
Mast cells Methylcellulose + cytokines (Tsai et al., 2000)
A third approach of selecting a particular population of cells is to generate ES
carrying a selection marker under the control of a promoter specific to the cell type
of interest. The first report using this method came from Klug et al who
differentiated ES cells carrying the a-cardiac myosin heavy chain fused to the neo
gene that allowed the selection of cardiomyocytes when the differentiated cells were
cultured in geneticin (G418) (Klug et al., 1996). Subsequently, this method was used
to generate purified neural precursors using the lineage-restricted marker Sox-2 fused
the /3-geo gene which not only served as a selection marker but also as a reporter (Li
et al., 1998). Billon et al have further refined this approach by using ES cells
expressing Sox-2 fused to the y3-geo gene to positively select for the neural precursor
cells and Oct-4 fused to the hygromycin-thymidine kinase gene to negatively select
for undifferentiated cells. This resulted in an increase in the purity of the neural
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precursor cells that were then further differentiated into oligodendrocytes (Billon et
ah, 2002). However, this approach is limiting in cell types where several subsets of
cells arise from the lineage-restricted markers such as in the hematopoietic system,
although a recent report has described enhanced hematopoietic differentiation of ES
cells conditionally expressing STAT 5 (Kyba et al., 2003). Moreover it appears that
generating pure populations of specific cell types may rely on the genetic
manipulation of lineage-restricted markers and transcription factors and with the
further delineation of specific pathways that govern the development of different cell
types this approach will most certainly be exploited in the future.
Therefore, differentiation of ES cells in the presence of conditioning cytokines such
as M-CSF or GM-CSF can be used to generate populations of myeloid cells.
Coupling this system to genetic manipulation of ES cells would provide an ideal
system for the production of genetically modified phagocytes, avoiding the need to
generate 'knockout' mice.
1.9 Gene targeting in ES cells
However, the most powerful use of ES cells is the generation of genetically modified
or 'knockout' mice. Homologous recombination allows the insertion of foreign
DNA into the genome between two arms of homologous DNA. Using a replacement
vector, chromosomal sequences can be replaced by the vector sequences by two
reciprocal recombinations involving the flanking regions of homologous DNA. The
first successful example of this was achieved using the selectable hypoxanthine
phosphoribosyl transferase (HPRT) gene locus (Doetschman et al., 1987; Thomas
and Capecchi, 1987). Gene targeting is this way causes complete deletion of the
gene. However, as discussed above, this may result in a severe phenotype and
embryonic lethality making it impossible to assess the gene function in vivo. These
obstacles have been overcome by conditional gene targeting, using the
bacteriophage-derived CrdLoxP recombination system that has been shown to be
applicable both in vitro (Sauer and Henderson, 1988) and in vivo (Lakso et al., 1992;
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Orban et al., 1992). The Cre recombinase of the bacteriophage PI recognises a 34bp
consensus sequence called LoxP (Hoess et ah, 1982; Sternberg et ah, 1981). The
LoxP motif consists of a core spacer sequence of 8bp and two 13bp palindromic
flanking sequences. A single recombinase molecule binds each palindromic
sequence of the LoxP site and mediates recombination within the spacer region to
bring the LoxP sites together. The core spacer sequence defines the orientation of the
LoxP site: if a segment ofDNA is flanked by two LoxP sites in the same orientation,
Cre excises the intervening segment of DNA leaving a single LoxP site behind (Fig
1.5a). Two LoxP sites in opposite directions allow the intervening DNA to be
inverted (Fig 1.5b).
Target genes can be modified by homologous recombination in ES cells so that LoxP
sites flank the gene or gene segment of interest. Importantly, when these ES cells are
used to generate targeted mice the gene of interest is 'silently targeted' and functions
normally. Targeted mice can then be crossed with mice expressing Cre in the tissue
of interest allowing manipulation of the gene in a cell type specific manner that is
known as conditional gene targeting. Conditional gene targeting, first demonstrated
by Gu and co-workers, used mice that contained the promoter and the first exon of
the DNA polymerase p gene {polfi) flanked with loxP sites. When crossed with mice
that specifically expressed Cre in T cells the polp gene was inactivated in the T cell
population only (Gu et ah, 1994). This powerful strategy has revolutionised gene-
targeting approaches. There are many Cre expressing mice available such as the
CD19-Cre mouse that allows tissue specific deletion in B cells (Rickert et ah, 1997).
Partial gene inactivation can be obtained using the 'balancer' strain that expresses
Cre under the control of the nestin gene (Betz et ah, 1996) and a Cre transgenic
strain, called 'deleter' mediates deletion in all cells including the germ cells (Lakso
et ah, 1992; Schwenk et ah, 1995). However, this system relies upon the
identification of tissue specific promoters that can limit its potential. Temporal
control over Cre can also be achieved by induction either at the transcriptional level
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Figure 1.5: Cre/LoxP recombination. Cre recombinase mediates the
deletion of intervenening segments of DNA flanked by two LoxP sites that are




or at the post-translation level using inducers such as tetracycline (Gossen and
Bujard, 1992) or tamoxifen (Metzger et al., 1995a) whereby Cre expression can be
activated by administration or withdrawl of the inducing agent.
Cre can also be delivered to cells by exogenous application, such as a virus or
purified protein. Adenovirus expressing Cre recombinase (Anton and Graham,
1995a) has been used for the efficient transfection of a variety of cell types in vitro
(Hoves et ah, 2003; Prost et ah, 2001a). Parts of the viral genome are replaced with
the Cre recombinase gene generating a replication deficient virus that is still capable
of host infection. This is a highly efficient method of transfection and is particularly
attractive for hematopoietic cells such as macrophages as they are heterogenous,
making the identification of good unique, active, tissue-specific promoters difficult.
More recently however, the properties of a number of viral derived peptides have
exploited for the cellular delivery of proteins and macromolecules thus providing an
alternative delivery method to adenoviral mediated gene transfer.
1.10 Cell-penetrating peptides
The cell membrane is inherently impermeable to macromolecules that lack
specialised membrane receptors or transport proteins. Generally most proteins or
peptides are internalised through receptor mediated endocytosis or uptake by
transporters. In the past few years there has been an increasing number of peptide
sequences reported to cross the cell membrane and deliver 'cargo' proteins to the
intracellular environment. These sequences are usually termed "cell-penetrating
peptides" or "protein transduction domains". Three peptide sequences in particular
HIV-TAT, the Antennapedia homeodomain and the Herpes Simplex virus protein
VP22 have been well characterised for the delivery of a variety of different proteins
although several other peptides with similar capabilities exist eg, SN50 (Lin et al.,
1995), pep-1 (Morris et al., 2001). The ability of the HIV-TAT protein to cross the
cell membrane was first reported in 1988 by Frankel & Pabo (Frankel and Pabo,
1988). TAT is a transcription-activating factor that is 86 amino acids in length and is
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involved in the replication of HIV. Frankel & Pabo demonstrated the cellular
permeability of TAT by delivering the purified peptide to cells containing the
reporter gene chloramphenicol acetyltransferase (CAT) that was under the control of
the HIV-1 long terminal repeat. When the TAT peptide entered the cells it resulted
in an increase in the expression of CAT from the HIV-1 promoter. Subsequent
studies using truncated versions of the TAT peptide have demonstrated that residues
37-72 and 48-60 are involved in the translocation of the peptide although the
truncated version containing residues 48-60 appears to be more efficient (Fawell et
ah, 1994; Vives et ah, 1997).
The Antennapedia homeodomain (ANTp) has also been shown translocate across the
cell membrane (Derossi et ah, 1994). This specific sequence of 60 amino acids in
length is composed of three a helices with one (3 turn between helices 2 and 3.
Derossi et al. have produced several mutant versions of this homeodomain and
classified their ability to enter cells in culture. Deletion of a tryptophan and a
phenylalanine residue within the third a helix resulted in the loss of translocation
indicating that the third helix was responsible for cell membrane permeability
(Derossi et ah, 1998). A 16 amino acid peptide between residues 43-58 has been
shown to be the minimal unit required to cross the cell membrane and is also known
as pentratin-1.
The most recently described cell-penetrating peptide is VP22, a DNA binding protein
from the Herpes Simplex virus type 1. While investigating the properties of the
structural proteins that make up the tegument region of the virus Elliot and co¬
workers discovered the intercellular trafficking properties of VP22 (Elliott and
O'Hare, 1997). The last 34 amino acids of this protein have been shown to be critical
for the cell permeability of this protein, the properties of which are discussed in
greater detail in chapter 5.
It is currently unknown how each of these peptides cross the cell membrane.
Translocation of each of these peptides has been shown to be energy independent and
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therefore does not involve classical receptor mediated endocytosis (Derossi et al.,
1994; Elliott and O'Hare, 1997; Vives et al., 1997). However, it is not clear if each
of these peptides use the same mechanism of cellular entry or not. Comparison of
the sequences (Table 1.2) has shown that each peptide is rich is arginine and lysine
amino acids rendering them highly basic and it is thought that this may be important
for contact with the negatively charged lipids of the cell membrane, mediating
cellular entry (Schwarze et al., 2000).
Table 1.2: Comparison of amino acid sequences of characterised cell-permeable
peptides PTD, protein transduction domain. Taken from Schwarze, 2000.





The one major difference between each of the peptides described is the size of the
'cargo' that can be delivered to cultured cells. The ANTp homeodomain in
particular, appears to be capable of only transducing proteins of less than 100 amino
acids in length (Derossi et al., 1998). However, both the TAT and the VP22 peptides
have been implicated in the delivery of much larger proteins such as P-galactosidase,
green fluorescent protein (GFP), p53, and the inhibitor protein p27kipl (Brewis et al.,
2000; Fawell et al., 1994; Nagahara et al., 1998; Phelan et al., 1998). Moreover the
TAT and VP22 peptides retain the ability to be exported from one cell and taken up
by a neighbouring cell although spread of the VP22 fusion proteins appears to be
greater than for TAT fusions (Elliott and O'Hare, 1997; Ensoli et al., 1993). Another
property that is shared between these peptides is that they are all delivered to the
cytoplasm and the nucleus of the transduced cell (Derossi et al., 1998; Elliott and
O'Hare, 1997; Vives et al., 1997) in the absence of any other additional transfection
reagents, making them ideal for investigating cellular responses where traditional
transfection methods are insufficient or undesirable. Primarily these peptides have
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been used to deliver functional proteins to the intracellular environment but are being
increasing used in conjunction with viral delivery vectors to evaluate their potential
for therapeutic gene delivery. At present, VP22 and ANTp have been fused to
replication deficient adenoviral and lentiviral vectors and their ability to deliver
proteins both in vitro and in vivo examined (Gratton et al., 2003; Lai et al., 2000;
Wills et al., 2001). These viral/peptide fusions appear to enhance viral cell entry and
improve gene expression at lower titres of virus and increase the distribution of the
delivered proteins. Therefore indicating that cell-permeable peptides may, in the
future play a role in the efficient delivery of gene therapy vectors.
1.11 Aims
The aim of this project was to generate genetically altered myeloid cells to determine
the function of key genes in apoptotic cell phagocytosis. Integrin av was chosen,
principally because of the difficulty in obtaining an integrin av knockout by
conventional methods. Two approaches were used:
1. Genetically modified ES cells were differentiated to macrophages and
dendritic cells.
2. Cre was delivered to macrophages cultured from mice carrying a "floxed"





Chapter 2: Materials and Methods
2.1 Embryonic Stem cell culture
Embryonic stem cell culture reagents that were routinely used are listed in appendix
I.
Three ES cell lines were used during the course of this work. The EFC-1 ES cells
used for the initial differentiation cultures and the CP1 ES cells used for titrating the
LIF activity were kind gifts from Professor Austin Smith, University of Edinburgh.
The E14 ES cell line (used previously by Dr Adam Lacy-Hulbert for the targeting of
the integrin av gene) and E14 ES cells carrying a disrupted integrin av gene were
used in the differentiation studies.
2.1.1 Preparation ofmitotically inactivated feeder layers
STO fibroblasts were cultured in ES cell medium lacking LIF. The cells were grown
in 162cm2 tissue culture flasks at 37°C in a 5% CO2 humidified incubator. Once
confluent, one flask was trypsinised and sub-cultured to maintain growing stocks and
a second flask was used to prepare STO feeder plates for ES cell culture. Mitomycin
C was made as a stock solution of lmg/ml with sterile PBS. Confluent monolayers
were treated with Mitomycin C at a final concentration of lOpg/ml in culture
medium for 2-3 hours at 37°C. During this time 6cm tissue culture dishes were
treated with 0.1% gelatin for at least 30 minutes. The cells were then washed three
times with phosphate buffered saline (PBS), trypsinised and plated into 6cm culture
dishes at a density of 1.2xl06 cells per dish. The fibroblasts were allowed to adhere
to the surface of the dishes for at least 2 hours before ES cells were added
2.1.2 Leukaemia inhibitory factor conditioned media
LIF conditioned media was produced by transfecting cells with the pCAGGSLIF
plasmid (a kind gift of Prof Austin Smith, University of Edinburgh). 5xl06 COS-7
cells were electroporated (EQUIBIO electroporator, Flowgen) with a double pulse of
750V/25pF followed by 100V/1500pF and 20pg of pCAGGSLIF plasmid
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(Appendix II). The cells were then cultured for four days and the supernatants
harvested, filter sterilised and stored at-20°C in 0.5ml aliquots.
The CP1 ES cell line was used to titrate the LIF activity. The ES cells were plated
onto gelatinised 24 well plates at density of 104 cells per well. The LIF conditioned
media was then added at various dilutions ranging from 1:100 to 1:500,000 with one
well containing no conditioned media and one containing LIF of a known activity.
The plates were incubated for 4 days and the cells fixed and stained with Leishman's
stain for 5 minutes. Prior to examination under a light microscope the cells were
washed with FLO and left to air dry. The stem cells appeared as small round
colonies of tightly packed cells that were intensely stained whereas the differentiated
cells formed larger spread out colonies with diffuse staining (Fig 2.1). Typically,
stock conditioned media diluted 1:1000 was sufficient for maintaining ES cells in an
undifferentiated state.
2.1.3 Routine culture ofEmbryonic Stem Cells
ES cells were routinely cultured on gelatin-coated plates or on mitotically inactivated
STO fibroblasts in a humidified 37°C incubator with 5% CO2. Tissue culture dishes
(6cm) were treated with 0.1% gelatin for at least 30 minutes prior to use. ES cells
were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with
15% foetal bovine serum (FBS), 4500mg glucose, lOmM sodium pyruvate, 1% non¬
essential amino acids, 2mM L-glutamine and 10"4M P-mercaptoethanol. Leukaemia
inhibiting factor (LIF) was added at a 1:1000 dilution of stock conditioned media.
ES cells were grown until approximately 80% confluent (48-72 hours after plating).
The medium was removed and the monolayer washed twice with IX mouse tonicity
phosphate buffered saline (mtPBS). 1ml of 0.05% trypsin-diaminoethanetetra-acetic
acid (EDTA) solution was added to the monolayer and incubated at 37°C, once the
cells had detached culture medium was added to quench the trypsin. The cell
suspension was then counted and centrifuged at l,000rpm for 5 minutes and the cells
resuspended and plated at a density of lxlO6 cells per dish.
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CP1 ES cells cultured in the absence of LIF
CP1 ES cells cultured in the presence of LIF
Figure 2.1:LIF titration. LIF conditioned media was titrated using the CP1
ES cell line. Cells cultured in the absence of LIF differentiated and showed
diffuse staining with Leishman's stain whereas in the presence of LIF the ES
cells grew in tightly packed colonies and showed intense staining.
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2.1.4 Differentiation of Embryonic Stem cells
Prior to differentiation ES cells that had been grown on feeder layers were plated
onto gelatin coated plates and passaged twice before use. The basic differentiation
protocol is as outlined in figure 2.2 however, several conditions were optimised as
indicated in chapter 4. EBs were formed by plating ES cells into bacterial grade
Petri dishes in differentiation media composed of Iscoves, 0.9% MeC unless
otherwise stated, 10% FBS (appendix I), 340pM monothioglycerol, 10pg/ml insulin,
10% L929 or GM-CSF conditioned media (Section 2.1.5 &6), recombinant murine
IL-3 at concentrations stated in text, 2mM L-glutamine, lOOU/ml penicillin and
100pg/ml streptomycin. 300-1000 ES cells were plated per dish depending on the
cell line used and the cultures placed at 37°C in a 5% CCF incubator for 14 days.
After 14 days EBs were disrupted by incubation in a solution of 0.25% collagenase,
20% FCS and PBS at 37°C for 1 hour with gentle agitation. The EBs were then
passed through a 21 gauge needle three times to allow dissociation to a single cell
suspension. The cells were then plated onto tissue culture dishes in differentiation
medium lacking MeC. Differentiated progeny appeared 2-3 weeks later and the
cultures were fed as required.
2.1.5 L929 conditioned media
L929 mouse fibroblast cell line was cultured in DMEM/F12 supplemented with 10%
FBS, lOOU/ml penicillin and 100pg/ml streptomycin. Cells were routinely sub-
cultured at 1/30 twice a week. To harvest M-CSF containing supernatant cells were
grown until confluency and left for a further 4 days. Media was then harvested,
sterile filtered and aliquots stored at -80°C.
2.1.6 GM-CSF conditioned media
The GM-CSF hybridoma cell line was a kind gift from Professor David Gray,
University of Edinburgh. Hybridoma cells were cultured in RPMI supplemented
with 5% heat-inactivated FBS, lOOU/ml penicillin, lOOpg/ml streptomycin, 2mM L-
glutamine and 10" M [3-mercaptoethanol. Cells were selected in media containing
G418 at a concentration of lmg/rnl and maintained at a concentration of 7.5-40x104
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ES cells cultured on gelatin coated plates to
eliminate contaminating feeder cells
ES cells cultured in bacterial grade petri
dishes in Methyl Cellulose (MeC)
supplemented with: 10%FCS, 10% L929




emerge from embryoid bodies
i
Day 14 embryoid bodies are either plated or
disrupted by incubation in
0.25%collagenase/10%FCS/PBS for 1 hour. EB are
then passaged through a 21 gauge needle six
times. Cells are counted and plated directly onto
either tissue culture or bacterial grade Petri dishes.
Embryoid body-derived cells are then analysed for:
Morphology Surface Phenotype Gene Expression
Figure 2.2: Overview of the ES cell differentiation protocol. ES cells
were differentiated for 14 days in methylcellulose supplemented with the
appropriate cytokines to drive differentiation towards cells of the myeloid
lineage. At day 14 the EBs were either plated or disrupted and the
differentiated cells expanded in culture for ~21 days before analysis of
morphology, surface phenotype and gene expresssion.
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cells/ml by passaging at 1:3 three times per week. To harvest the supernatant, cells
were washed three times and resuspended in media lacking geneticin (G418) at a
density of 30-40x104 cells/ml in 20mls and placed in a 162cm2 flask. Cultures were
grown for a further 4-5 days until the cells were dense (0.75-lxl06 cells/ml) but the
media not exhausted. The supernatant was then collected by centrifugation, and
aliquots stored at -80°C.
2.1.7 Flow cytometry
All antibodies were purchased from Pharmingen unless otherwise stated and the
following primary conjugated antibodies used: F4/80-APC (Clone CI:A3-1 Caltag),
F4/80-PE (Clone CI:A3-1 Caltag), F4/80-FITC (Clone CI:A3-1 Serotec) CDlla-PE
(Clone 2D7), CDllb-PE (Clone Ml/70), CDllc-APC (Clone ML3), CDllc-PE
(Clone ML3), CD14-PE (Clone rmC5-3), CD40-PE (Clone 3/23), CD54-PE (Clone
3E2), CD80-PE (Clone 16-10A1), CD86-PE (Clone GL-1), I-Ab-FITC (Clone AF6-
120.1) and GR-l-PE (RB6-8C5).
Cells were harvested, washed in PBS and resuspended in flow buffer (appendix I)
before blocking in 10% mouse serum for 20 minutes. Cells were then labelled with
antibodies at final dilution of 1:150, on ice and in the dark for 1 hour. Unbound
antibody was washed off with flow buffer and the cells pelleted by centrifugation at
330g for 3 minutes. The cells were then resuspended in 200pl of flow buffer and
analysed using FACSCalibur (Becton-Dickinson) and FlowJo® software. All
samples were compared to the relevant isotype control.
2.1.8 Immunofluorescence (ES derived cells)
ES derived cells were fixed with 4% paraformaldehyde for 20 minutes and washed
with PBS. Cells were blocked in 10% mouse serum before staining with 1:1000
dilution of phycoerythrin conjugated F4/80 and FITC conjugated CD lib
(Pharmingen).
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2.1.9 ES DC maturation
ES DCs were harvested by gentle washing and re-plated into fresh tissue culture
plates containing differentiation medium for 2-3 hours. Cultures were then
stimulated with lpg/ml LPS for 24 hours. The following day the non-adherent cells
(mature DCs) were collected by centrifugation (lOOOrpm, 5 minutes), plated into
fresh differentiation media (no LPS) and cultured for a further 48 hours. Lresh media
was also added to the culture dishes that had been stimulated allowing more mature
DCs to be harvested.
2.1.10 Phagocytosis assays
2.1.10.1 Isolation ofhuman neutrophils
Human neutrophils were isolated on my behalf by various members of the
laboratory. Human neutrophils were extracted from peripheral blood of healthy
volunteers as described previously (Haslett et al., 1985). Blood was drawn into
citrated 50ml falcon tubes and spun at 350g for 20minutes. Plasma was removed and
6mls of 6% dextran added to the remaining fraction. Tubes were inverted and
allowed to sediment for 20minutes. During this time a Percoll (Amersham,
Buckinghamshire, UK) gradient was prepared. 100% Percoll was made to 90% by
the addition of 4ml of 10XPBS to 36mls 100% Percoll. Using this 90% Percoll
gradients were made from fractions containing 79%, 68% and 55% Percoll by the
addition of 1XPBS without Ca2+/Mg 2+. 2.5mls of the 68% fraction was overlayed
onto 2.5mls of the 79% fraction in a 15 ml falcon tube. The leukocyte-enriched
fraction was harvested from the top layer after the dextran sedimentation of the blood
and pelleted at 350g for 6 minutes. The pellet was resuspended in 2.5mls of the 55%
Percoll, overlayed onto the pre-made gradient and centrifuged at 720g for 20
minutes. Peripheral blood mononuclear cells (lymphocytes and monocytes) were
harvested from the top interface and neutrophils from the bottom interface. Cells
9+ 9+
were washed twice in PBS without Ca /Mg before use. This yielded highly pure
human neutrophils (>90%). Autologous serum was made by clotting 10ml of plasma
in glass tubes by the addition of 200pl of 1M CaCh at 37°C.
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2.1.10.2 Generation ofapoptotic neutrophils (PMNs)
Human neutrophils were allowed to undergo constitutive apoptosis by aging
overnight in Iscoves medium supplemented with lOOU/ml penicillin, lOOpg/ml
streptomycin and 10% autologous serum. Prior to overnight aging, cells were
stained using a green cell tracker dye (5-chloromethylfluoreescein diacetate,
CMFDA, Molecular Probes, Leiden Holland) at a density of 20x106 cells/ml in
serum free Iscoves plus lOpl of 2mg/ml CMFDA for 15 minutes at 37°C. Cells were
then diluted to 4xl06 cells/ml in Iscoves with autologous serum. After aging cells
were 40-80% apoptotic as assessed by cytospin morphology.
2.1.10.3 Flow basedphagocytosis assay
Flow cytometry based phagocytosis assays: ES derived myeloid cells were incubated
with fluorescently labelled apoptotic cells at a ratio of ~4:1 apoptotic cells: ES
derived cells for 30 minutes or 2 hours. Assays were carried out either by adding
apoptotic cells to the culture plates or performed in U-bottomed 96 well plates.
Myeloid cells were counterstained with F4/80-PE or APC before flow cytometry
analysis. Phagocytosis gates were set by comparing labelled cells in the absence of
apoptotic cells with cells that had interacted with apoptotic cells at 37°C (gating
described in grater detail in chapter 3). Some phagocytosis studies were carried out
in the presence of the inhibitory peptide GRGDSP (Gly-Arg-Ala-Asp-Ser-Pro) or the
control peptide GRADSP (Gly-Arg-Gly-Asp-Ser-Pro) at 0.5mg/ml. Cells were
incubated with inhibitory peptide during the interaction with apoptotic cells. Cells
were then analysed as described above.
2.1.11 Magnetic cell sorting of differentiated cells
Differentiated cells were removed from the culture plates by gentle washing with
culture media. Cells were then harvested by centrifugation, re-suspended in MACS
buffer (appendix I) and incubated with CD1 lb PE antibody at 1:50 dilution for 15
minutes at 4°C. Cells were washed twice with MACS buffer and 107 cells
resuspended in 80pl of MACS buffer plus 20pl of MACS anti-PE Microbeads
(Miltenyi Biotec) and incubated at 4°C for 15 minutes. Following labelling with
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magnetic beads the cells were washed in MACS buffer and applied to a positive
selection column (Miltenyi Biotec). Both the retained fraction (macrophages) and
the flow through were collected and plated in culture. Before plating, the cells in
each fraction were analysed by flow cytometry for the surface marker F4/80 as
described previously.
2.1.12 Genomic DNA isolation
Genomic DNA (gDNA) was extracted from ES cells by resuspending approximately
107 cells in 3mls of lysis buffer (appendix I) before incubation at 55°C overnight.
The DNA was precipitated with 6mls of cold ethanol containing 900pl of 5M NaCl
and incubated at room temperature for 15 minutes. The DNA was then centrifuged
at 2000rpm for 10 minutes and the DNA transferred to a clean tube containing 1.5ml
of 70% ethanol using a yellow tip (DNA strands were rolled around tip). The DNA
was then transferred to a clean tube containing 500pl of TE buffer and incubated at
37°C overnight.
PCR amplification was performed on genomic DNA using integrin av primers 4f6
(ggtgactcaatgtgtgaccttcagc) and 5b3 (cacaaatcaaggatgaccaaactgag). The cycle
parameters were: 1 cycle of 96°C for 5 minutes followed by 40 cycles of 94°C for 30
seconds, 64°C for 30 seconds, 74°C for 1 minute and 1 cycle of 74°C for 5 minutes.
2.1.13 RNA isolation
RNA was extracted using the Trizol method (Life Technologies). Typically cells
were resuspended in Trizol at a concentration of 106 cells per ml and frozen at -80°C
until required. RNA was isolated by incubating the samples at room temperature for
5 minutes followed by the addition of 0.2ml chloroform per 1ml of Trizol. Samples
were gently inverted and centrifuged at 12000g for 15 minutes, 4°C. The clear
aqueous phase was removed and the RNA precipitated by the addition of 0.5ml
isopropanol per 1ml of Trizol. Samples were incubated for 10 minutes at room
temperature and then centrifuged at 12000g for 10 minutes at 4°C. The RNA pellet
was washed with 75% ethanol and centrifuged at 7500g for 5 minutes at 4°C. After
36
Chapter 2: Materials and Methods
air- drying the pellet RNA was dissolved in RNAse free water at 20pl per 1ml of
Trizol. Contaminating DNA was removed by treatment with RNAse free DNAse
and the concentration and purity determined by measuring the absorbance at
260/280nm.
2,1.14 cDNA synthesis
Complementary DNA (cDNA) synthesis was performed using Superscript™ (Life
technologies), lpg of total RNA was added to oligo dT primer at a concentration of
0.5pg/pg ofRNA and made up to 12pl with nuclease free water. Samples were then
heated to 70°C for 5 minutes and chilled on ice. A master mix was prepared
containing 4pl of 5x RT buffer, lpl dNTP mix, 2pl of 0.1M dithiothreitol (DTT) and
lpl (200 units) Superscript reverse transcriptase for each sample. Samples were
briefly spun, 7pl ofmaster mix added and incubated at 42°C for 1 hour. The reaction
was terminated by incubation at 70°C for 15 minutes and then on ice for several
minutes before storage at -20°C.
cDNA was amplified as follows; a 50pl reaction volume was used for each PCR
composed of: IX Taq buffer, 1.5mM MgCf, 0.2mM dNTPs, 0.1 pM of each primer,
lpl of diluted template DNA (pg), 0.5pl of Taq and lOOng of template DNA. The
cycle parameters were: 1 cycle of 96°C for 2 minutes, followed by 30 cycles of 96°C
for 30 seconds, annealing temperature for 30 seconds, 72°C for 1 minutes/kb of
product and finally 74°C for 5 minutes. Primer sequences, annealing temperatures
and expected product sizes are shown in table 2.1.
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Table 2.1: RT-PCR primers, annealing temperatures and expected product
sizes.





















RNA was isolated as previously described. All reagents were purchased from
Applied Biosystems (Perkin-Elmer, Foster City, CA). cDNA synthesis was
performed using Taqman multiscribe reverse transcriptase kit. A total reaction
volume of 50pl was used, composed of: 200ng of RNA sample, IX Taqman reverse
transcriptase buffer, 5.5mM MgCb, 500pM of each dNTP (deoxy dNTP mix),
2.5pM Random Hexamers, 0.4U/pl RNAse inhibitors, 1.25U/pl of reverse
transcriptase and RNAse free water to 50pl. The cycle parameters for the cDNA
synthesis were 1 cycle of 25°C for 10 minutes followed by 1 cycle of 48°C for 1 hour
and an inactivation step of 95°C for 5 minutes.
The primers and probes to be used in the real-time PCR reaction were pre-mixed
(FAM mix) and stored at -20°C until use (table 2.2). For each gene, 90pl of each
primer (25pmol/pl) and 300pl (5pmol/pl) probe were made up to a total volume of
2mls to create the FAM mix. The real-time PCR reaction was carried out in a total
volume of 25pl composed of: 12.5pl of Taqman master mix, 7jlxI of FAM mix,
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1.25f.il of 20X 18S (internal control), 2.5pi of cDNA at 1:5 dilution and RNAse free
water to 25jal. 1.25pl of 10X gene mix was used in place of the FAM mix for the
assay on demand kits. The PCR reactions were carried out using an ABI PRISM®
7700 sequence detection system.


































Assays on demand gene expression kits from Applied Biosystems: Primer/Probe
mixes for CD36, phosphatidylserine receptor and scavenger receptor A, ABC-1 and
low-density lipoprotein receptor.
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RNA levels relative to ribosomal RNA were calculated using the difference between
the "detection cycle number" for the gene and the ribosomal RNA.
2.2 Macrophage Culture
2.2.1 Bone marrow derived macrophages
Bone marrow derived macrophages were cultured from either integrin av floxed or
DOM (carrying floxed stop p geo reporter see 5.3.3) mice bred in house at the
University of Edinburgh animal facility. Femurs were removed from mice and
dipped in 70% ethanol before being placed in macrophage media (DMEM F/12
supplemented with 10% FBS and lOOU/ml penicillin, 100pg/ml streptomycin, 10%
L929 conditioned media). Bone marrow was flushed from femurs and resuspended
in lOmls ofmacrophage media. Cells were either plated at 0.4x106 cells per well of
a 24 well plate or at a cell density of 0.4xl06 cells/ml in Teflon pots (Savillex, USA).
Cells were fed on days 2 & 5 of culture and used at day 7. Phenotyping was carried
out as previously described.
2.2.2 Adenoviral gene transfer
Adenoviral Cre & GFP were gifts from Dr F Graham & Dr M Hitt, McMaster
University, Ontario, Canada. Batches of each virus were kindly prepared by Dr
Sallenave, University of Edinburgh. COS-7 cells and bone marrow derived
macrophages were grown in 24 well plates and treated with either virus in 500pl of
their respective culture media for 24 hours. Once infected, the virus containing
media was removed from the cells and replaced with fresh media and the cells
cultured for a further 24-48 hours. Virus was used at between 25-500 plaque
forming units (pfu)/cell which is equivalent to a multiplicity of infection (MOI) of
25-500. Stock virus titres of 8.96xl010 plaque forming units (pfu)/ml for AdCre and
6.68xl010 pfu/ml for AdGFP were used.
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2.2.3 Genomic DNA isolation
400pl of lysis buffer (appendix I) was added to each well of a 24 well plate and the
plates incubated at 55°C overnight to extract genomic DNA from macrophages. To
prevent evaporation, plates were placed on a platform in a Tupperware container
with water in the bottom. The following day DNA was precipitated with 800pl of
ethanol containing 12pl of 5M NaCl, and the plates incubated for 15 minutes at room
temperature. Plates were then centrifuged at 2000rpm for 10 minutes and the ethanol
gently removed before washing the DNA 3 times in 400pJ of 70% ethanol. After the
last wash, plates were left upside down to air dry for 30 minutes before the DNA was
resuspended in 200pl ofTE buffer at 37°C overnight.
2.2.4 Plate based phagocytosis assay
Phagocytosis assays were also performed in 24 well plates: Fluorescently labelled
apoptotic cells were incubated with day 7 macrophages (+/- adenoviral Cre) at a ratio
of 4:1 apoptotic cells:macrophages for 2 hours in 500pl of DMEM/F12. Assays
were carried out in the presence or absence of the inhibitory peptide GRGDSP or the
control peptide GRADSP at a concentration of 0.5mg/ml. After 2 hours, further
phagocytosis was prevented by the addition of ice-cold PBS, and unbound apoptotic
cells removed by vigorous washing with PBS before fixation with 200pl of 4%
paraformaldehyde. Three hundred cells were counted over 3 fields for each
condition and the percentage of phagocytosis calculated.
2.3 Generation of DNA constructs (molecular techniques)
Routinely used buffers and solutions are listed in appendix I.
2.3.1 Transformation of bacteria with plasmid vectors or ligated products
TOP 10 competent cells (Invitrogen, Paisley UK) were used for all transformations.
The competent cells were thawed on ice and lOng of plasmid or ligated product
added. Cells were then gently mixed and incubated on ice for 30 minutes, heat-
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shocked for 90 seconds at 42°C and placed back on ice for a further 2 minutes. 1ml
of Luria Bertani (LB) broth (appendix I) was added and the cells placed at 37°C for
45 minutes in a shaking incubator ~150rpm. Transformations were then centrifuged
at lOOOrpm for 30 seconds, the cells resuspended in lOOpl of LB broth and plated
onto LB agar plates containing the appropriate antibiotic. Plates were incubated at
37°C overnight to allow colony growth.
2.3.2 DNA purification
DNA was extracted using either mini or maxi prep kits from Qiagen (West Sussex,
UK) as per manufacturer's instructions. Briefly, single bacterial colonies were used
to inoculate larger cultures of LB broth containing the appropriate antibiotic. The
bacterial cultures were grown overnight in a 37°C shaking incubator at ~250rpm.
Cultures were cleared by centrifugation and resuspended in buffer PI, lysed with
buffer P2 and neutralised with buffer P3. Cellular debris was then removed by
centrifugation at >13,000rpm for 30 minutes and the cleared lysate applied to a DNA
binding column. After several washes the DNA was eluted from the column and
precipitated using iso-propanol. The DNA was then washed in a 70% ethanol
solution to remove contaminating salts and the pellet air dried before re-suspension
in an appropriate volume of Tris-EDTA (TE) buffer.
2.3.3 Restriction digest and modifying enzymes
Restriction enzymes were purchased from Promega or New England Biolabs. DNA
was digested using the appropriate restriction enzyme at a volume of <10% of the
final reaction volume in 1X optimal reaction buffer supplied with each enzyme and
bovine serum albumin (BSA).
Ligation of digested DNA was performed at 1:3 or 1:10 vectorfinsert molar ratio.
Typically lOOng of vector was incubated with the appropriate amount of insert in IX
ligase buffer and 1U of T4 DNA ligase (Promega) for ~3 hours at 22°C.
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Blunt-ended fragments for the cloning of the bacterial expression vector
pETVP22Cre were generated either using Klenow or Mung Bean Nuclease (New
England Biolabs). The 5'overhang generated by restriction digest with HindlU was
filled by incubating the DNA in IX Klenow buffer containing 40pM of each
deoxynucleotide triphosphate (dNTP), O.lmg/ml BSA and 1U of Klenow polymerase
at room temperature for 10 minutes. The reaction was stopped by incubation at 75°C
for 10 minutes.
The Ncol site from the pETl Id vector was removed by restriction digest with Ncol
followed by treatment with Mung Bean Nuclease (endonuclease). The digested
DNA was incubated at 30°C in IX reaction buffer (supplied with enzyme) with 1U
of nuclease for 2, 5, 10, or 20 minutes. The reaction was stopped by the addition of
2j.il of DNA loading buffer and snap freezing in an ethanol/dry ice mix. The DNA
was then run on an agarose gel and the DNA purified using a gel extraction kit
(Qiagen).
2.3.4 Agarose gel electrophoresis
Agarose gels were routinely used between 0.8%-2% (w/v) depending on the size of
the fragments to be separated. Agarose was added to IX Tris Boric acid EDTA
(TBE) solution diluted from a 10X stock, to give the final concentration of agarose
(w/v), and this was heated in a microwave until dissolved. Once cool, 0.5pg/ml
ethidium bromide was added and the agarose mix poured into a gel cast and left to
set. Samples were loaded in 2-5(0.1 of loading buffer depending on the sample
volume. Generally 5pl of lkb or lOObp ladder was loaded and the gel run at 150V
for approx 30 minutes.
2.3.5 Polymerase chain reaction (PCR)
Primers were purchased from Hybaid or MWG Biotech. Pfu polymerase (Promega)
was used for each of the cloning steps (PCR products B&C) except for A which is
described in table 2.1. A 50pl reaction volume was used for each PCR composed of:
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IX pfu polymerase buffer, 1.5mM MgCh, 0.2mM dNTPs, 0.1 pM of each primer,
lpl of diluted template DNA (pg), 0.5pl of pfu polymerase and lOOng of template
DNA. The cycle parameters were: 1 cycle of 96°C for 2 minutes, followed by 30
cycles of 96°C for 30 seconds, annealing temperature for 30 seconds, 72°C for 1
minutes/kb of product and finally 74°C for 5 minutes. Each of the primer sequences
and annealing temperatures is given in table 2.3.
Table 2.3 Primer sequences and annealing temperatures used for the
construction of pnLacZLoxP and VP22Cre.





1 cycle of 90°C




















Sequencing was carried out by Oswel DNA service. DNA was sequenced with the
primers as stated in chapter 5 and the sequences are described in table 2.4.
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Table 2.4 Sequencing primers.










Site-directed mutagenesis was performed using the primers LZLPSDM1
(aggagcgcaccatcttcttcaaggacg) and LZLPSDM2 (gccctgagcaaagaccccaacgagaag)
purchased from Hybaid. The mutagenesis reaction mix was composed of: IX pfu
turbo DNA polymerase buffer (Stratagene Europe, Amsterdam, The Netherlands),
0.2mM dNTPs, l.OpM of each primer, lp.1 of pfu turbo DNA polymerase and lOOng
of template DNA. The cycle parameters were: 1 cycle of 95°C for 2 minutes,
followed by 30 cycles of 95°C for 30 seconds, 55°C for 30 seconds, 65°C for 2
minutes/kb plasmid and 1 cycle of 75°C for 7 minutes. The mutagenesis reaction
was then digested with Dpnl for lhour at 37°C before transformation in TOP 10
electrocompetent E.coli.
2.3.8 COS-7 cell line
COS-7 cells were maintained as sub-confluent cultures at 37°C in a 5% CO2 humid
incubator in 165cm2 flasks containing DMEM supplemented with 10% FBS, 2mM
L-glutamine, lx non-essential amino acids, lOOU/ml penicillin and lOOpg/ml
streptomycin. Cells were passaged at 1:10 three times per week.
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2.3.9 Amaxa transfection technology
COS-7 cells were transfected using Amaxa transfection technology (Amaxa
Biosystems, Cologne Germany). Cells were washed in PBS, trypsinised, centrifuged
and the pellet resuspended at 1.5xl06 cells/ml in the optimised buffer, buffer V
(supplied by Amaxa). Typically between 2-5pg of plasmid DNA was incubated with
lml of cell solution and placed in a transfection cuvette. Cells were then placed in
the Amaxa electroporator and pulsed using program A27, the transfected cells were
then placed in 75cm2 flasks in 15mls of RPMI supplemented with 10% FBS,
lOOU/ml penicillin and lOOpg/ml streptomycin. Twenty four to 48 hours later the
cells were analysed for expression of the plasmid.
2.3.10 P-galactosidase staining
Cells transfected with p-galactosidase expressing constructs were washed in PBS and
fixed in 2%formaldehyde/0.2% glutaraldehyde for 10 minutes at room temperature.
The fixative was then removed and the cells washed in PBS and incubated in P-
galactosidase stain (appendix I) overnight at 37°C.
2.3.11 Immunofluorescence
COS-7 cells transfected with VP22Cre were fixed in ice-cold methanol for 2
minutes. Cell were then blocked with PBS containing 10% FCS for 20 minutes
before staining with 1:1000 dilution of a rabbit polyclonal anti-Cre antibody
(Novagen, supplied by CN Biosciences Nottingham UK) for 1 hour. Cells were
washed twice in PBS and Cre expression detected with an Alexa 568 primary
conjugated goat anti-rabbit secondary (Molecular Probes, Leiden Holland) at a 1:500
dilution.
2.4 Preparation of recombinant protein
Routinely used buffers and solutions are listed in appendix I.
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2.4.1 Purification of recombinant proteins from E.Coli
BL21 (DE3) pLysS competent cells were transformed with the bacterial expression
plasmids and plated onto LB agar plates containing the appropriate selection
antibiotics (chloramphenicol and ampicillin or kanamycin). The following day a
single colony was used to inoculate 50ml of LB broth plus antibiotic that was grown
overnight in a 37°C shaking incubator (~250rpm). The overnight culture was then
diluted 1:20 in 950ml of LB broth plus antibiotic and grown to an A6oo -0.8-1.0,
0.8mM P-D-isopropyl-thiogalatosidase (IPTG) was added to induce the culture
which was then grown for a further for 3 hours. The bacterial cells were harvested
by centrifugation at 4000rpm for 10 minutes at 4°C and the pellet stored at -70°C
overnight or until required.
On the day of purification the pellet was thawed on ice and lysed using a solution of
BugBuster reagent (5ml/g wet cell paste)(Novagen) and benzonase (lpl/5ml
BugBuster reagent)(Novagen). A protease inhibitor cocktail was added at this stage
to prevent breakdown of the protein. Cleared lysate was obtained after centrifugation
at >13,000rpm for 30 minutes. 5mls of the cleared lysate was incubated with 5mls of
Ni-NTA agarose (Qiagen) on a rotating platform for 1 hour at 4°C before packing
into a column. The column was then washed 5 times with 5mls of wash buffer
(50mM NaLBPtT}, 300mM NaCl and 5mM Imidazole pH 8.0) before elution with
lOmls of elution buffer (50mM NaH2P04, 300mM NaCl and 250mM Imidazole pH
8.0). The eluted fraction was collected in 1ml volumes and protein levels
determined. The fractions containing the highest levels of protein were dialysed
against PBS followed by DMEM/F12 before storage at -80°C.
2.4.2 Protein concentration
Protein concentrations were measured using DC protein assay kit (Bio-Rad, Hemel
Hempstead, UK). A "standard curve" was prepared using BSA ranging from 0.2 to
1.5mg/ml. 25pl of standards and samples were added to a 1.5ml eppendorf and
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incubated with assay reagents for 15 minutes. The absorbance was read at 750nm
and the concentration of the samples determined by linear regression.
2.4.3 SDS-PAGE & Western blotting
SDS reducing buffer (see appendix 1) was added to cell lysates and boiled at 96°C
for 5 minutes. Denatured samples were applied to 12% agarose gels with 4%
stacking gels (see appendix 1), and electrophoresed at 125 volts for approximately 1
hour in IX running buffer. Protein was then blotted onto PVDF (Hybond-P,
Amersham, Little Chalfont, UK) in an electroblotting apparatus (BioRad). PVDF
membrane was pre-wetted in methanol for 10 seconds before being equilibrated in
transfer buffer. The gels were placed onto the membrane and 2 pieces of filter paper,
also soaked in transfer buffer, were placed on either side. Fibre pads soaked in
transfer buffer were placed either side of the filter paper and the entire sandwich was
placed into the gel holder cassette with the gel closest to the grey side of the cassette.
The process was repeated for the second gel. The cassettes were placed in the
electrode module, the tank filled with cooled IX transfer buffer and the cooling
block added. Transfer was performed at 80mA per gel for 90 minutes.
2.4.4 Coomassie staining of SDS-Page gels
SDS-PAGE gels were stained with Coomassie blue stain (appendix I) for 30 minutes
on a rocking platform. Coomassie blue stain was then removed and the gels washed
in several changes of destain (appendix I) until the protein bands were clearly visible.
2.4.5 Antibody detection
Blots were blocked in PBS containing 0.5% non-fat milk powder (Marvel) for 1 hour
at room temperature on a rocking platform. Blots were subsequently probed with a
polyclonal rabbit anti-Cre antibody (Novagen) diluted 1:5000 in PBS containing
0.5% non-fat milk powder and 0.05% Polyethyleneglycol sorbitanmonolaurate
(TWEEN 20) and incubated on a rolling platform at 4°C overnight. The following
day the blots were washed 3 times in PBS/TWEEN and detected with a horseradish
peroxidase (HRP)-conjugated goat anti-rabbit antibody (DAKO) for 1 hour at room
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temperature. Blots were washed three times in PBS/TWEEN and the signal was
detected by enhanced chemiluminesence (ECL, Amersham) and X-ray film (MR-1,
Kodak, Rochester, NY).
2.5 Microscopy
All images were captured using an inverted microscope (Zeiss) fitted with a
CoolSnap camera and OpenLab 3.0 image acquisition software (Improvision).
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Differentiation ofES cells into
myeloid cells
Chapter 3: Differentiation of ES cells into myeloid cells.
3.1 Introduction
ES cells remain totipotent and undifferentiated when cultured in the presence of
cytokines such as LIF or co-cultured with stromal cell layers that produce LIF (Smith
et al., 1988b). Upon cytokine withdrawal ES cells spontaneously differentiate into
many cell lineages that contribute to all three germ layers (endoderm, ectoderm,
mesoderm) (Evans and Kaufman, 1981; Martin, 1981). This spontaneous
differentiation can be manipulated by the addition of specific cytokines or
conditioning factors into the culture system that can drive differentiation towards a
particular cell type and enhance the numbers of cells obtained.
Following removal from stromal feeder layers or in the absence of LIF, ES cells form
embryoid bodies (EBs), a cluster of differentiated cells that recapitulate many aspects
of early embryo development (Doetschman et al., 1985). Although EBs will form
spontaneously there are several ways in which they are routinely and reproducibly
generated, the main three being I) suspension in liquid culture or II) culture upon a
monolayer of stromal cells or III) suspension culture in a semi-solid mixture.
One method of EB formation is to culture ES cells in liquid culture either in bacterial
grade Petri dishes or in "hanging drop" culture. When plated into bacterial grade
Petri dishes the lack of substrate causes the ES cells to aggregate and form EB,
however these EBs are not as uniform as those generated in MeC and may be prone
to attaching to the plastic resulting in a reduction in differentiation (Wiles and Keller,
1991). A modification of this method, the hanging drop, is to culture low numbers of
ES cells in droplets of media suspended from the lid of a culture plate for several
days. The close proximity of the ES cells in these cultures promotes the generation of
EBs, which can then be transferred into standard liquid culture or into MeC cultures
for assays of hematopoietic precursors (Keller, 1995).
A second method of initiating differentiation is to culture ES cells on a monolayer of
stromal cells. Several stromal cell lines are available which give rise to
%
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macrophages. One in particular, the OP9 cell line does not express functional M-
CSF and is used to differentiate ES cells to those of the lymphoid lineage and
hematopoietic cells other than macrophages (Nakano et ah, 1994; Senju et al., 2003).
This co-culture method involves plating ES cells on a monolayer of stromal cells and
sub-culturing them onto fresh stromal cells after days 5 and 10 of differentiation.
This allows removal of undifferentiated cells and the formation of clusters of
differentiated cells that can be expanded in liquid culture.
The simplest method of producing EBs is to use the semi-solid culture system
reported by Wiles and Keller (Keller et al., 1993; Wiles and Keller, 1991) where
MeC, (wood pulp) previously used in assays for hematopoietic precursor cell
development (Schmitt et al., 1991) was used to provide a three-dimensional matrix to
support the developing EBs. Briefly, ES cells were seeded at a low density in a MeC
suspension containing various combinations of cytokines and growth factors in
bacterial grade Petri dishes to prevent cell adherence. This allowed the formation of
uniform EBs in a synchronous manner, which could then be plated into liquid culture
for the expansion of hematopoietic cells.
Wiles and Keller used this system to investigate the influence of several cytokines on
the ability of the differentiating EBs to generate specific cell types. After two weeks
in culture either in the presence or absence of cytokines they observed that the EBs
ruptured releasing a mass of differentiated cells consisting mainly of macrophages
and erythroid cells and in some instances neutrophils and mast cells. The addition of
erythropoietin increased the number of erythroid cells associated with the EB and
when used in conjunction with IL-3 these numbers were further increased along with
prolonged survival of the cells. IL-3 and IL-1 either alone or in combination were
also found to enhance the numbers of EBs associated with macrophages at around
day 12, although only IL-3 had an effect on the development of mast cells and
neutrophils at around day 20. The presence of M-CSF or GM-CSF in the IL-3
cultures further augmented the number of macrophage producing EB therefore
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suggesting that for macrophage differentiation the ideal combination of cytokines is
IL-3 and M-CSF (Wiles and Keller, 1991).
Each of these methods described allows the efficient generation of EB and
differentiated progeny. The method of differentiation chosen depends on the desired
cell type and the questions being asked. The hanging drop method and the use of
stromal cells are more commonly used for analysis of hematopoietic and lymphoid
precursors (Palacios et ah, 1995; Potocnik et ah, 1997), whereas the MeC method has
been widely used for the generation of macrophages (Clarke et ah, 2000; Faust et ah,
1994; Moore et ah, 1998; Wiles and Keller, 1991). It is for this reason that this was
the method of choice for the differentiation of ES cells to macrophages in our
laboratory.
However, during the course of this work Fairchild et al. published the first report
describing the directed differentiation of dendritic cells from ES cells (Fairchild et
ah, 2000). The ESF116 ES cell line derived from the blastocyst of a CBA mouse
was differentiated by seeding ES cells into bacteriological Petri dishes in the absence
of cytokines. After 14 days the EB were plated into tissue culture dishes and the
media supplemented with IL-3 and GM-CSF. As early as 4 days after plating, cells
with morphology resembling dendritic cells developed and continued to rapidly
increase in number over the following 10 days in culture. The ES-derived dendritic
cells grew in tightly packed clusters that could be harvested by gentle washing and
used for analysis of surface phenotype, response to maturation stimuli and their
ability to stimulate primary T-cell responses (Fairchild et ah, 2000). This
development allowed us to extend the differentiation of ES cells in our laboratory to
include the generation of ES derived dendritic cells.
Differentiation of hematopoietic cells from ES cells has been widely used by many
groups not only in studies examining hematopoietic precursors (Clarke et ah, 2000)
and transgene activation (Faust et ah, 1994) but also in more functional studies such
as the role of macrophages in atherosclerosis (Moore et ah, 1998). Unlike cells of
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the myeloid lineage ES cells are easily transfected therefore permitting over-
expression, inactivation or deletion of a particular gene of interest. Subsequent
differentiation of these targeted ES cells allows analysis of developmental or
phenotypic changes in the desired cell type that may not have been possible in vivo
due to embryonic lethality (Keller, 1995). Here, this particular aspect of ES cell
biology has been exploited to enable the investigation of integrin av in phagocytosis.
Until now, studies examining a role for integrin av in phagocytosis have been limited
as mice carrying a null mutation in the integrin av gene die mid-gestation or
perinatally (Bader et ah, 1998).
The main aims of this part of the project were to:
1. To establish the technique of differentiating ES cells to myeloid cells using
the EFC-1 ES cell line.
2. To utilise this method to differentiate ES cells (El4 cell line) carrying a
disrupted integrin av gene.
3. To determine whether myeloid phagocytes derived from E14 ES cells in
which av has been disrupted represent a suitable system for analysis of the
role of integrin av in the phagocytosis of apoptotic cells.
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3.2 Characterisation of EFC-1 ES cell differentiation
3.2.1 EB formation during hematopoietic differentiation of ES cells
The differentiation capacity of ES cells varies considerably with cell line. It was
important, therefore, to use a cell line capable of reproducible differentiation when
establishing this technique in our laboratory. The data presented in this chapter was
generated using the EFC-1 ES cell line that is routinely used to study hematopoietic
differentiation (Baird et al., 2001).
A protocol based on that of Wiles and Keller was used to generate embryoid bodies
(EBs) and is outlined in figure 3.1. EFC-1 ES cells cultured on gelatin coated plates
in the presence of LIF grew in tightly packed colonies (Fig 3.2). When these cells
were cultured in MeC in the absence of LIF they proliferated and formed dense cell
aggregates, EBs (Fig 3.2). The EBs gradually increased in size (200-500pm) and
density and by day 8 clusters of differentiated cells could be seen emerging from the
central EB mass. Occasionally, the development of red blood islands is observed in
some EBs. Between days 12 and 14 of culture EBs reached their maximum size of
~l-2mm in diameter, and ruptured, releasing differentiated cells (Fig 3.2). At day 14
EB cultures were disrupted and plated for expansion and analysis of differentiated
cells.
3.2,1 Reverse Transcriptase-Polymerase Chain Reaction analysis of differentiating
EB
RT-PCR analysis has already been carried out on differentiating EB and some of the
genes involved in this process are described in the literature, but it was important to
determine if the genes of interest for our experiments were expressed. Gene
expression in differentiating EBs (days 6 and 13) was compared to bone marrow and
bone marrow derived macrophages (BMDM) at days 3, 5 and 7 of culture. The
macrophage marker MME (Shapiro et al., 1992) was expressed at constant levels in
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Figure 3.1: Overview of the differentiation protocol for ES derived
myeloid cells. ES cells were seeded into methylcellulose cultures in
bacteriological Petri dishes to allow the formation of EB. After 14 days
the EB were either disrupted and/or plated into tissue culture plates and
the differentiated cells expanded for ~21 days. The ES derived myeloid
cells were then harvested and analysed or if DCs the cells were re-
plated for maturation studies.
EFC-1 ES cells + LIF EB: day 3
EB: day 5 EB: day 8
EB: day 12 EB: day 14
Figure 3.2: Hematopoietic differentiation of EFC-1 ES cells. Stages
of EB formation in methlycellulose media containing IL-3 and M-CSF
from undifferentiated ES cells to fully differentiated EB surrounded by
















Figure 3.3: RT-PCR analysis of EB compared to bone marrow derived
macrophages. RNA was harvested from bone marrow macrophage
cultures at days 0, 3, 5 and 7 and from day 6 and 13 embryoid bodies. RT-
PCR analysis was performed for MME, integrin av, pH1, HPRT and p-actin.
(see text and abbreviations).
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the onset of expression occurring between days 6 and 13 (Fig 3.3), therefore
indicating that MME is not expressed by macrophage precursors. In contrast integrin
av was present at low levels in day 6 EBs with expression increasing as
differentiation proceeds (Fig 3.3). BMDM also expressed integrin av with the
highest levels detected at day 5 of culture. Embryonic globin (PHI) expression was
absent in bone marrow cultures but was expressed at high levels in day 6 EBs and
was seen to decrease by day 13. Hypoxanthine phosphoribosyltransferase (E1PRT)
and P-actin were used as controls. The expression of MME confirmed that the
differentiating EBs showed commitment to the macrophage lineage and importantly,
the EBs expressed the gene of interest, integrin av. Therefore, EBs, were disrupted
and the macrophages expanded in the presence of IL-3 and M-CSF or GM-CSF.
3.2.3 Differentiated Progeny
When plated, disrupted EBs gave rise to an assortment of cell types. Partially
disaggregated EBs adhered strongly to the tissue culture plates and spread into a tight
network of stromal cells (Fig 3.4a). These cell layers were often observed to beat
spontaneously due to the presence of cardiac myocytes (Doetschman et al., 1985). In
some cultures other morphologically distinct cell types such as adipocytes could be
seen in distinct areas within the cell monolayers (Fig 3.4b). In addition to these cell
dense regions, smaller more distinct populations of cells were seen physically
separate from the EB surrounding layers. These presumably arose from non¬
adherent or highly motile precursor cells derived from EBs and showed the
morphology of myeloid cells. Importantly, these putative myeloid cells showed a
subtly different morphology depending on the cytokines in the culture medium; cells
generated in the presence of M-CSF were adherent with a macrophage-like polar
morphology (Fig 3.4c). In contrast, cells generated with GM-CSF were less adherent
and exhibited a more 'spiky' dendritic like appearance (Fig 3.4d).
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Figure 3.4: Cells generated from the differentiation of EFC-1 ES
cells. EB disrupted with collagenase and plated onto tissue culture
plastic give rise to various different cell types A) densely packed region
surrounding EB x10 , B) adipocytes x 10 C) & D) myeloid cells grown in
the presence of IL-3 and either M-CSF or GM-CSF respectively.
Magnification x16.
Phase F4/80
CD11 b Merge CD11b F4/80
Figure 3.5: Immunofluorescence studies of macrophage surface
markers. Surface expression of the macrophage marker F4/80 (PE
conjugated) and the myeloid cell marker CD11b (FITC conjugated). The
cultures are a mixed population of cells that express both markers
(arrows) and cells that express CD11b only (arrow head). Magnification
x16.
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3.2.4 Immunofluorescence studies
To confirm the myeloid identity of these cells, they were stained for the
macrophage/monocyte markers F4/80 and CDllb. Two populations of cells were
apparent (Fig 3.5). Phase contrast revealed cells with a round phenotype and cells
with a more elongated morphology. Merged images clearly showed that the rounded
cells were positive for both F4/80 and CDllb and were likely to be macrophages
while those that showed a more elongated morphology were only positive for CD1 lb
, possibly representing monocytes or immature macrophages indicating that cultures
are a mixed population ofmyeloid cells at different stages of development.
3.2.5 Surface phenotype of ES derived cells by flow cytometry analysis
Further analysis of macrophage/monocyte markers was performed using flow
cytometry analysis of ES cell derived cultures. Two to three weeks after EB
disruption and plating the differentiated cells were harvested using ice cold
PBS/EDTA. Analysis by forward/side scatter (FSC/SSC) showed a heterogeneous
population of cells with of cell debris of low FSC/SSC (Fig 3.6). Staining with
F4/80 showed that 63.4% of total cells were F4/80 positive (~5xl 03 macrophages per
EB). These F4/80 positive cells formed a distinct population identifiable by
FSC/SSC. Myeloid cells derived from ES cells differentiated in M-CSF were
positive for F4/80 (high & low), CDllb, CD14 and CD54 (ICAM-1) comparable to
BMDM (Fig 3.6 & 3.8). However, unlike BMDM they exhibited only low levels of
CD1 la staining and weak staining for CD1 lc and Grl (Fig 3.6).
Cells from ES cells differentiated in GM-CSF showed a very different profile by
forward and side scatter. A much more distinct population of cells was observed but
this was only -10% of the total cell population (Fig 3.7). Expression of the surface
markers CD1 lb, CD1 lc and CD54 were comparable to both ES cells cultured in M-
CSF and BMDM (Fig 3.6, 3.7 & 3.8). They were also positive for F4/80 but lack the
high expressing population. In contrast to cells cultured in M-CSF they do not
express CD14 but have greater levels of CD1 la (Fig 3.7). Figures 3.6 and 3.7 show
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Figure 3.6: Surface phenotype of ES derived cells grown in IL-3 and
M-CSF. Cells harvested from cultures grown in IL-3 and M-CSF were
analysed by flow cytometry for expression of F4/80, CD11a, CD11b,
CD11c, CD14, CD54 and Gr1. A) F4/80 staining of total cells allowed
identification of a distinct F480 positive population (outlined in blue). This
gate was used for the subsequent analysis of the other cell surface







Figure 3.7: Surface phenotype of ES derived cells grown in IL-3 and
GM-CSF. Cells harvested from cultures grown in IL-3 and GM-CSF were
analysed by flow cytometry for expression of F4/80, CD11a, CD11b,
CD11c, CD14, CD54. No surface staining was detected in the low



















Figure 3.8: Surface phenotype of bone marrow derived
macrophages. Day 7 Bone marrow derived macrophages were analysed
for expression of F4/80, CD11a, CD11b, CD11c, CD14, CD54. All surface
markers are shown in red and are phycoerythrin labelled except F4/80
which is labelled with FITC. Isotype controls are shown in blue.
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either M-CSF or GM-CSF is similar to that of BMDM with subtle differences.
However, the numbers of cells obtained were relatively low.
3.2,6 ES macrophages have the ability to phagocytose both latex beads and apoptotic
cells
Macrophages play an important role in the phagocytosis of foreign or apoptotic
material and the aim of this project was to investigate the role of integrin av in this
process. Having generated a population of cells expressing macrophage markers (ES
M(j>) it was necessary to determine whether they had the ability to phagocytose. ES
derived cells were incubated with 2pm FITC labelled latex beads for 30 mins and
analysed by flow cytometry. ES derived cells clearly separated into a phagocytic
(High FSC/SSC) and non-phagocytic (Low FSC/SSC) population, corresponding
with previous analysis of F4/80 expression. 51.2% of the macrophages (high
FSC/SSC) had ingested latex beads with 21.1% having ingested 1 bead (red arrow),
14.5% ingested 2 beads (green arrow) and 15.6% ingested >3 beads. The ability of
ES M(|) to phagocytose larger targets was also examined (Fig 3.10). ES M(j) were
cultured with fluorescent (green) apoptotic PMNs for 30 mins or 2 hours and
analysed by flow cytometry. ES M(|) were identified by F4/80 staining and
phagocytosis determined by incorporation of apoptotic cell associated green
fluorescence. After 30 mins interaction 80% of the ES M<j) ingested apoptotic cells,
increasing to 86% after 2 hours. These results confirm that ES M(|), like primary or
bone marrow derived macrophages, possess the ability to phagocytose.
3.3 Optimisation of ES differentiation protocol
3.3.1 Effect ofIL-3
ES cells differentiate to macrophages, expressing macrophage markers and are
capable of phagocytosis but the yields obtained were low. Therefore, to increase the
numbers of macrophages produced by differentiating ES cells various steps of the
culture protocol were optimised. Macrophage differentiation is dependent on IL-3
66
—* > 3 beads
Figure 3.9: Phagocytosis of latex beads. ES M<(> were incubated with
an excess of 2pm FITC labelled latex beads for 30 mins. Cells were
gated by FSC/SSC into macrophages (gate 1) and non-macrophages




Figure 3.10: Phagocytosis of apoptotic cells. ES M<j> were incubated
with fluorescent green labelled apoptotic neutrophils for either 30 minutes
or 2 hours. A) ES derived macrophages were gated as the high FSC/SSC
population based on previous experiments. F4/80 positive cells were
then gated (A) and unlabelled macrophages that had ingested apoptotic
neutrophils were excluded from analysis (B). Phagocytosis was
assessed by gating on the F4/80+ ES macrophage population (C).
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and M-CSF. The presence of 1L-3 in the differentiation cultures greatly enhances the
number of EB containing macrophages over those differentiated in M-CSF alone
(Wiles and Keller, 1991). It was for this reason it was decided to vary the
concentration of IL-3 used in the culture system. EFC-1 cells were differentiated in a
fixed concentration of M-CSF (10% CM) and increasing amounts of IL-3 (8ng-
800ng/ml). Cells were harvested 14 days after plating and analysed by flow
cytometry for surface expression of F4/80 and CD1 lb.
Figure 3.1 la shows representative flow cytometry plots for cells cultured at 8ng/ml
IL-3. The majority of high FSC/SSC cells were CDllb+F480+ with 8ng/ml IL-3
giving the highest percentage (74% and 73 % respectively of gated cells) (Fig 3.11b).
However, only 6% of the total cell population fell within this gate (Fig 3.11a)
compared with 45% in previous differentiations. The percentage of F4/80 or CD1 lb
positive cells in the whole population was also lower than previously observed, at
8ng/ml IL-3 only 8% of the population was positive for either marker decreasing to
3% in cultures supplemented with 800ng/ml IL-3 (Fig 3.11c). Overall, increasing the
IL-3 concentration produced fewer ES M(j) in total and reduced the macrophage
proportion of the high FSC/SSC cells.
3.3.2 Disruption versus plating of EB cultured in M-CSF or GM-CSF
Differentiated cells can be expanded from EB either by disruption or plating of intact
EB straight into tissue culture dishes (Wiles, 1993). This latter method has the added
benefit of allowing continual harvesting of the macrophages over several weeks
permitting larger numbers to be produced. In an attempt to increase the numbers of
cells generated/harvested, ES cells were differentiated in M-CSF or GM-CSF plus
IL-3 and the EB either disrupted or plated intact. 14 days after plating, differentiated
cells were harvested using ice-cold PBS/EDTA solution and analysed by flow
cytometry for surface expression of F4/80 and CD1 lb.
Plating of intact EB cultured in M-CSF gave rise to a higher percentage of positive
cells within the macrophage gate. CD1 lb was expressed by 54% of the cells and
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66% were expressing F4/80 compared to only 8% of cells positive for either marker
in the cultures where the EB had been disrupted (Fig 3.12a). Cells cultured in GM-
CSF also demonstrated a similar pattern of expression of F4/80 and CD1 lb. Again,
plating of EB produced higher numbers of cells expressing either marker compared
to those that had been disrupted (Fig 3.12b). Nevertheless, regardless of the method
of plating or the cytokine used only small percentages of the whole populations lay
within the macrophage gates suggesting that the macrophages were not successfully
being removed from the plates.
3.3.3 Harvesting of differentiated cells from plated EB
In the experiments discussed above it was highlighted that the percentage of
macrophages in the harvested cells was extremely low. This could have been due to
the ES cells not differentiating as well as before or that the macrophages were not
being removed from the plates. Several different approaches and cell detachment
agents were assessed for their ability to lift the macrophages.
The first approach taken was adapted from that previously by reported Moore et al.
(Moore et ah, 1998). Single EB were plated into each well of a 24 well plate, after 7
days and every two days thereafter the supernatants were harvested and re-plated into
fresh 24 well plates. Very few macrophage-like cells were harvested and after 2-3
harvests the EB plates stopped producing cells. The experiment was repeated but
~10 EBs were plated into wells of a 6 well plate and left for 14 days. Cells were
harvested by gentle washing of the plates with culture medium and the cells re-plated
into fresh plates. After 2-3 days the re-plated cells were examined by light
microscopy. Unexpectedly there were no cells with macrophage morphology and
instead, the cells looked like ES cells (Fig 3.13a&b).
The second approach was to compare the ability of ice-cold PBS/EDTA, trypsin and
collagenase to detach the macrophages from the plates. Figure 3.13d-f shows a panel
of phase contrast micrographs that give an overview of the diversity of macrophage
clusters observed within the culture plates. 20-30 EB were plated per 10 cm tissue
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Figure 3.11: Effect of IL-3 concentration on macrophage
differentiation. Differentiation of EFC-1 cells was carried out in
increasing concentrations of IL-3 and the differentiated progeny
analysed by flow cytometry for the percentage of F4/80 and CD11b
positive cells. A) representative flow cytometry plots of cells cultured in
8ng of IL-3. Bar graphs showing the percentage of F4/80 and CD11b
positive cells in the gated macrophage population (b) and the whole
population (c) .
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Figure 3.12: Effect of disruption versus plating on macrophage
number. EB generated by differentiating EFC-1 cells in IL-3 and either
M-CSF (a) or GM-CSF (b) were either disrupted with collagenase before
plating or plated straight into tissue culture dishes. The differentiated
progeny were analysed by flow cytometry for the percentage of F4/80 or
CD11b positive cells.
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culture dish and left to adhere and spread (Fig 3.13c). After 14 days in culture larger
rounded cells thought to be macrophages appeared and were quite often
encompassed by the plated EB (Fig 3.13d). Other areas of the cultures were
colonised by very large, flat cells that seemed to provide a matrix for the
macrophages (Fig 3.13e) or by clusters of macrophages that settled away from the
regions where EB had plated (Fig 3.13f). To harvest the macrophages the plates
were incubated with PBS/EDTA, trypsin or collagenase and passed through an 80pm
cell filter to remove the larger EB. The cells were then analysed for surface
expression of F4/80 and CD1 lb. None of the cells analysed by flow cytometry were
positive for either marker (data not shown) suggesting that little or no macrophages
were present in the cultures or that the cells were lost during the filtering step.
3.3.4 Magnetic cell sorting of ES derived macrophages
To circumvent the problems with harvesting and to enrich for the macrophages that
were not adherent to the EB layer the cultures were sorted using magnetic beads. 14
days after plating 9x10ft cells were harvested from the plates using ice cold
PBS/EDTA and incubated with CDllb-PE. The labelled cells were then incubated
with anti-PE microbeads (Miltenyi Biotec) and bound to a magnetic cell separator
(MACS, Miltenyi Biotec). Unsorted cells and both the unretained and retained
fractions were analysed for morphology and surface expression of F4/80. Labelling
of the unsorted population with F4/80 showed that 64% of the high FSC/SSC cells
gated were indeed macrophages. Sorting of the cells with the magnetic beads clearly
enriched for F4/80 positive (retained fraction) cells (Fig 3.14a). The sorted cells
when plated showed strikingly different morphology (Fig 3.14b). The F4/80 positive
cells grew predominately in a monolayer with some sparsely populated regions. At a
higher magnification these cells distinctly looked like macrophages unlike the F4/80
negative fraction where the cells were more fibroblastic in morphology. The method
of magnetic cell sorting was successful in generating relatively pure (85%)
populations of macrophages however, the numbers of macrophages harvested was
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A) B)
Figure 3.13: Morphology of ES-derived macrophages after plating. A
& B) Cells that have been harvested in the culture supernatants and re-
plated. C) Small area of a plated EB. D) example of ES macrophages
encompassed by the EB. E) macrophages growing at the edge of an EB.
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Figure 3.14: Magnetic cell sorting of ES derived macrophages.
Differentiated cells were labelled with F4/80 antibody, incubated with
beads and bound to a magnetic cell sorter. Unretained and retained
fractions were collected and analysed for morphology (a) and surface
expression of F4/80 (b).
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still of some concern as only 7% of the total number of cells harvested were retained
in the positive cell fraction.
3.3.5 Effect of serum change on EFC-1 differentiation
At this time the data discussed earlier in this chapter was presented as a poster at a
British Society of Immunology meeting where it was suggested that changing the
serum used to differentiate the cells might improve the numbers of cells generated
(Paul Fairchild, personal communication). Previous differentiations had been carried
out using serum that had been pre-tested to support the in vitro differentiation of ES
cells (Stem Cell Technologies) and was substituted with serum purchased from
Labtech.
In an endeavour to overcome the problems experienced with harvesting, it was also
decided to try and generate dendritic cells (DC) that would be less adherent than
macrophages. The EFC-1 ES cells were differentiated using a protocol based upon
the method described by Fairchild et al. (Fairchild et al., 2000). ES cells were plated
in the absence of cytokines into 10cm Petri dishes and left to form EB. After 3 days
spherical EBs had appeared but by day 5 they had attached to the surface of the
dishes and spread, losing their differentiation potential. The bacterial dishes used for
this experiment may have been slightly "sticky" so it was decided to induce EB
formation in the MeC cultures previously used.
An outline of the culture conditions is given in Figure 3.15a. ES cells were cultured
either in MeC supplemented with lOOOu/ml IL-3 and 25ng/ml GM-CSF from the
onset of differentiation (+/+) or at the time of EB plating (-/+). At day 3 of
differentiation small spherical EB had formed in both sets of cultures indicating that
IL-3 and GM-CSF had no effect upon the early stages of differentiation (Fig 3.15b
upper panel). By day 14 the EB had considerably increased in size and were
surrounded by hematopoietic colonies. No differences were observed between the
two conditions except that EB cultured in the presence of cytokines were surrounded
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Figure 3.15: Effect of serum change on EB formation. EFC-1 ES
cells were differentiated using Labtech serum in the presence or
absence of cytokines. A) overview of the culture conditions for cells that
were grown in cytokines from initiation of differentiation (+/+) and cells
that were only exposed to cytokines at the time of plating (-/+). B)
Representative phase contrast micrographs of EB at days 3 and 14 of
differentiation for both culture conditions. Magnification x10.
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Figure 3.16: Effect of Labtech serum on differentiated progeny.
EB differentiated in Labtech serum for 14 days either in the presence or
absence of cytokines were plated and cultured for a further 21 days in
the presence of cytokines. Representative phase contrast micrographs
are shown for cells cultured in IL-3 and GM-CSF from initiation of
differentiation(+/+) (A) and cells cultured in IL-3 and GM-CSF from day
of plating (-/+) (B).
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observation was not definitive as there was great variability in the numbers of cells
surrounding any one EB independent of the culture conditions used.
The differentiated progeny arising from EB cultured in the presence or absence of
cytokines were very similar but exhibited morphology markedly different to that seen
in former differentiations. As before, the cultures were quite heterogeneous in that
some areas of the culture plates were more densely populated than others, this was
especially evident in the regions surrounding the plated EB. Initially, the cells that
appeared formed a confluent monolayer encircling the plated EB, as time progressed
smaller more irregular shaped cells emerged and began to aggregate loosely adhering
to the monolayer (Fig 3.16a&b). Fewer cells were found in areas where there was no
EB but these did become confluent if the plates were left in culture for several
weeks. Figure 3.16a&b lower panels show more clearly the protrusions emanating
from the smaller cells indicating a more dendritic like morphology compared to the
more rounded macrophage morphology observed in earlier differentiations. To
determine whether these cells were in fact DC-like, the cells were analysed by flow
cytometry for surface expression of several DC markers. The loosely adherent
clusters were harvested by gentle washing with PBS and labelled with F4/80, CD1 lc,
CD40, CD80 and CD86. Analysis of the cells by FSC/SSC showed less debris in the
cultures and a more distinct population of cells in both of the culture conditions
compared to earlier ES M(j) cultures. Cells cultured in cytokines from the onset
generated higher numbers of cells (64.8%) that could be gated by FSC/SSC
compared to the cells supplemented with cytokines at the time of plating (36.9%)(Fig
3.17). Despite this difference in gated cell number the surface phenotype of both sets
of cells was identical. F4/80 was expressed at moderate levels although to a slightly
greater degree in the cells that had been exposed to cytokines for longer. The
differentiated cells expressed relatively high levels of the DC marker CD80 and
moderate levels of CDllc but lacked surface expression of CD40 and CD86 (Fig
3.17). Expression levels for each of the DC markers were comparable between both








Figure 3.17: Surface phenotype of differentiated progeny cultured
in Labtech serum. Cells harvested from cultures grown in either (+/+)
or(-/+) cytokines were analysed for surface expression of F4/80 and the
dendritic cell markers CD11c, CD40, CD80 and CD86.
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3.4 Differentiation of E14 ES cells
3.4.1 Targeting of integrin qv in the E14 ES cell line
The work presented in the first part of this chapter was carried out using the EFC-1
ES cell line that is routinely used by others for ES differentiation studies. Elowever,
prior to the beginning of this project, the integrin av gene was targeted with LoxP
sites in a different ES cell line (El4 ES cell line) by Dr Adam Lacy-Hulbert. These
were used to generate integrin av floxed mice in work that ran closely in parallel
with the ES differentiation work presented here. The strategy used to target integrin
av is described in figure 3.18. The targeting vector comprises of a neomycin
resistance cassette flanked by two Frt sites inserted upstream of exon 4 of the
integrin av gene. The Frt NEO cassette and Exon 4 also flanked by two LoxP sites.
ES cells were transfected with the targeting vector and those containing the targeted
locus selected for using G418. The targeted clones were then grown in increasing
concentrations ofG418 to drive recombination in the second allele (Mortensen et al.,
1992). ES cells containing the double-targeted locus were transfected with the FLP
recoinbinase to delete the neomycin resistance cassette producing a silently targeted
integrin av gene. These ES cells were used to generate integrin av floxed mice. To
produce ES that were lacking the integrin av gene the ES cells could also be
transfected with Cre recombinase although this was not done for these experiments.
3.4.2 Serum batch testing for the parent E14 ES cell line
Having established and optimised the method of differentiating ES cells with the
EFC-1 cell line it was important to determine if the cell line we had used in our
targeting studies was also capable of generating macrophages and dendritic cells. As
discussed, variations in batches of serum can affect both the growth and
differentiation of ES cells. Five different batches were tested for their ability to
support EB formation using the E14 ES cell line. Each batch was tested in triplicate
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Figure 3.18: Targeting strategy for the deletion of the integrin av
gene. Integrin av targeting was carried out by Dr Adam Lacy-Hulbert.
E14 ES cells were transfected with the targeting vector and positive
clones selected for using G418. Positive clones containing on targeted
locus were then cultured in increasing concentrations of G418 to drive
recombination in the second locus. Transfection of the cells with Flp
recombinase removes the neomycin resistance cassette and leave
double floxed loci. Subsequent transfection with Cre recombinase
would allow the deletion of the integrin av gene although this was not
done in these experiments.
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condition. Alter 14 days the cultures were scored for the number of EB formed and
the appearance of hematopoietic colonies.
The average number of EB produced for each of the five batches was between 40-70
per culture. The addition of cytokines to the system did not affect the total numbers
ofEB obtained except for batch 2 where the numbers of EBs increased from 45 to 72
(Fig 3.19a&b). In the absence of cytokines, hematopoietic colonies were still
generated, however the numbers increase upon the addition of IL-3 and GM-CSF.
Batch 2 showed the greatest increase with the numbers of EB plus hematopoietic
colonies rising from 10 to 30 (Fig 3.19a&b). The ratio of total EB to those
expressing hematopoietic colonies was the highest for batch 5 although the actual
number of hematopoietic expressing EB was not that different from batch 2 (Fig
3.19a). Batch 4 was not affected by the presence of cytokines (Fig 3.19a&b).
Overall the addition of cytokines increased the frequency of EB associated with
hematopoietic colonies. These EB were plated onto tissue culture plastic and left for
a further 21 days. The differentiated cells produced were analysed for the expression
of the surface markers F4/80 and Cdllb to determine which of the five batches
would be used in subsequent experiments. Figure 3.20a shows how the flow
cytometry data was analysed for each batch, using batch 5 as an example. The cells
were harvested by gentle washing with PBS and each sample stained for F4/80 APC,
CD1 lb FITC or with the relevant isotype controls. The cells were first gated upon
by FSC/SSC and then the gated cells plotted as histograms (Fig 3.20a).
The differentiated cells arising from each of the five batches were similar in that 50-
80% of each cell population expressed the two myeloid cell markers F4/80 and
CDllb (Fig 3.20b). Batches 2 and 5 produced a marginally higher percentage of
positive cells although no differences were observed between each of the batches.
From this data it was decided to use batch 5 for future experiments as it gave the
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□ Total EB □ EB + Hematopoietic colonies
Figure 3.19: Serum batch test. Five different serums were tested for
their ability to support EB formation. E14 ES cells were cultured in MeC
with (a) or without (b) cytokines for each serum. At day 14 the cultures
were scored for EB formation and the presence of hematopoietic
colonies. Results expressed as the mean of one experiment performed

























□ F4/80 □ CD11b
Figure 3.20: Surface phenotype of differentiated cells from serum
batch test. At day 14 EB for each serum were plated in differentiation
medium with cytokines and cultured for a further 21 days. The cells
were then analysed by flow cytometry for expression of the surface
markers F4/80 APC and Cd11b FITC. A) Representative analysis of flow
data using serum 5. B) Bar graph showing the percentage of F4/80 and
Cd11 b positive cells for each batch.
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formed and produced a slightly higher percentage of myeloid cells in the
differentiated cultures.
3.4.3 Cell number titration for the parent E14 cell line
The optimal seeding density of ES cells at the initiation of differentiation varies
depending on the cell line used. During the serum testing it was noted that the MeC
media was becoming exhausted by day 7 of differentiation, this may have been due
to the number of ES cells plated or that the EB were attaching to the culture dish
promoting rapid cell proliferation. It was therefore necessary to titrate the number of
E14 ES cells plated into the MeC cultures and the percentage ofMeC used.
E14 cells were plated in the presence of IL-3 and GM-CSF at a cell density of 50,
100, 200, 300 or 400 cells per culture in either 0.9% or 1.1% MeC. Cultures were set
up in triplicate and after 14 days scored for the number of EBs formed, the presence
of hematopoietic colonies and the colour of the medium. A score of one indicated
that the media was still pink at day 14, two indicated that the media was orange and
three indicated that the media was exhausted. Figure 3.21 shows that the number of
EB formed at each cell density was consistently higher in the 1.1% than the 0.9%
MeC cultures. In contrast the number of EB associated with hematopoietic colonies
was comparable between the two sets of cultures (Fig 3.21a&b). However, at a
seeding density of 300 cells per dish the medium colour differed between the two
percentages of MeC. At day 14 the cells plated in 0.9% MeC had depleted the
medium turning it orange/yellow (score 3) in colour whereas in the 1.1% cultures the
medium was still pink (score 1) (Fig 3.21c). In addition, it was also observed that in
1.1% MeC the EB remained suspended unlike in the 0.9% cultures where they
appeared to be settling near the bottom of the plate. Based upon these observations it
was decided only to analyse the differentiated progeny from the cultures seeded at a
density of 300 cells per plate in 1.1% MeC and that these were the optimum
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Figure 3.21: E14 seeding density titration. ES cells were plated in
0.9% (a) or 1.1% (b) MeC supplemented with cytokines and cultured for
14 days. Cultures were set up with 50, 100, 200, 300 or 400 cells plated
per dish and scored for EB formation, the presence of hematopoietic
colonies and medium colour. A score of 1 indicates the media was still
pink, two indicates that the media was orange and a score of 3 indicates
the media was exhausted. Results expressed as the mean of one
experiment performed in triplicate +/- standard deviation.
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3.4.4 Morphology and Phenotype of differentiated E14 cells
Dendritic cells derived from both bone marrow and ES cells have a tendency to grow
in small clusters of cells (Fairchild et al., 2000; Senju et al., 2003). E14 ES cells that
had been cultured at a seeding density of 300 cells per plate in 1.1% MeC and
allowed to form EBs were plated and left in culture for 21 days. Figure 3.22 shows
representative pictures of the E14 differentiated progeny at days 7, 14 & 21 after
plating. At day 7 the EBs had adhered to the tissue culture plastic and spread. In
areas of the culture dish not colonised by EBs small numbers of irregular shaped
cells were observed, these cells increased in number forming small aggregates that
were loosely attached to an adherent monolayer (day 14). By day 21 the small
aggregates of cells had formed larger tightly packed clusters of cells that could be
harvested by gently washing with PBS. Both the adherent and non-adherent
fractions were analysed by flow cytometry.
Each fraction was analysed for surface expression of CDllb, F4/80, CD86 and
CD 11c. Fifty percent of the non-adherent cells were F4/80+CDl lb+CDl lc+
although the surface expression was slightly higher for F4/80 than CD 11c (Fig
3.23a). Similar expression profiles were obtained for the adherent cell population.
Again, 50% of the adherent cells were F4/80+CDl lb+CDl lc+ positive (Fig 3.23b).
Double staining of the adherent cells for CD lib/CD 11c revealed a population of
cells that were CD1 lb+CDl lclow(Fig 3.23b). These cells may have represented a
separate population of myeloid cells or may have been cells that are un-activated.
One of the defining characteristics of DCs is their ability to mature upon stimulation
with LPS. The non-adherent cells showed a slightly higher percentage of CDllc
positive cells than the adherent cells and were used to test the maturation ability of
the E14 derived dendritic cells.
88










Day 14 after plating
Day 21 after plating
5
*A, 'v- • :S->->V ' —"$,h /?> : ,»*
• <» , <f . -.tv,. 4ms:l ■ t.:»tj
, *;< !<%.; •.. J&hV iA
£j=^«tV§£f iJ ;:*Xf ' -■ >. ■ v -•y ■! vfciS;!•.'.v *Y .
Figure 3.22: Morphology of E14 derived cells after titration of
seeding density. Representative phase contrast micrographs of E14
derived cells on days 7, 14 & 21 after plating from ES cells cultured in
1.1% MeC at a seeding density of 300 cells per dish. Magnification x10
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Figure 3.23: Surface phenotype of E14 derived Myeloid cells. EB
cultured in 1.1% MeC at a density of 300 cells per dish were plated and
cultured for 21 days. Non-adherent (a) and adherent (b) cells were
analysed by flow cytometry for F4/80, CD11b, CD11c and CD86
expression, n=1.
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3.4.5 Maturation of E14 ES-derived dendritic cells
Figure 3.24 gives an overview of the culture protocol used to harvest mature
dendritic cells. DCs clusters were harvested from the EB containing plates by gentle
washing and re-plated. 2-3 hours later, maturation was induced by adding lpg/ml
LPS. The next day the mature DCs were harvested as non-adherent cells and plated
into fresh media (no LPS). The stimulated plates were also re-fed with fresh medium
allowing more of the mature DCs to be harvested at 48 hours.
After re-plating the dendritic cells formed a very heterogeneous population with the
DCs either in lightly adherent clusters or non-adherent in the supernatant (Fig 3.25).
Figure 3.25a shows a cluster of DCs from a culture stimulated with LPS. At the
higher magnification dendrites and veils of cytoplasm could be seen on the cells at
the very edges of the clusters. However the mature phenotype was more easily seen
in the non-adherent cells (Fig 3.25b). When examined at a higher magnification the
non-adherent dendritic cells clearly showed the mature DC phenotype (Fig 3.25c).
Maturation of the DCs in this way resulted in very low yields of the non-adherent
mature dendritic cells (~4xl05 from three stimulated plates). The few cells that were
obtained from the stimulated plates were analysed by flow cytometry for surface
expression of the DC marker CD86 (Fig 3.26). The stimulated cells showed a much
tighter population of cells by forward and side scatter suggesting that the maturation
of the DC results in a more homogeneous population although the cultures contained
a lot of cell debris (Low FSC/SSC). Surface expression of CD86 is clearly
upregulated on the cells that have been treated with LPS compared to the control.
Taken together the surface phenotype and the morphology of LPS treated cells
indicated that the ES derived DCs can be matured and respond in the same way as
their bone marrow derived counterparts.
3.4.6 Real-time PCR analysis of phagocytic receptor expression in ES DCs
The phagocytic receptors expressed by ES DCs were assessed using real-time PCR.
The transcription of these receptor genes was determined by expression profiling of
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Figure 3.24: Overview of the culture method used for maturation
studies. DC clusters are harvested from EB containing plates and re-
plated before stimulation with 1pg/ml LPS for 24 hours. The matured
DCs were then harvested from the supernatant and plated into fresh
media. The stimulated plates were also replenished with fresh media









Figure 3.25: Morphology of cells stimulated with LPS.
Representative phase contrast micrographs of ES-derived dendritic cells
after stimulation with 1 pg/ml LPS for 24 hours. A) clusters of dendritic
cells at two different magnifications in the re-plated cultures. B) non¬
adherent mature dendritic cells.
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Figure 3.26: LPS Stimulation of non-adherent cells. Non-adherent
cells harvested from differentiated E14 ES cells were stimulated with ±
1pg/ml LPS for 24 hours. DCs were gated by high FSC/SSC and
analysed for expression of the maturation marker CD86. Isotype control
shown in blue.
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CD lib sorted cells. Messenger RNA levels are presented relative to expression
levels in the well characterised BMDM. The majority of genes were expressed at
lower levels than in the BMDM (-10%). This may reflect the internal controls used
for real-time PCR, as all transcripts are measured relative to ribosomal RNA.
However, CD47, integrin P3, ABC1, and CD91 were more highly expressed in ES
DCs than in BMDM, compared to other genes. CD36 showed much lower
expression than in BMDM and TSP 1 showed no expression (Fig 3.27).
3.4.7 Differentiation of putatively integrin qv disrupted E14 ES cells
The data presented in the first part of this section described the differentiation of the
E14 ES cell line and the successful generation of ES derived DCs. The next step was
to determine whether ES cells targeted for integrin av were capable of differentiation
in the same way. Several setbacks were encountered when trying to culture the ES
cell lines carrying the floxed loci however more success was achieved with the ES
cells containing the double targeted locus including the neomycin resistance cassette
(Fig 3.18). The presence of the neomycin cassette results in disruption of the
integrin av gene effectively creating knockout cells. It was these cells that were used
to investigate the role of integrin av in the phagocytosis of apoptotic cells by ES
derived dendritic cells.
Prior to the differentiation of integrin av disrupted ES cells, genomic DNA was
isolated and a PCR performed to confirm the presence of the neomycin resistance
cassette (Fig 3.28). The primers 4f6 and 5b3 amplified a ~1 kb band that confirmed
that the neomycin cassette was present, the absence of a 700bp band showed that the
ES cells were targeted in both loci. The integrin av disrupted ES cells were
differentiated in the same media as the E14 ES cell line. As previously described it
was important to establish the optimum seeding density. ES cells were plated at 300,
400, 600, 800, 1000 and 1500 cells per culture in triplicate and after 14 days scored
for the number of EB formed and the presence of hematopoietic colonies. The
colour of the media was also scored 1, 2 or 3 with a score of 1 indicating the media
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Figure 3.27:Real-Time PCR analysis of ES DCs . Real-time PCR
was performed on CD11b sorted ES DCs and bone marrow derived
macrophages. Data presented for each of the phagocytic receptors as





















Figure 3.28: PCR of integrin av disrupted ES cells. A) Schematic
showing the neomycin disrupted integrin av gene, the targeted gene, the
position of the primers 4f6 and 5b3 and the expected product sizes. B)
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Figure 3.29: Differentiation of integrin av disrupted ES cells.
Integrin av disrupted cells were plated at seeding densities of 300, 400,
600, 800, 1000 and 1500 cells per culture to determine the optimum
seeding density for ES cell differentiation (A). Results expressed as
mean of one experiment performed in triplicate +/- standard deviation.
The colour of the media was scored to give an indication of the
maximum number of cells that could be plated without depletion of the
media. A score of one indicates the media was still pink, two indicates
the media was orange and a score of three indicates the media was
yellow (B). (C) representative phase contrast micrographs of the
differentiated progeny. Magnification x10.
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was still pink, a score of 2 indicating that the media had turned orange and a score of
3 indicating that the media was yellow (exhausted). Seeding densities of 300 and
400 cells per culture generated EB but these were quite low in number (~40 EB)
compared to seeding densities of 600 or 800 cells (-60 EB). The higher seeding
densities of 1000 and 1500 produced a high number of EB (80-100) with over half of
those associated with hematopoietic colonies (Fig 3.29a). Scoring of the media
colour showed that at seeding densities of 600 and 800 the media was still orange but
at 1000 and 1500 the media had become exhausted by day 14 of the differentiation
(Fig 3.29b). Although the higher seeding densities produced ideal numbers of EB
associated with hematopoietic colonies it was decided to use 800 cells per culture as
the media was not exhausted and good numbers of hematopoietic expressing EB
were obtained.
Figure 3.29c shows representative photomicrographs of the differentiated progeny
arising from the differentiation of integrin av disrupted ES cells. One week after
plating many non-adherent dendritic cells were apparent in the cultures with some
forming larger lightly adherent clusters. After 3 weeks the numbers of DC clusters
had increased dramatically although this varied depending on the number of EB in
any one plate (-30 EB/plate). These dendritic cell clusters showed a similar
morphology to the cells arising from the differentiation of wild type ES cells (Fig
3.29) indicating that disruption of integrin av did not affect the differentiation
capacity of the ES cells. For ease, from this point onwards, DCs arising from the
differentiation of integrin av disrupted ES cells will be termed DCa/'".
3.4,8 Maturation of DCou,""
DCav were stimulated with lpg/ml LPS as described in figure 3.24 and analysed
by flow cytometry for the DC surface markers CD 11c, CD80, CD86, CD40, and
major histocompatibility complex II (MHC II) (Fig 3.30). Levels of surface
expression of CD1 lc remained unaltered in the cells stimulated with LPS although a













Figure 3.30: LPS stimulation of integrin av disrupted ES derived
dendritic cells. ES derived dendritic cells were stimulated with 1 (ag/ml
LPS for 24 hours and analysed for surface markers CD11c, CD80,
CD86, CD40 and MHC II by flow cytometry.
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to the resting cells. CD80, CD86 and MHC II were all expressed at comparable
levels in the resting cells and each showed a marked upregulation when stimulated
with LPS. CD86 expression was also similar to that observed for the DCs derived
from the wild type ES cells (Fig 3.26). Unlike the other surface markers CD40 was
expressed at relatively low levels in the resting cells but similarly upregulated it upon
stimulation with LPS. The morphology and surface expression profiles exhibited by
these DCav is comparable to that observed for bone marrow derived dendritic cells
indicating that loss of integrin av does not affect the differentiation and maturation of
DCs, therefore confirming that these cells can be used as a model system in which to
study the role of integrin av in the phagocytosis of apoptotic cells by DCs.
3.4.9 Role of integrin av in apoptotic cell phagocytosis by DCav "7"
The role of integrin av in apoptotic cell phagocytosis was investigated using the
integrin inhibitory peptide RGD. DCav"7" were fed fluorescent (green) apoptotic
PMNs (-50% apoptosis) in the presence of the integrin av inhibitory peptide RGD
(0.5mg/ml) and the irrelevant control RAD (0.5mg/ml) for 2 hours. Phagocytosis
was then assessed by flow cytometry with DCav"" counterstained with F4/80 APC
and analysed as previously described (section 3.2.6). The level of phagocytosis in
the absence of peptides was considerably lower (31.5%) than previously observed for
macrophages (86%) derived from the EFC-1 ES cell line (Fig 3.31 & 3.10).
Nevertheless, phagocytosis of apoptotic cells by DCav "" was inhibited by RGD
(22.8%) compared to the control peptide (31.4%)(Fig 3.31). This was at variance
with data obtained from BMDM from P3"7" mice (Fig 1.3) and suggested that the DC
av "7" culture might contain cells expressing av or that putatively DC av"7" express low

































Figure 3.31: Failure of RGD to inhibit DCav"/_ apoptotic cell
phagocytosis. DCav_/" were incubated with apoptotic cells for 2 hours in
the presence of the inhibitory peptide RGD and the irrelevant control RAD.
DCav_/"were counterstained with F4/80-APC and phagocytosis assessed
by flow cytometry, n=1.
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3.5 Discussion.
This chapter has focussed on the characterisation of myeloid cells generated through
the differentiation of ES cells. As described by Wiles and Keller, differentiation of
the EFC-1 ES cell line in MeC cultures supplemented with IL-3 and either M-CSF or
GM-CSF resulted in the formation of EB, which upon disaggregation and plating
gave rise to multiple cell types (Wiles and Keller, 1991). Surface phenotype alone is
not sufficient to distinguish between different populations of myeloid cells and other
factors such as adherence and cytochemical analysis should be considered.
However, due to the relatively low numbers of cells obtained per differentiation the
proportion of differentiated cells that had developed into cells of the myeloid lineage
was assessed by flow cytometry. This method allowed the expression of several cell
surface markers to be examined simultaneously without the need for high cell
numbers and also provided an easy system for the identification ofmacrophages that
had ingested apoptotic cells in the flow based phagocytosis assays.
The numbers of cells harvested from the differentiation cultures were significantly
lower (5xl03 cells per EB) than that reported by others (~4xl05 cells per EB) (Faust
et al., 1994). Phenotyping of the differentiated cells by gene expression or protein
surface expression showed that a high percentage (-60%) of the cells generated were
indeed macrophages. However, the percentage of macrophages present in the
cultures may be underestimated due to the variability of the control antibody results.
The level of fluorescence observed for the control antibodies was higher than
expected suggesting that further titration of the amount of antibody used is required.
In addition, altering the amount of serum used to block the cells or isotype controls
from different sources could have been tested resulting in a higher percentage of
macrophages being detected.
An inherent property of macrophages is their ability to phagocytose unwanted or
foreign particles. Phagocytosis studies of ES Mcj> showed that they retained the
capacity to ingest not only latex beads as previously reported (Moore et ah, 1998) but
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also apoptotic PMNs. The ability of ES M(j> to ingest apoptotic cells was assessed by
flow cytometry and as a result it was difficult to discriminate between apoptotic cells
that had been ingested or had adhered to the surface of the macrophage. To
overcome this, prior to flow cytometry, macrophages that had interacted with
apoptotic cells could have been treated with trypsin to remove any cells that had
adhered. Alternatively, macrophages could have been sorted by the intensity of the
apoptotic cell labelling as those that had been ingested would not be as bright as
those bound to the surface of the macrophage. Nevertheless the macrophages
generated by differentiating ES cells were highly phagocytic rendering them ideal for
investigating the receptors expressed and the phagocytic ability that they confer upon
the macrophage.
To increase the numbers of myeloid cells generated by differentiating ES cells
several conditions in the differentiation protocol were altered; I) the concentration of
IL-3 used; II) the method of expansion of the differentiated cells; III) the method of
harvesting the terminally differentiated cells; and finally IV) the effect of serum
change.
The first parameter to be assessed was the concentration of IL-3 used in the culture
protocol. IL-3 has been shown to be the key cytokine involved in the differentiation
of ES cells to myeloid cells and when combined with M-CSF greatly enhanced the
numbers of EBs associated with macrophage-like cells (Wiles and Keller, 1991).
Although IL-3 is not expressed in the developing EBs it has been shown to exert a
proliferative effect on early stem and hematopoietic progenitor cells (Migliaccio et
al., 1988; Sonoda et al., 1988). However, increasing the concentrations of IL-3 used
in the differentiation of EFC-1 ES cells failed to increase the numbers of myeloid
cells produced with only -10% of the total cells harvested comprised of
macrophages.
The second condition to be altered was the way in which the differentiated cells were
cultured. Two methods have been published for the expansion of differentiated cells
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from EBs. EBs can either be disrupted using collagenase and the cell suspension
plated (Clarke et al., 2000; Keller et ah, 1993) or intact EBs plated into tissue culture
plates (Moore et ah, 1998; Moore et ah, 2001; Wiles and Keller, 1991). Comparison
of these two methods showed that plating of the intact EBs gave rise to greater
numbers of myeloid cells than the disruption of the EBs regardless of the CSF
cytokine used. This may have been due to the method of disruption of the EBs
resulting in the loss of the myeloid precursor cells, However, as seen in the IL-3
experiment the total numbers of macrophages were still quite low (10-15% of the
harvested cells). Although EB plating failed to increase the yield of macrophages the
cell numbers were higher than for disrupted EBs therefore, EB plating became the
method of choice for expansion of the differentiated cells.
Having determined that plating of the EBs was more successful than disruption,
different methods of harvesting the macrophages were tested. A previous report
(Moore et al., 1998) suggested that macrophage precursors could be harvested from
EB-containing plates and re-plated to generate macrophage cultures. However, when
this was attempted, no macrophages were generated and the re-plated cells looked
more like undifferentiated ES cells. Morphological analysis of the cultures showed
that many of the macrophage-like cells were attached to the EB layers with a few
distinct clusters of macrophages separate from the EBs. To harvest these cells
several cell detachment reagents were tested. Flow cytometry analysis of the cells
removed from the plates showed no expression of the myeloid markers F4/80 and
CDllb suggesting that either, no macrophages were present in the cultures or that
the cells had been lost during filtering of the cell suspension to remove the EBs. In
the cultures containing F4/80+ cells, magnetic cell sorting could be used to purify
macrophages. However, although this generated a relatively pure population of cells
the yield was still low, therefore confirming that the underlying problem was not
isolating differentiated cells but that very few of the differentiated cells were actually
macrophages.
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The final condition to be altered in the culture protocol was the batch of serum used.
Serum can affect both the growth and differentiation of ES cells (Wiles, 1993) and it
was suggested that changing the batch of serum used might improve the numbers of
macrophages generated. At this time attention was also turned to generating ES
derived dendritic cells (Fairchild et al., 2000) to overcome the problems experienced
with the harvesting of the macrophages. Initially the EFC-1 ES cells were
differentiated as described by Fairchild et al. but the EBs that formed adhered to the
culture dish and the differentiation potential was lost. Flowever when the EFC-1 ES
cells were seeded into MeC either in the presence or absence of cytokines (IL-3 and
GM-CSF) EB formation occurred as normal. No differences were observed between
the EBs generated using the cytokine conditions described by Fairchild et al and
those previously used in the differentiation cultures. Interestingly, changing the
serum gave rise to differentiated progeny that were smaller in size compared to
previous cultures. In addition these cells showed a surface phenotype similar to bone
marrow derived dendritic cells and to ES derived dendritic cells described by others
(Fairchild et al., 2000; Senju et al., 2003).
Changing the serum used in the differentiation cultures had a profound effect on the
numbers of cells generated with between 40-60% of the differentiated cells falling
within the myeloid cell gate (as determined by FSC/SSC) compared to -40% in the
original differentiation cultures and ~15% in the optimisation cultures. The decrease
in yield and purity of the cells between the original cultures and the optimisation
cultures could be due to the slight changes in the differentiating protocol or in the
method of harvesting but is more likely to be due to the ES cells. The ES cells may
have already become slightly differentiated or were not as healthy as those used in
the initial cultures accounting for the inability to improve the macrophage number, as
it is possible that the EB were not producing many hematopoietic precursors and
were unable to differentiate to large numbers of macrophages. Moreover, some ES
cell lines are more readily differentiated in vitro (Wiles and Keller, 1991) and
although the EFC-1 ES cells were capable of generating macrophages, differentiation
of other ES cell lines may help improve the yield. In addition, the cell number may
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also have been increased as a result of switching the differentiated cell type from
macrophages to the less adherent DCs. Therefore in conclusion, by changing the
serum and the cytokine used in the differentiation protocol we have generated a
myeloid cell that can be easily harvested, is dendritic-like in morphology and surface
expression and is of interest for our work on phagocytosis.
Similar to the EFC-1 ES cell line, the E14 ES cell line (used for the targeting work)
was also capable of differentiation. Prior to the differentiation of E14 ES cells
carrying a disrupted integrin av gene the ability of the E14 ES cells to generate
myeloid cells was assessed. Based on the data presented in the first part of this
chapter the E14 ES cell line was cultured in IL-3 and GM-CSF to drive
differentiation towards the production of dendritic cells.
As discussed previously batch variations in serum can influence the growth and
differentiation of ES cells. To ensure that the Labtech serum used in the
differentiation of the EFC-1 ES cell line was optimal for the E14 ES cells five
batches of serum were tested. Each of the five batches produced the normal number
of EBs (50-100 EB per dish) expected for cultures beyond day 6 of differentiation
(Wiles, 1993). The percentage of the differentiated cells that were positive for
CD1 lb and F4/80 were comparable for each of the batches tested. Flowever, batch 5
(Labtech Serum) produced slightly higher numbers of EBs associated with
hematopoietic cells and differentiated cells that showed expression of myeloid cell
surface markers so was the batch of choice for future experiments.
The number of ES cells required to give good differentiation varies with ES cell line
and any genetic manipulations that have been made. Ideally each time a new cell
line or targeted cell line is used the number of ES cells required should be titrated to
ensure that the optimum seeding density is used (Wiles, 1993). In the batch testing
experiment the media was becoming exhausted after 14 days in culture when 400 ES
cells were plated. In addition it was noted that the EBs appeared to be settling near
the bottom of the dish rather than suspended in the MeC. Increasing the percentage
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of MeC used in the cultures from 0.9% to 1.1% prevented the adherence of the EBs
and at each seeding density a slightly higher number of EBs formed than in the 0.9%
MeC. A seeding density of 300 cells per dish in 1.1% MeC was found to be optimal,
as the media was not exhausted by day 14 of culture. This seeding density was
considerably lower than that required for differentiation of the EFC-1 ES cell line
(800 cell per dish).
The morphology of the differentiated progeny was similar to the cells derived from
the EFC-1 ES cell line ~ 12 days after plating, although by day 20 the E14 derived
cells had aggregated and formed large clusters of cells that were lightly attached to
an adherent monolayer of cells. The morphology of these cells was highly
reminiscent of dendritic cells cultured from mouse blood (Inaba et al., 1992) and
showed greater similarities to the ES derived DCs described in the literature
(Fairchild et al., 2000; Senju et al., 2003). Harvesting of both the adherent and non¬
adherent fractions showed that these E14 derived DCs were F4/80+ CD1 lb" CD1 lc+
CD86" and were capable of up-regulating CD86 upon stimulation with LPS. In
addition stimulation of the DCs changed the morphology with more dendrites and
veils of cytoplasm apparent. The surface phenotype and morphology exhibited by
these cells closely resembles both bone marrow derived dendritic cells and other ES
derived DCs excluding F4/80 that is only expressed on ES DCs (Fairchild et al.,
2000; Lutz et al., 1999; Senju et al., 2003).
Unexpectedly, the change of ES cell line resulted in larger numbers of ES derived
dendritic cells that were more comparable to those described by Fairchild et al than
those derived from the EFC-1 ES cell line, thus providing evidence that generation of
high numbers ofmyeloid cells from ES cells is not only strongly dependent on serum
but also the ES cell line used.
The differentiation of integrin av disrupted ES cells provides further evidence that
the E14 ES cells are better than the EFC-1 ES cells for generating myeloid cells. The
number of ES cells required to give good differentiation of the integrin av disrupted
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ES cells was higher than that for the wild type ES cells. Nonetheless, the
morphology of the differentiated cells from these cultures were comparable to those
for the wild type differentiations indicating that the loss of integrin av had no effect
on the differentiation of the ES cells to myeloid cells
One of the most attractive properties of generating myeloid cells from ES cells is
ability to continually harvest cells over a period of time (Fairchild et ah, 2000;
Moore et al., 1998; Wiles and Keller, 1991). The numbers of cells that could be
obtained from the E14 ES cultures was greatly enhanced, as harvesting of the cells
and replenishment of the culture media on the EB containing plates allowed cells to
be harvested 2-3 times from the one culture plate over ~4 weeks. Previously this was
not observed with the differentiated EFC-1 ES cells and was not assessed in the
differentiation of the untargeted E14 ES cells although it is expected that these cells
will also be capable of regenerating the cultures. The ability to harvest greater
numbers of dendritic cells allowed a more extensive profile of maturation markers to
be assessed. The upregulation of MFIC class II and each of the co-stimulatory
molecules CD40, CD80 and CD86 provided further confirmation that the ES derived
DCs are similar to their bone marrow counterparts and other ES derived dendritic
cells (Fairchild et al., 2000; Lutz et al., 1999; Winzler et al., 1997).
Expression profiling of ES DCs showed that these cells expressed many of the
receptors also expressed in BMDM, a cell type in which apoptotic cell phagocytosis
has been well characterised. Interestingly, ES DCs showed a relative increase in
integrin p3, CD47 and ABC1 and a reduction in expression of CD36. This suggests
that ES DCs may use a subtly different recognition complex for apoptotic cells,
perhaps using avP3 but without the involvement of TSP 1 and CD36. The increased
expression of CD47 is intriguing as CD47 can form complexes with avp3 and is
involved in inflammatory signalling in DCs.
The main objective for developing ES differentiation to macrophages was to assess
whether these cells could be used to investigate the role of integrin av in apoptotic
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cell phagocytosis. Dendritic cells, like macrophages, have been shown to be capable
of apoptotic cell phagocytosis and in human systems this appears to be mediated by
av|35 (Albert et al., 1998a) or av(33 (Rubartelli et al., 1997). DCs derived from ES
cells lacking functional av integrins differentiated normally and phagocytosed
apoptotic cells. The levels of phagocytosis observed by the DCotv were slightly
lower than those previously observed for the EFC-1 derived macrophages although
this is not unexpected as macrophages engulf apoptotic cells more efficiently than
dendritic cells (Albert et al., 1998a). One of the fall-backs with using the integrin av
disrupted DCs for phagocytosis studies is that the control cells have to be generated
from a separate differentiation culture. Unfortunately, difficulties were encountered
with the differentiation of the control cells and the results are therefore difficult to
interpret. Ideally, ES cells silently targeted for integrin av should be differentiated
and the av gene deleted using Cre at the desired time, allowing both control cells and
cells lacking integrin av to be generated from the one differentiation culture.
Previously this approach has been hampered by the inability to efficiently transfect
myeloid cells with Cre but alternative methods have been tested and are discussed in
the following chapters.
Surprisingly, in view of previous data (section 1.4, Fig 1.3) the phagocytosis of
apoptotic cells by DCav_/" was inhibited by the integrin antagonistic peptide RGD
suggesting that integrin av was still being expressed. Cell surface staining was used
to verify expression of integrin ocv, however no staining could be detected for either
wild type BMDM or the DCav_/". Therefore in the absence of confirmation of
integrin av expression, it was concluded that the DCoU7" did not represent a
sufficiently rigorous system for assessment of the role of integrin av in the
phagocytosis of apoptotic cells.
In summary, ES cells can be differentiated successfully in the presence of IL-3 and
M-CSF or GM-CSF to macrophages and DCs respectively. Differentiation of high
numbers of cells is dependent on the ES cell line and the serum used and upon
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routine harvesting of the differentiated cells the cultures can be maintained for
several weeks. These ES derived myeloid cells are highly phagocytic and the ES






Chapter 4: Generation of constructs
4.1 Introduction
The second approach that was taken to investigate the role of integrin av in
phagocytosis of apoptotic cells was to deliver Cre to primary myeloid cells cultured
from mice in which integrin av was targeted by flanking with LoxP sites. However,
macrophages and dendritic cells are highly refractory to most transfection methods
although some success has been achieved with adenoviral vectors and an integrin-
targeted synthetic vector known as the LID vector (Uduehi et al., 2003). Recently, a
number of proteins have been identified that can translocate across the eukaryotic
cell membrane in the absence of any additional transfection reagents. These proteins
can carry a variety of other macromolecules with them into many different cell types
although this has never been demonstrated for macrophages. At the onset of this
work only one of the transduction proteins, VP22 had been shown to mediate cellular
entry of other proteins of >25 kDa in size into cells such as the COS-7 cell line and
terminally differentiated skeletal muscle cells (Derer et al., 1999; Elliott and O'Hare,
1997). This discovery highlighted VP22 as a potential delivery vehicle for the Cre
recombinase enzyme.
VP22 is a 38 kDa structural protein that is encoded by the UL49 gene of the Herpes
Simplex virus type 1 (Elliott and Meredith, 1992). This protein has been shown to
retain the unique property of intercellular transport whereby the protein is exported
from the cell in which it is synthesised and imported into its surrounding neighbours
(Elliott and O'Hare, 1997). This intercellular spreading of the VP22 protein has been
characterised by two distinct patterns of cellular localisation. VP22 is predominately
located in the cytoplasm of the cells in which it is expressed and in the nucleus of
cells into which it has spread, where it binds chromatin (Elliott and O'Hare, 1997).
The mechanism by which this occurs is currently unknown, although VP22 is
thought to be exported via a Golgi independent process, termed nonclassical
secretion, as treatment of cells expressing VP22 with Brefeldin A did not inhibit
protein transduction (Elliott and O'Hare, 1997). The manner in which VP22 is
transported into cells is also unclear. The ability of the VP22 protein to spread
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between cells at 4°C indicated that it is an energy independent process that does not
involve normal endocytosis. However, the sensitivity of VP22 import to
cytochalasin D showed that uptake of the protein may in some way involve the
microfilament network within the cell (Elliott and O'Hare, 1997; Elliott and O'Hare,
1998). This initial paper describing the intercellular trafficking properties of VP22
also investigated the potential of VP22 to deliver larger proteins to a cell monolayer
(Elliott and O'Hare, 1997). VP22 was fused to the 27 kDa GFP protein to create a 65
kDa fusion protein. When expressed in COS-1 cells the protein was shown to exhibit
a similar pattern of cellular localisation to the wt VP22 indicating that GFP did not
inhibit the trafficking properties of the transduction protein.
To test the ability of VP22 to deliver the 35 kDa Cre recombinase into cells
containing floxed genes, plasmids that expressed fusion proteins had to be created.
This chapter focuses on the generation of plasmids for expression of a VP22Cre
fusion protein in both eukaryotic and prokaryotic systems and a reporter construct
that will permit analysis of the cell permeability of the VP22Cre fusion protein.
4.2 Generation of pVP22Cre
4.2.1 Cloning Strategy for pVP22Cre
A schematic representation of the cloning strategy used to construct pVP22Cre is
shown in figure 4.1. The background vector used was the commercially available
plasmid pVP22mjWHis (Invitrogen)(appendix II). The plasmid contains the VP22
gene from Herpes Simplex virus under the control of the CMV IE promoter, a myc
epitope for antibody detection, a His tag to enable purification and ampicillin and
neomycin resistance cassettes for selection. Cre could be inserted into the multiple
cloning site, in frame, to produce a VP22-Cre-/7zyc-His fusion protein. The insert,
Cre recombinase was amplified from a Cre expressing plasmid using the VP22Cre f
and r primers to introduce a Notl restriction site at beginning of the Cre sequence and
an Xbal site at the terminal end. These primers removed the Cre ATG sequence and
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Figure 4.1: Schematic representation of the cloning strategy used to
generate pVP22Cre. The Cre PCR product was amplified from Cre with the
two primers VP22cre f and VP22Cre r to introduce the Not\ and Xba\ sites




Not I Xba I
pVP22 mycM\s tatccagcacagtggcggccgctcgagtctagagggcccgcggtt...
I I! I l l I II I I I I II I I I I I II
Seauenced DVP22Cre tatccagcacagtggcggccgctccaatctgctgaccgtgcacca..H K
llI IIlI I I I I I I I I I I I I II II I I I II I I l
0re gcggccgctccaatctgctgaccgtgcacca..
Sequenced with BGHr:
Not I Xba I
pVP22 mycMis tatccagcacagtggcggccgctcgagtctagagggcccgcggtt.
I I I II I I I I I I I I I I II I
Sequenced pVP22Cre aaacaggggcctgctggaagatggcgatctagagggcccgcggtt
lI IlIlllI Il I I I I I I I I II I I I I I I I l II II
_ aaacaggggcctgctggaagatggcgatctaga
Cre
Figure 4.2: Restriction digests of VP22Cre ligations. A) Schematic showing
restriction sites and expected product sizes for Age I and Hind Ill/C/al digests
and the localisation of the sequencing primers VP221f and BGHr. Presence of
the Cre insert was detected by AgeI restriction digest (B) and the orientation of
the insert determined by Hind Ill/C/al double digest (C). D)Sequencing of
VP22Cre with VP221f and BGHr primers aligned with the parent vector pVP22
myc/His and the Cre gene.
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the normal Cre stop codon. Subsequently, Cre was digested with Notl/Xbal and
ligated with Notl/Xbal digested pVP22wyc/His.
4.2.2 Characterisation of VP22Cre Ligations
Restriction digests were performed on several clones arising from the ligation of
pVP22myc/His and Cre to detect the presence and the orientation of the insert. The
clones were first cut with AgeI. AgeI cuts once at the beginning of the Cre sequence
and once in the VP22 vector releasing a lkb fragment if the insert is present (Fig
4.2a). All but three of the clones analysed released the expected band of lkb and
were subjected to further digests to determine the orientation of the insert (Fig 4.2b).
Double digest with restriction enzymes Hindlll (VP22 vector) and Clal (Cre)
released a 2kb fragment when the Cre insert was in correct orientation (Fig 4.2a) or a
lkb fragment if incorrect. Six of the clones analysed linearised when digested with
either Hindlll or Clal and produced the expected band of 2kb when digested with
both enzymes simultaneously; one representative digest is shown (Fig 4.2c).
Importantly, single digests with Clal produced one band, confirming that only one of
the Cre inserts had integrated. To confirm the restriction digests, the six clones were
sequenced and matched to the correct pVP22Cre sequence. Figure 4.2d shows the
sequence data of one of the correct pVP22Cre clones aligned with pVP22wyc/His
and the Cre PCR product. The rest of the Cre sequence was also examined (data not
shown) to ensure no mutations had been introduced during the PCR reaction.
4.3 Generation of the bacterial expression plasmid pETVP22Cre
4,3.1 Cloning strategy for pETVP22Cre
Experiments describing the use of the HIV-TAT transduction protein have
consistently used recombinant protein purified from bacteria allowing large
quantities of protein to be produced and greater control over the amount of protein
added in the culture system (Frankel and Pabo, 1988; Nagahara et al., 1998). To
enable the VP22Cre to be expressed in a prokaryotic system the VP22Cre coding
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Figure 4.3: Cloning strategy used to generate pETVP22Cre. pVP22Cre
was cut with restriction enzymes Hind\\\ and PmeI to release the sequence
containing the genes for VP22 and Cre and the myc/His tag for purification.
After conversion to a blunt-ended fragment the VP22Cremyc/His sequence




































I I II I I I I I I I I II I I
..TAAGAAGGAGATATACAGCTTATTATGACCTCTCGCCGCTCCGTG..




Sequenced with T7 terminator:
Nco I
AAGAAGGAGATATACCATGGCTAGCATGACTGGTGACAGCAA
II II I II I I I II I I I I I I I I I I I
.CACCATCACCATTGAGTTTGCTAGCATGACTGGTGGACAGCA
I I I I I I II I II I I I I II I I
. CACCATCACCATTGAGTTTAAACCCGCTGATCA





Figure 4.4: Restriction digests of pETVP22Cre. A) Schematic showing
restriction sites and expected product sizes for C/al digest. Presence and
orientation of the VP22Cre insert was determined by C/al digest (B). Correct
clones 3, 7, 8, 11 produced bands of 640 bp and the remaining vector 7.1kb.
C) Correct sequence of pETVP22Cre aligned with the sequences for pET11d
and pVP22Cre and the translated sequence showing the translational start
(M) which is the first ATG following the transcriptional start site and stop(*)
codon following the His tag.
Chapter 4: Generation of constructs
pVP22Cre was digested with Hindlll and PmeI to release the 2kb VP22Cre wye/His
fragment. The Hindlll site was then filled in using Klenow to generate a blunt end
for ligation to match the blunt Pmel digest end (Pmel digest leaves no overhang upon
digestion). The pETl Id vector was then cut with Ncol and treated with mung bean
nuclease to create blunt-ends (Fig 4.3).
4.3.2 Characterisation of pETVP22Cre ligations
Few clones were generated from the ligations. Following restriction digest with Clal
several clones released a 640bp band indicating the presence and correct orientation
of the VP22Cre insert (Fig 4.4b). However, the sizes of the bands for the remaining
vector varied between 5 and 9kb. Mung bean nuclease can overdigest DNA and
therefore clones of the correct size were selected. Four of the clones (3, 7, 8, 11) had
a band of ~7kb and the correct 640bp band and were analysed by DNA sequencing.
Only one of the clones when aligned with the pETlld and pVP22Cre sequences
contained correct insertion of the VP22Cretfiyc/His fragment in frame (Fig 4.4c).
4.4.Generation of the reporter construct pnLacZLoxP
It was necessary to produce a reporter construct that could detect Cre activity and
hence could be used to determine the efficiency of pVP22Cre transduction. Such
reporters generally consist of a detectable reporter gene (such as LacZ or GFP) where
expression is blocked until Cre mediated recombination, usually through a LoxP
flanked transcriptional stop sequence. However in preliminary experiments these
reporters appeared to be 'leaky' allowing some reporter expression. To prevent these
problems a new reporter construct was designed. This plasmid expressed LacZ but
following Cre mediated recombination, switched to expressing enhanced green
fluorescent protein (EGFP). As EGFP was completely separated from the necessary
transcriptional start sequences until Cre activity, the reporter would not be leaky.
Furthermore LacZ would allow detection of cells that contained the reporter but had
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PEYFPLOXP ccggactcagatctcgagccatggggcccaagaagaaacgcaaagt..
II I I I I I I I I I I I I I I I I I I II I I I II I I I I I I
PCR product A tcgagccatggggcccaagaagaaacgcaaagt..
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Figure 4.6: Cloning step 1; generation of EYFPLoxP plasmid. PCR
product A was generated using primers ATGNLSLoxP forward and reverse.
A)The short 70bp product was ligated into the Xho\ and BamHI sites of the
background pEYFP-N1 vector to give plasmid pEYFPLoxP (4.77 kb). B)
Sequence of pEYFPLoxP aligned with pEYFP and PCR product A and the
translated sequence showing the translation start codon (M).
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4.4.1 Cloning Strategy for pnLacZLoxP
Figure 4.5 gives an overview of the cloning strategy used to construct pnLacZLoxP.
The background vector used was the EYFP-N1 vector available from Clontech.
Three sets of primers ATGNLSLoxP f and r, LoxPegfpnlf and egfp3r, and LacZ f
and r were used to create the PCR products A, B and C respectively. In turn, each of
the PCR products were ligated with the background vector EYFP-N1 to give
plasmids pEYFPLoxP (Step 1), pELoxPGFP (Step 2) and the final plasmid
pnLacZLoxP (Step 3).
ATGNLSLoxP forward and reverse primers were used to create PCR product A
containing the transcriptional start (ATG) and the nuclear localisation sequence
(NLS) along-with the first LoxP site flanked by Xhol and BamHl restriction sites.
This 70bp sequence was then ligated with the relevant sites in the EYFP-N1 vector
(4.7 kb) to give the 4.77kb plasmid pEYFPLoxP (Fig 4.5)(Step 1). Insertion of PCR
product A removed an EcoRI site from pEYFP-N 1. Ligation reactions were enriched
for by digestion with EcoRI to remove any contaminating background vector before
transformation. Plasmids that did not digest with EcoRI were sequenced to confirm
insertion and the plasmid pEYFPLoxP was used as the background vector for step 2
of the cloning (Fig 4.6).
The second step of the cloning strategy was to introduce the gene for GFP preceded
by the second of the LoxP sites. The two primers LoxPegfpnlf and EGFP3r were
used to amplify iEGFP from the iEGFP expressing plasmid that contains a version of
EGFP with two introns that increase expression of the gene (appendix II). The
LoxPegfpnlf primer placed a BamHl restriction site and the second of the LoxP
sequences in front of the GFP to give PCR product B. This was then digested with
BamHl and RsrGI (terminal end of GFP) to ligate with the corresponding sites in
plasmid pEYFPLoxP. Restriction digests using BamHl and BsrGl were performed
on clones arising from the ligation. Each of the clones tested linearised when
digested with either of the enzymes to give the expected band of 4.9kb confirming
that only one of the inserts had integrated (Fig 4.7). Double digest with both
123
eATG NLS ^HHHVilIN iEGFP
Step 1 Step 3 Step 2























































Figure 4.7: Cloning step 2; generation of ELoxP GFP plasmid. Primers
LoxPegfpnlf and EGFP3r were used to introduce a BamHI site and LoxP site
before the GFP gene. PCR product B was ligated into the BamH 1/BsrGI sites
of pEYFPLoxP. Diagnostic digest of a representative clone arising from the
ligation produced a linearised band of 5 kb if cut with either BamHI or BsrGI
and released a 1 kb band when cut with both enzymes.
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A) ^PELOXP GFR CGTCCAGGAGCGCACCACCTTCTTCAAGGACGACGGC.
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iEGFP CTACCTGAGCACCCAGTCCGCCCTGAGCAAAGACCCC..
Figure 4.8: Base Changes in GFP sequence inhibit GFP fluorescence.
DNA sequencing of pELoxPGFP plasmid revealed two base changes in the
iEGFP sequence that resulted in loss of GFP expression (A). Base changes
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Figure 4.9: Cloning Step 3; generation of pnLacZloxP. Cloning of PCR
product C with plasmid pELoxPGFP completed the final pnLacZLoxP
plasmid. A) Clones containing the 3 kb insert were clearly visible on a DNA
agarose gel. B) Restriction digest of the longer clones gave bands of 550 bp
and 8.4 kb when cut with EcoRI and linearised when cut with Not\. Double
digest released three bands of 550 bp, 1 kb and 7.4 kb.
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enzymes released a band of l.lkb (Fig 4.7) in size indicating that the LoxP GFP
insert had replaced the smaller 800bp EYFP gene present in the background vector to
give plasmid pELoxPGFP.
The plasmid was sequenced to check for mutations arising through PCR
amplification. Two mutations were found, T300C and G820A (a thymidine to
cytosine conversion and a guanine to adenine conversion) (Fig 4.8a). Both the base
changes caused amino acid changes in the protein and the resulting protein showed
no fluorescecnce (Fig 4.8a). Neither of the mutations were found to be present in the
template DNA and therefore must have occurred during the PCR amplification of
GFP. To avoid introducing further mutations by PCR it was decided to use site-
directed mutagenesis to correct the base changes. Previously PCR product B had
been cloned into a pGEM T vector (Promega) and this was used as a template in the
mutagenesis reaction. The two primers LZLPSDM 1 and 2 were used to correct both
of the base changes in one round of mutagenesis. Having successfully corrected the
GFP sequence and confirmed that the GFP fluorescence was restored (Fig 4.8b) the
insert was re-ligated with pEYFPLoxP to create the correct version of pELoxPGFP.
The final cloning step to generate the reporter construct pnLacZLoxP was to clone
the P-galactosidase gene between the two LoxP sites. Again, two primers LacZ
forward and reverse were used to amplify the gene from a P-galactosidase expressing
plasmid (PCR product C). The background vector pELoxPGFP was digested with
restriction enzyme BamW\ and PCR product C with the restriction enzyme BglW.
Once cut these enzymes leave compatible ends allowing insertion of the LacZ gene
to complete the pnLacZLoxP construct. Clones containing the LacZ insert were
clearly visible on an agarose gel as they were 3kb greater in size than the
pELoxPGFP plasmid (Fig 4.9a). To confirm which of the longer clones contained
the insert in the correct orientation double digests with EcoKl and Notl were
performed. Three of the final clones produced the expected product sizes of 550bp,
1 kb and 7.4 kb (Fig 4.9b) and were checked by DNA sequencing. Figure 4.1 Oa
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pELoxP GFP taatgtatgctatacgaagttatcggatccataacttcgtataatgta..
I I I I I I I I I I I I I I I I I I I I I I I I I
pnLacZLoxP taatgtatgctatacgaagttatcggatctcgtcgttttacaacgtcg..









I I I I I II I I I I I I I II I I I I I I II II II
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Bgl II
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Figure 4.10: Sequencing of pnLacZLoxP. DNA sequencing with primers
LZLP 1 f/1 r and 2f/2r confirmed the correct alignment of the p-galactosidase
gene between the two LoxP sites completing the reporter plasmid (A). B)
schematic and translated sequence showing the recombination of
pnLacZLoxP after Cre mediated deletion and the translational start codon in
the iEGFP.
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shows the sequence data for the reporter construct using primers LZLP lf/lr and
2f/2r to confirm to correct ligation of the insert between the two LoxP sites.
Sequences for the pELoxPGFP plasmid (Step 2) are aligned with either end of the
LacZ gene to demonstrate the final sequence for pnLacZLoxP. In the presence of
Cre the P-galactosidase gene is deleted and the LoxP sites recombine allowing
expression of the GFP. Figure 4.10b shows the recombined sequence and its
translation confirming that the start codon of the GFP is in frame with the translation
initiation codon and will allow expression ofGFP.
4.5 Functional studies of pnLacZLoxP and VP22Cre
4.5.1 Cellular Localisation of VP22Cre
To establish if the fusion of Cre to VP22 affected Cre expression, COS-7 cells were
transiently transfected with the pVP22Cre plasmid. 24 hours later the cells were
fixed with ice-cold methanol (-20°C) and labelled with a rabbit polyclonal anti-Cre
antibody together with a primary conjugated Alexa 568 goat anti-rabbit secondary.
VP22Cre expression was predominantly nuclear but at higher magnification (x32)
some cells showed punctate staining around the nuclear rim, this was particularly
notable where cell fusion had occurred (Fig 4.11). High background fluorescence
was also observed however there was clear distinction between expressing and non-
expressing cells. Mock transfected cells were negative for the Cre.
4.5.2 Verification of plasmid function
Firstly, the activity of Cre in VP22Cre and the ability of pnLacZLoxP to act as a
reporter were tested. COS-7 cells were transfected with pnLacZLoxP or a control
LacZ expressing plasmid. Both plasmids expressed functional LacZ and no p-
galactosidase activity was seen in the mock transfected cells (Fig 4.12). Importantly,
no GFP expression was observed in the pnLacZLoxP transfected cells. High levels
of Cre mediated deletion were visible in cells that had seen either pVP22Cre or the









Figure 4.11: Expression of VP22Cre in COS-7 cells. Localisation of
VP22cre expression in transiently transfected COS-7 cells using an anti-
Cre antibody and an Alexa 568 (red) conjugated secondary antibody.
130
pnLacZLoxp pnLacZLoxp no ere
Figure 4.12: pnLacZLoxP and pVP22Cre expression, p-galactosidase
expression (blue) can be clearly detected in cells transfected with
pnLacZLoxP. Upon Cre mediated deletion GFP fluorescence is clearly
visible.
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The number of cells showing green fluorescence was slightly higher in the Cre-pac
cells than in those that had been transfected with pVP22Cre, this was probably due to
each plasmid being under a different promoter. However, the number of GFP (60%)
positive cells was also greater than the number of cells expressing (3-galactosidase
(40%) suggesting that either the X-Gal stain was not sensitive enough to detect all
the cells expressing the reporter, or that there was a problem with the translation or
folding of the protein in some cells.
4.5 Discussion
To evaluate the potential of VP22 to translocate Cre across the cell membrane three
plasmids were generated: to express VP22Cre in eukaryotic cells, to express
VP22Cre in prokaryotic cells and a reporter construct that would detect Cre activity.
Antibody detection of VP22Cre in transfected COS-7 cells showed that VP22Cre
exhibited a similar pattern of cellular localisation described for VP22 and other VP22
fusion proteins (Elliott and O'Hare, 1999; Phelan et al., 1998; Wybranietz et al.,
1999). However, more significantly, it confirmed that fusion of the two proteins
does not affect the ability of cells to express the Cre protein.
The reporter construct pnLacZLoxP was designed such that cells that were
expressing the reporter could be detected by staining for LacZ and only after
exposure to Cre would express GFP. Dual transfection of the reporter with
pVP22Cre or a control Cre plasmid resulted in the expression ofGFP confirming that
pnLacZLoxP was functional as a reporter construct. More importantly, it also
confirmed that fusion of the Cre recombinase to VP22 did not interfere with the
ability of Cre to recognise the LoxP sites and mediate deletion.
The dual transfection experiments confirmed that the two plasmids can be highly
expressed in the COS-7 cell line and that they function as a recombinase and as a
reporter. Nevertheless, these experiments were not sufficient to determine whether
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Cre affects the transduction potential of VP22. Antibody detection of VP22 is
routinely used to determine intercellular spreading of VP22 fusion proteins (Aints et
al., 1999; Elliott and O'Hare, 1997; Phelan et ah, 1998). Detection of the VP22Cre
in this way suggests that many of the cells contain the protein, however as the cells
have been transfected, it is impossible to determine whether this is a result of
transfection, cell division or intercellular spread of the protein. Moreover it would be
more reliable to determine transduction of the VP22Cre by co-culturing cells
expressing the protein with nai've cells or cells expressing the reporter construct.
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5.1 Introduction
Conditional mutagenesis using the Cre/LoxP recombination system has become a
fundamental tool in understanding how genes function in vivo (Lewandoski, 2001).
However, the potential of site-specific recombination is limited by the difficulty in
expressing the recombinase enzyme in the desired cell type and at specific stages of
development. Three main strategies have been employed to gain temporal and
spatial control over Cre mediated recombination in vivo:
I) Tissue specific expression of Cre from transgenes. The approaches
generally use portions of promoters from genes expressed solely in the
tissue/cell type of interest. Occasionally Cre is 'knocked into' a gene (eg.
CD19-Cre) allowing increased specificity or level of expression and
avoids the problems of inappropriate expression of chimerism seen in
transgenics (Rickert et al., 1997). However, this method relies on finding
a suitable gene in the cell type of interest, this has proven to be difficult
for macrophages and dendritic cells, as many of the genes they express
are shared by other myeloid cells. In addition the approaches require
expression of the transgene in a particular tissue and many transgenes are
silenced in the hematopoietic system. This approach has also proved to
be time consuming and costly as it requires the generation of several
mice.
II) Induction of Cre activity, either at the transcriptional level with inducers
such as tetracycline (Gossen and Bujard, 1992) and the interferon
inducible promoter Mxl (Kuhn et al., 1995) or by controlling cellular
localisation of recombinase (eg tamoxifen) (Metzger et al., 1995b;
Schwenk et al., 1998). This is perhaps the most widely used method of
initiating Cre recombination but is limited by the toxicity of inducers, the
leakiness of the system before induction and it provides little cell type
specificity.
III) Delivery of Cre into cultured cells either by transfection or by adenoviral
delivery (Anton and Graham, 1995b). This can be useful in vivo if the
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cell type of interest can be specifically targeted although has greater
potential in vitro if the cells of interest can be readily cultured. This is the
case for monocyte cells that if cultured from targeted mice and treated
with Cre could be re-introduced in vivo. Moreover this method is far less
time consuming and costly than crossing floxed mice with Cre expressing
mice and allows greater control over the time and cell type specificity of
recombination.
The potential for the delivery of Cre to cultured macrophages was explored. To
avoid adverse responses to virus, two transduction proteins VP22 and MTS were
tested alongside adenovirus.
5.2 Cre delivery using transduction proteins
5.2,1 VP22 delivery ofCre
Many of the reports describing the transduction properties ofVP22 have been carried
out using VP22GFP fusion proteins and a variety of different cultured cell types
(Brewis et ah, 2000; Derer et ah, 1999; Wybranietz et ah, 1999). Much of this work
has focussed on the localisation of the VP22GFP in cells expressing the fusion
protein and in the cells that it has entered. Only two reports have described the use
of VP22 to deliver functional enzymes that affect target cells. In the first of these
reports VP22 was fused to p53 and used to induce apoptosis in a human
osteosarcoma cell line (SAOS-2 p53 deficient cells). When COS-1 cells expressing
the VP22 p53 fusion protein were cultured with nai've SAOS-2 cells apoptosis could
be detected in the SAOS-2 cells using TUNEL staining suggesting that functional
p53 had been delivered (Phelan et ah, 1998). The second report used VP22 to
introduce herpes simplex virus thymidine kinase (VP22-TK) to a human kidney
epithelial cell line (293T) to evaluate its potential in suicide gene tharapy.
Thymidine kinase makes cells sensitive to ganciclovir, and addition of VP22-TK to
cultured cells increased cell death following ganciclovir treatment, again
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demonstrating localisation of a VP22 fusion protein to the cytoplasm (Liu et al.,
2001).
The potential of VP22 to deliver active proteins to many cell types, and to deliver
these proteins to the nucleus, made it an ideal candidate for delivery of Cre. This
was particularly appealing for macrophages that are resistant to many methods of
transfection and due to their role in host defence are not ideally suited to viral
transfection. Also, a VP22 fusion protein can be delivered by co-culturing cells or a
conditioned supernatant/purified protein, therefore lending itself perfectly to the
methods used for the in vitro culture of macrophages. The transduction ability of
VP22 was tested using two cultures of COS-7 cells, one transfected with pVP22Cre
and another with reporter plasmid (pnLacZLoxP). One day post-transfection
VP22Cre expressing cells were plated with the reporter cells at a 1:1, 1:10 and 1:50
ratio in serum free medium and left in culture overnight. The cells were then
analysed by microscopy and flow cytometry for evidence of Cre mediated
recombination. The reporter construct was transfected with high efficiency with
~60% of the cells expressing (3-galactosidase 48 hours after transfection. However
no GFP expression was observed for any of the co-culture conditions suggesting that
Cre activity was not delivered to the reporter cells (Fig 5.1a). Flow cytometry
confirmed the microscopy results although showed a small peak (arrow) of GFP
fluorescence that was probably caused by slight read through of the reporter plasmid
in 1% of the cells (Fig 5.1b). This was only seen 48 hours after transfection and was
also seen in cells transfected with reporter and cultured alone, so was independent of
any Cre expression. These results indicated that the VP22Cre fusion protein
expressed by the COS-7 cells was not capable of intercellular spread or was
translocated into neighbouring cells but unable to function correctly following
translocation. Therefore, Cre delivery from VP22Cre expressing cells was not a
viable route of delivery.
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pnLacZLoxP 48 hrs post-transfection Co-culture 1:1 ratio
p-galactosidase activity Fluorescence (GFP)
■iCOS-7 pnLacZLoxP
□COS-7 VP22Cre 1:1 ratio with COS-7 pnLacZLoxP
■ COS-7 VP22Cre 1:10 ratio with COS-7 pnLacZLoxP
IH COS-7 VP22Cre 1:50 ratio with COS-7 pnLacZLoxP
Figure 5.1: Assessment of VP22Cre transduction. COS-7 cells
transiently transfected with either pnLacZLoxP or pVP22Cre were co-
cultured at 1:1, 1:10 and 1:50 ratios for 16 hours. Cells were then
assayed for p-galactosidase acitivity and the expression of GFP. X-gal
staining indicated that -60% of the transfected cells expressed the
reporter construct however, fluorescence microscopy (A) and flow
cytometry (B) showed no GFP expression indicating that there was no
transduction of the VP22Cre protein.
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5.2.1 Purification of pETVP22Cre
In the absence of VP22Cre translocation from transfected COS-7 cells, it was
decided to generate recombinant purified protein to determine if soluble protein was
capable of translocation and delivery of functional Cre into reporter cells. The 72
kDa VP22Cre protein was expressed in BL21(DE3) pLysS bacteria. Protein was
prepared from bacterial cultures and His tag protein purified using a nickel affinity
column. The expected 72 kDa protein could not be detected in the His tag purified
fraction by Coomassie or Western blot with anti Cre antibody and was only present
as a faint band in total protein fractions. Three prominent bands of 30, 25 and 18
kDa were seen and only a band of 25 kDa was purified by the His tag (Fig 5.2a&b).
Very low amounts of protein were present in the eluted fraction and predominant
proteins were only 20 kDa in size. The absence of the 72 k Da protein VP22Cre is
most likely the result of cleavage of the protein by the bacteria. Therefore, the
purification of the VP22Cre protein from bacteria was not a suitable method for
generating VP22Cre protein.
5.2.2 MTSCre delivery ofCre
During the course of this work a paper was published describing the use of another
transduction protein to traffic Cre recombinase into cells (Jo et al., 2001). Jo et al
utilised the 12 amino acid membrane translocation sequence (MTS) from Kaposi
fibroblast growth factor 4 that had been previously shown to permeate the cell
membrane (Lin et al., 1995; Rojas et al., 1998). The expression plasmid for His6-
NLS-Cre-MTS (MTSCre) (Fig 5.3a)(a kind gift from Dr Earl Ruley, Vanderbilt
University School of Medicine) was used to produce recombinant protein as an
alternative to pETVP22Cre.
The 42Kda MTSCre protein was purified from BL21(DE3) pLysS competent
bacteria using a nickel affinity resin (Ni-NTA agarose Qiagen). Fractions from each
step of the purification procedure were run on a 12% SDS-PAGE gel and analysed
by Coomassie staining and Western blot (Fig 5.3). The MTSCre protein was
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Figure 5.2: VP22Cre protein purification.
A) Schematic representation of VP22Cre protein showing VP22, Cre
recombinase, myc/His tag for detection and purification. SDS-PAGE
analysis of VP22Cre protein purification. B) Coomassie stained gel and
C) Western blot analysis of purification fractions detected with an anti-
Cre antibody. The 72 kDa VP22Cre protein was not detectable in any
of the fractions.
A) Cre MTS
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Figure 5.3: MTSCre protein purification.
A) Schematic representation of the MTSCre protein. SDS-PAGE
analysis of MTSCre protein purification. B) Coomassie stained gel and
C) Western blot analysis of purification fractions detected with an anti-
Cre antibody. The same cell equivalent amount of protein was loaded in
each lane.
p-galactosidase activity Fluorescence (GFP)
n COS-7 pnLacZLoxP
I COS-7 pnLacZLoxP + MTSCre 25 pg/ml
I I COS-7 pnLacZLoxP + MTSCre 50 pg/ml
PI COS-7 pnLacZLoxP + MTSCre 100 pg/ml
| COS-7 pnLacZLoxP + MTSCre 200 pg/ml
I I COS-7 pnLacZLoxP + MTSCre 400 pg/ml
Figure 5.4: Assesment of MTSCre cell permeability. COS-7 cells
transfected with pnLacZLoxP were incubated with purified MTSCre
protein at 25, 50, 100, 200, 400pg/ml. X-gal staining showed -50-60%
of the cells were expressing the reporter but no GFP fluorescence was
observed in any of the culture conditions as shown by microscopy (A)
or flow cytometry (B).
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detected using an anti-Cre antibody (Novagen). A prominent band in the Western
blots, MTSCre was detected in the total bacterial protein and in the column purified
fractions. MTSCre was also detected in the insoluble fraction but similar levels of
protein were also apparent in the flow through and the first of the washing steps
suggesting there was sufficient protein in the cleared lysate to saturate the column
(Fig.5.3). Elution from the column showed that the MTSCre protein had been
enriched and that fractions 2-7 contained the highest levels of the protein. Flowever
several other bacterial proteins were also co-purified and a second protein of similar
size to the MTSCre protein was the predominant protein in the eluted fraction (Fig
5.3). Nevertheless high concentrations of the MTSCre protein were obtained and the
protein was used without further purification.
5.2.3 Assesment ofMTSCre Transduction
COS-7 cells transfected with the reporter pnLacZLoxP were used to assess whether
the purified MTSCre protein was capable of inducing recombination. MTSCre was
incubated with the reporter cells at concentrations of 25, 50, 100, 200 and 400pg/ml
in serum free media overnight. The following day the cells were analysed by
fluorescent microscopy and flow cytometry. Despite high levels (-60% of the cells)
of expression of P-galactosidase no GFP fluorescence was observed in cells that had
been incubated with MTSCre protein at any of the concentrations shown (Fig 5.4a).
Flow cytometry analysis of the same cells showed a slight increase in
autofluorescence in the treated cells but confirmed that no deletion had taken place as
indicated by the lack of GFP expression (Fig 5.4b). A slight increase in fluorescence
was observed in 1% of the cells (Fig 5.4b arrow) as in the VP22Cre co-culture
experiments (Fig 5.1) but again this was due to slight read through of the reporter
construct.
5.2.6 Interim discussion
The data presented in this section has evaluated the ability of two transduction
proteins VP22 and MTS to introduce Cre into cells containing floxed genes. Co-
culture of cells expressing VP22Cre fusion protein with cells expressing the reporter
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construct pnLacZLoxP resulted in no detectable transduction of the protein. Several
possibilities exist to explain this lack of transduction: I) Fusion of the Cre
recombinase to the VP22 protein in some way inhibits the ability of VP22 to be
exported and imported into neighbouring cells. A recent report by Stroch et al. also
failed to detect intercellular spread of VP22 fused to IkBa from expressing to non-
transfected cells, although addition of exogenous protein from cell free extracts of
cells expressing the VP22IkBa protein resulted in transduction of the protein (Stroh
et al., 2003). Similarly this may also be the case for the VP22Cre but suggests that
the intercellular spreading of VP22 fusion proteins may be dependent on the
structure of the protein that it is fused to. II) The size of the VP22Cre fusion protein
may hinder intercellular transport. However, fusion of the p53 gene to VP22 (Phelan
et al., 1998) produced a protein of 90 kDa that did not affect the transduction
potential of the VP22. Ill) Cre also has intrinsic nuclear localisation ability (Le et
al., 1999) and therefore it may be that a 'tug of war' exists between the Cre and the
VP22 with the Cre trying to localise to the nucleus and the VP22 trying to exit the
cells, resulting in absence of translocation. Ill) VP22Cre was capable of
translocation to neighbouring cells but unable to localise to the nucleus to function.
IV) The VP22Cre may be delivered not function as a recombinase in the co-cultured
cells. This is highly unlikely as dual transfection of VP22Cre with the reporter
construct resulted in deletion of P-galactoidase and expression of GFP, confirming
that the fusion protein works as a recombinase.
Attempts to produce recombinant VP22Cre were unsuccessful. Consistent with other
reports (Kueltzo et al., 2000; Normand et al., 2001; Stroh et al., 2003) expression of
the VP22Cre in a bacterial expression system resulted in cleavage and loss of the
recombinant VP22Cre protein. Previously it has been shown that the C-terminal half
of the protein is essential for the transport function of VP22 (Elliott and O'Hare,
1997). Normand et al. showed that VP22 fusion proteins containing C-terminal
residues 159-301 could be produced in large quantities by expression in bacteria
without cleavage of the protein and that they retained the transduction properties of
the full length VP22 protein (Normand et al., 2001). Due to time constraints and the
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availability of the MTSCre transduction protein a truncated VP22Cre fusion protein
was not generated. Although the failure to produce recombinant VP22Cre protein is
likely to be linked to the use of full length VP22 it must also be considered that Cre
is itself a phage protein and when expressed at high levels can be also be toxic
(Loonstra et al., 2001).
Exogenous application of purified MTSCre protein on cells expressing the reporter
pnLacZLoxP also showed no detectable signs of Cre activity. This was unexpected
as the original work describing MTSCre as a transduction protein showed high levels
(-80%) of recombination in floxed cells treated ex vivo with the recombinant protein
(Jo et al, 2001). The reason for this difference remains unknown. It is possible that
co-purifying bacterial proteins interfere with the MTS translocation ability. Initially
it was decided that the contaminating proteins co-purified with the MTSCre protein
would have little or no effect on the transduction of the protein but it is possible that
these bacterial proteins could be causing the MTSCre to aggregate therefore
preventing it crossing the cell membrane. Nonetheless, without further purification
of the protein it remains unclear as to whether these proteins render the MTSCre
ineffective.
Some controversy exists surrounding the potential of transduction proteins to cross
the cell membrane. Lundberg et al. propose that the nuclear localisation of the
transduction proteins observed in antibody detection of VP22 and TAT fusion
proteins is a fixation artifact when the cells are fixed with methanol (Lundberg et al.,
2003; Lundberg and Johansson, 2001). Moreover evidence is provided for binding
of these fusion proteins to the cell membrane and it is suggested that the proteins are
taken up by constitutive endocytosis. Another group also report that VP22 and TAT
bind to the cell membrane but do not mediate membrane translocation of the
diptheria Toxin A fragment (Falnes et al., 2001). However, the work describing the
use of Cre recombinase fused to the MTS or TAT transduction proteins (Jo et al.,
2001; Peitz et al., 2002) strongly argues against the cellular binding of these proteins
as Cre is required to be expressed in the nucleus to mediate deletion ofLoxP targeted
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genes. The experiments discussed in this chapter were in no way exhaustive and
cannot challenge the proposal that VP22 does not translocate across the cell
membrane. Although the transduction proteins tested did not result in cellular
delivery of Cre it is suggested that the intercellular trafficking of VP22 may be
dependent on its fusion partner and that this work merits further investigation.
5.3 Adenoviral delivery of Cre.
Recombinant adenoviruses have been used to efficiently deliver a variety of genes to
a broad spectrum of cell types (Anton and Graham, 1995b). The ability to easily
manipulate the adenoviral genome and the ease with which adenovirus can be
propagated in high titres renders them particularly suitable as vehicles for gene
delivery (Russell, 2000). Adenovirus uptake is mediated by avP3 and otvp5 and
expression of delivered genes is transient because the virus does not integrate into the
host genome (Anton and Graham, 1995b). This is particularly important for the
expression of Cre recombinase as sustained expression would result in cellular
toxicity. Anton and Graham were the first to describe recombination of LoxP sites
using adenoviral delivery of Cre (Anton and Graham, 1995b). Since, this approach
has been widely used to gain temporal and spatial control over Cre mediated
recombination both in vitro and in vivo (Prost et al., 2001b; Rohlmann et al., 1996;
Shibata et al., 1997). Adenoviral gene transfer has been used with some success for
the transfection of macrophages in vitro (Kluth et al., 2001). To overcome the
difficulties experienced with Cre delivery by transduction proteins, adenovirus
expressing Cre recombinase was used to mediate deletion of floxed genes in both
COS-7 cells expressing a reporter and in integrin av targeted macrophages.
5.3.1 Adenoviral delivery of Cre to pnLacZLoxP reporter cells
The Adenovirus expressing Cre (kind gift from Dr Graham, McMaster University,
Canada and batches were kindly prepared by Dr Sallenave, University of Edinburgh)
is a replication deficient virus (El deleted). The adenoviral Cre (AdCre) was first
tested on COS-7 cells expressing the pnLacZLoxP reporter at various multiplicities
146
Chapter 5: Cre delivery
of infection (MOI) and the cells analysed by fluorescence microscopy and flow
cytometry for expression of GFP (Fig 5.5). The lowest dose tested (MOI 25) was
sufficient to cause relatively high levels of recombination as judged by the number of
cells expressing GFP (Fig 5.5a). However, at an MOI of greater than 75 the cells had
started to round up and detach from the plates indicating that infection at the higher
doses was toxic to the cells (Fig 5.5a). This cell death was probably a combination
of the amount of virus used but also that both GFP and Cre recombinase can be toxic
when expressed at high levels.
Flow cytometry of the cells showed that at an MOI of 25 -40% of the cells were
expressing GFP, at MOIs of greater than 25 -50% of the cells were expressing GFP
suggesting complete transduction (Fig 5.7b). At an MOI of greater than 50 the
percentage of GFP positive cells started to level off, which was not surprising as the
number of cells expressing GFP is limited by the number of cells expressing the
reporter (-40-50%). Analysis of the geometric mean fluorescence intensity (GMFI)
showed that increasing the MOI used did not affect the amount of GFP expressed in
the cells (Fig 5.7b). This was expected, as the amount of GFP expression is
dependent on the promoter driving the reporter and not on virus transduction.
Having confirmed the efficiency of the AdCre (-100%) it was decided to use it on
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Figure 5.5: Adenoviral Cre delivery to reporter cells. COS-7 cells
transfected with the pnLacZLoxP were incubated overnight with
adenoviral Cre at increasing levels of infection. Cells were then
analysed by microscopy (A) and flow cytometry (B) for expression of
GFP. Positive cells were gated as less than 1% of control and the
geometric mean fluorescence intensity measured for the positive cells.
Magnification x10.
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5.3.2 Adenoviral GFP titration in primary macrophages
Adenoviral transfection of human monocyte derived macrophages requires the
addition of lipofectamine™(Invitrogen) to gain successful levels of transfection (Dr
Sallenave, personal communication). To determine the optimum conditions for
adenoviral transfer in mouse bone marrow derived macrophages (BMDM)
adenovirus expressing GFP (AdGFP) was used (a kind gift of Dr Hitt, McMaster
University, Canada and batches were kindly prepared by Dr Sallenave, University of
Edinburgh). BMDM were cultured overnight in macrophage media containing
AdGFP at MOI of 25, 75, 100, 200 or 500 ± lipofectamine. The cultures were then
analysed by microscopy and flow cytometry for the expression of GFP. Cells
incubated with AdGFP in the absence of lipofectamine showed a high percentage
(90-95%) of GFP expression (Fig 5.8) using an MOI of 75 and above. MOI of >200
appeared to be toxic to the cells and this was reflected in the GMFI which decreased
from 1100 to ~800 when an MOI of 500 was used (Fig 5.6b). In comparison
macrophages cultured in the presence of lipofectamine showed lower transduction
efficiency (<60%) and lower GMFI in expressing cells (Fig 5.9b). Therefore, based
on the data obtained from the titration of AdGFP it was decided that an MOI of 75 or
100 of AdCre in normal macrophage media would introduce sufficient levels of the
AdCre to mediate deletion of the floxed genes without inducing high levels of cell
death.
5.3.3 Role of integrin qy in apoptotic cell phagocytosis
To investigate the role integrin av may play in the phagocytosis of apoptotic cells
integrin av was deleted in BMDM using AdCre infection of macrophages carrying a
floxed integrin av gene. BMDM from mice carrying a Cre activated P-galactosidase
reporter (Mao et ah, 1999) were used as a control because they allow Cre mediated
recombination that will not affect integrin av. The following day the virus
containing media was removed and fresh media added and the cells cultured for a
further two days. Cre recombination was assessed by PCR of genomic DNA from
untreated and treated macrophages from both the integrin av floxed mice and control.
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Figure 5.6: Adenoviral GFP delivery to primary macrophages.
Bone marrow derived macrophages were incubated with increasing
MOI of adenoviral GFP. MOI of 75 and above is sufficient to cause
-100% transfection. Magnification x10.
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Figure 5.7: Adenoviral GFP delivery to primary macrophages in
the presence of lipofectamine. Bone marrow derived macrophages
were incubated with increasing MOI of AdGFP in the presence of
lipofectamine. Lipofectamine appears to inhibit the levels of
transfection compared to macrophages cultured in media plus AdGFP
(Fig 6.8). Magnification x10.
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The 4f6/5b3 primers amplified the expected 900bp product from the integrin av
targeted macrophages (Fig 5.8). The treatment of integrin av floxed macrophages
with AdCre resulted in recombination (-70%) as indicated by the amplification of
the deleted product (250bp) but the recombination was not complete as the 900bp
floxed band was also amplified. Flowever the amount of the 900bp product was
decreased compared to the untreated integrin av floxed cells. In each of the
treatments macrophages from the control mice showed amplification of the 600bp
band expected for the untargeted integrin av gene showing that AdCre had no effect
on the normal genomic locus (Fig 5.8).
The macrophages were then fed with 24-hour aged (fluorescent) human neutrophils
(-55% apoptosis) for 2 hours, GRGDSP the integrin specific inhibitory peptide or
the control peptide GRADSP were added to block integrin av function. Interestingly
the levels of apoptotic cell phagocytosis were unaffected by the loss of integrin av
suggesting that while av is not essential for phagocytosis it must able to regulate the
process as GRGDSP inhibits phagocytosis through integrin av (5.9a). Apoptotic cell
phagocytosis was inhibited by GRGDSP in integrin av floxed macrophages (Fig 5.9).
In contrast av floxed macrophages treated with AdCre showed no inhibition of
phagocytosis in the presence of RGD compared to controls. Phagocytosis of
apoptotic cells in the control floxed macrophages was also inhibited by RGD in all of
the treatments confirming that loss of inhibition observed for integrin av deleted
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Figure 5.8: Detection of integrin av deletion by PCR. A) Schematic
showing the positions of the PCR primers and the expected product
sizes for wild type, floxed and deleted cells. B) PCR of gDNA from
Integrin av floxed and control macrophages that were treated with
AdCre at MOI of 75 and 100.
A)
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Figure 5.9: Role of integrin in phagocytosis. Integrin av floxed
macrophages (A) and macrophages from a control floxed mouse (B)
were treated with AdCre at MOI of 75 and 100. Apoptotic cell
phagocytosis was then assessed in the presence of the inhibitory
peptide RGD or the irrelevant control peptide RAD.
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5.3.4 Discussion.
Adenovirus was used as an alternative to the transduction proteins VP22 and MTS to
efficiently deliver Cre to cells containing floxed DNA. Infection of COS-7 cells
expressing a reporter (pnLacZLoxP) with adenoviral Cre showed that almost all of
the cells that were expressing the reporter had undergone recombination within 24
hours of infection. This observation combined with the relatively low levels of
infection (MOI 25) required for recombination indicate that adenoviral delivery of
Cre is both a simple and extremely efficient method of deleting LoxP targeted genes.
A wide variety of genes and a broad spectrum of cell types have been transfected
using adenovirus including human monocyte derived macrophages and dendritic
cells (Anton and Graham, 1995b; Hoves et al., 2003). However, adenoviral
transfection of bone marrow derived macrophages has not previously been reported.
It was essential, therefore to determine ifmacrophages could be infected in a similar
manner. Infection of bone marrow derived macrophages with an adenovirus
expressing GFP showed that macrophages were readily infected, with almost 100%
of the monolayer expressing GFP after 24 hours incubation with the virus. In
contrast to human monocyte derived macrophages and dendritic cells that require
infection under serum free conditions and in some cases the addition of a lipid
transfection reagent (Hoves et al., 2003)(Dr Sallenave, personal communication),
bone marrow derived macrophages could be infected in their normal media
(containing FCS and L929 conditioned media). Therefore confirming that like the
COS-7 cells, macrophages can easily be transfected with high efficiency using
adenovirus even at relatively low MOI, allowing delivery of Cre to the targeted cells.
The successful transfection of bone marrow derived macrophages using adenoviral
Cre allowed the investigation of the role of the integrin av gene in apoptotic cell
phagocytosis. avP3 (vitronectin receptor VnR) was first implicated in phagocytosis
by Savill and colleagues (Savill et al., 1990). They demonstrated that uptake of
apoptotic neutrophils was inhibited by monoclonal antibodies to either the a or p
subunits of the VnR and by the tetrapeptide RGDS. Phagocytosis of apoptotic
neutrophils was also inhibited by the natural RGD bearing proteins vitronectin and
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fibronectin (Savill et al., 1990). Since, then avp3 has also been reported to be
involved in the engulfment of apoptotic bodies by DCs (Rubartelli et al., 1997)
although in human systems this is thought to be mediated by avPs (Albert et al.,
1998a). To date, much of the work implicating integrin av in phagocytosis has been
carried out using blocking antibodies and the synthetic peptide RGD. Loss of
function experiments (knockout) are difficult because integrin av null mice either die
in ntero or perinatally (Bader et al., 1998). However gain of function experiments
have been reported. Transfection of avP3 into 293T cells confers increased
phagocytic ability, through a complex involving CrkII-pl30cas-Dockl80 activation of
Racl (Albert et al., 2000).
The data presented in this chapter shows that deletion of integrin av in macrophages
had profound implications for apoptotic cell phagocytosis. Treatment of the integrin
av floxed macrophages with adenoviral Cre caused deletion of the floxed av gene.
Recombination was not complete, although the levels of recombination cannot
accurately be determined from the PCR. Nevertheless, loss of integrin av did not
affect the levels of apoptotic cell phagocytosis but served to prevent inhibition of this
phagocytosis by RGD. Similar results were observed in work done in collaboration
with Dr Adam Lacy-Hulbert using mice carrying null mutations for P3 or p5 (Fig 1.3)
(Reynolds et al., 2002). In both knockouts, phagocytosis was comparable to control
cells. However, RGDS was unable to block phagocytosis in but continued to
block in p5"7" cells. This would suggest that RGD is specifically inhibiting
phagocytosis through 0^3 and not through avPs or other integrins. Macrophages
express other RGD binding integrins, and it is unlikely that P3 is the only target for
RGDS. Indeed, at high concentrations, RGD causes detachment of macrophages, a
phenomenon that occurs in the P3"" macrophages (Dr Adam Lacy-Hulbert, personal
communication). It is important to note that RGD peptides exert a variety of
biological effects and have been shown to induce anti-inflammatory, anti-coagulant
and anti-metastatic activities ((Romanov, 1999; Schwarz et al., 1998; Vassilev et al.,
1999)). In particular RGD peptides have been shown to induce anoikis (an
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anchorage-dependent form of apoptosis) in several different cell types ((Chen et ah,
1997; Levrey Hadden and Henke, 2000; Perks et ah, 1999) however, this
phenomenon was not observed during the time period with which the phagocytosis
assays were carried out. Therefore, RGD does have effects independent of P3, but its
effects on phagocytosis are solely via 0(^3.
There are two potential mechanisms to explain these observations: Firstly, it may be
that in the absence of avP3 other phagocytic pathways are upregulated to maintain
phagocytosis. It is likely that in the BMDM cultures the macrophages are
undergoing apoptosis (possibly triggered by the adenovirus) exerting a 'tonic' effect
on expression of phagocytic pathways. Real-time PCR expression data from within
our laboratory has shown that CD36"7" and SRAV" macrophages have increased
expression of p3 integrins relative to control BMDM suggesting that in the absence
of CD36 or SRA, other potentially compensatory phagocytic pathways were
upregulated. Similarly in mice lacking p3 and low-density lipoprotein receptor
(LDLr or CD91) CD36 expression has been shown to be upregulated in smooth
muscle cells (Weng et ah, 2003).
Alternatively, avP3 may act as a negative regulator of normal phagocytosis, by
regulating involvement of other integrins or receptors. avP3 ligands such as RGDS,
antibodies or matrix proteins probably cause downregulation of phagocytic
machinery. Evidence for such integrin crosstalk has already implicated P3 in the
regulation of asPi phagocytosis (Blystone et ah, 1994; Blystone et ah, 1999).
Furthermore Pi integrins have been shown to influence the binding and uptake of
apoptotic cells by leukocytes (Schwartz et ah, 1999; Vernon-Wilson et ah, 2003).
However, to address the mechanisms involved in maintaining phagocytosis in the
absence of integrin av further studies using a combination ofblocking antibodies and
knockout mice will be required.
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Despite the initial promise of transduction proteins as vehicles for Cre delivery into
macrophages the data presented in this chapter has shown that this approach is
limited by several factors I) the ability of VP22 fusion proteins to traffic between
cells is not as simple as first thought. II) the translocation potential of the VP22
fusion protein may be dependent on the fusion partner and III) the inability to
produce large quantities of recombinant protein. Nevertheless, the most simple and
efficient method of transfecting macrophages with Cre in vitro was found to be
adenoviral gene transfer. One of the main advantages of delivering Cre to cells in
this way is that it allows the deletion of the LoxP targeted genes at desired time
points within the cells of interest (Wang et al., 1996). Moreover, the ability to
knockout specific genes in vitro lends itself to the potential for re-introducing the
cells back into mice to assess the role of particular genes/cell types in vivo and
importantly it allows the investigation of gene function where knockout mutations
prove to be embryonic lethal (Anton and Graham, 1995b). However there is one
major drawback with this approach. Adenoviral gene transfer elicits an immune
response that can result in the removal of the infected cells (Akagi et al., 1997).
Several attempts have been made to overcome this response that is the result of the
activation of CD8+ lymphocytes against the cells expressing the virus. In particular
the use of immunosuppressive drugs has permitted sustained expression of genes
delivered by the virus (Kafri et al., 1998) although it is thought that further
debilitation of the virus by removal of all viral coding regions may be required to






Chapter 6: General conclusions and future work.
The ultimate aim of this thesis was to produce myeloid cells lacking the integrin av
gene to allow the investigation of the role that av integrins play in the phagocytosis
of apoptotic cells. Due to the lethal phenotype of the av knockout mouse, two
alternative complementary approaches were used. In the first approach, ES cells
carrying a disrupted integrin av gene were differentiated into DCs. In the second
approach Cre was delivered to macrophages cultured from integrin av targeted mice
to allow deletion of the gene.
Prior to the differentiation of genetically modified ES cells, wild type ES cells were
used to characterise the potential of this system to generate myeloid phagocytes
capable of ingesting particles such as apoptotic cells. As presented in this thesis ES
cells were successfully differentiated to macrophages and DCs in the presence of the
cytokines IL-3 and either M-CSF or GM-CSF. Both the ES cell line and the serum
used were critical factors in generating large numbers of these cells. The cytokines
used did not generate pure populations of either cell type and most cultures were
likely to be a mixture of both. Comparison of the fluorescence intensity profiles for
ES derived cells and BMDM showed a more heterogeneous pattern of expression for
each of the surface markers in the ES derived cells. This suggested that not only
terminally differentiated macrophages and DCs were present in the cultures but
probably many precursor cells at different stages of development. This was not
unexpected as the cytokines used to drive the differentiation of ES cells are not only
involved in driving differentiation towards the terminally differentiated macrophages
and DCs but are also important in each stage of differentiation from pluripotent stem
cells to myeloid cells to monocyte precursors (Fig 7.1).
E14 ES derived cells were able to regenerate DCs upon routine harvesting of the
cultures permitting the maintenance of long-term cultures. This suggested that early
precursor cells present in the cultures were probably capable of self-renewal. One
possible explanation for this is the presence of stromal cells in the cultures containing
plated EBs, these cells probably condition the media with factors that help maintain
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Figure 6.1: Cytokine regulation of hematopoiesis. IL-3, GM-CSF and M-
CSF drive hematopoiesis from pluripotent stem cells to myeloid stem cells and
finally to terminally differentiated cell types such as macrophages and DCs
taken from Kuby,1997.
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renewal of the precursor cells. In comparison, cultures of BMDM do not appear to
regenerate from stem cells, although BMDM will proliferate in the presence of M-
CSF. This may be due to the absence of the factors required to maintain renewal of
progenitor cells but it is more likely that in culture the BMDM arise from a precursor
cell that is more committed than those present in the differentiated ES cultures.
Surface phenotype alone is not sufficient to distinguish clearly between macrophages
and DCs in culture and the morphology and functional characteristics such as
adherence, phagocytic capability and the ability to up-regulate co-stimulatory
molecules must also be considered. These ES derived myeloid cells were highly
phagocytic and phagocytosed both inert particles such as latex beads and apoptotic
cells. ES derived DCs could also be matured with LPS and while the capacity of ES
derived DCs to stimulate a T-cell response has previously been shown by others
(Fairchild et al., 2000; Senju et ah, 2003) it was not assessed during the course of this
work. Nevertheless, both macrophages and DCs generated by the differentiation of
ES cells were similar in surface phenotype to bone marrow derived myeloid cells and
showed some of their functional attributes.
The differentiation of genetically altered ES cells was successful in that ES cells
carrying a disrupted integrin av gene differentiated in a similar manner to normal ES
cells. The DCs arising from the differentiation of these ES cells were comparable to
those derived from normal ES cells and were capable of both phagocytosis and
maturation. However, DCs putatively bearing a disrupted integrin av gene did not
exhibit phagocytic properties expected from studies of P3_/" macrophages and
expression of functional integrin av could not be excluded. Instead, adenoviral
delivery of Cre to integrin av floxed macrophages proved to be a more useful method
of generating av null macrophages. The major advantage of delivering Cre to floxed
BMDM is that greater numbers of cells lacking the floxed gene can be generated
relatively easily, but this method requires the generation of targeted mice that is both
costly and time consuming. Alternatively, delivery of Cre to targeted ES derived
cells allows the investigation of genes in specific cell types without the need to
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generate a conditionally targeted mouse. One disadvantage of differentiating ES
cells was that the cultures often contain several different cell types unlike the cultures
of BMDM. While the use of cytokines to drive differentiation was effective in
skewing the differentiation towards a particular cell type, cultures of pure cell types
cannot be generated by this method. This could be overcome by the introduction of
selectable markers into lineage-restricted genes (Billon et al., 2002). At present this
is difficult for myeloid cells as they are very heterogeneous but with further
delineation of the transcription factors involved in hematopoietic differentiation this
approach could be exploited in the future.
Phagocytosis studies using (33*A macrophages showed that in the absence of this
integrin phagocytosis was unaffected but was no longer inhibitable by the
antagonistic peptide RGD. Similar results were obtained for macrophages lacking
integrin aV) however phagocytosis by DCs derived from ES cells carrying a disrupted
integrin av gene could still be inhibited by RGD. This raised the question of whether
the inhibition was a result of functional expression of integrin av. One way to
address this would be to carry out immunohistochemistry studies. Previous attempts
to detect surface expression of av and P3 integrin subunits were unsuccessful with the
antibodies available but different antibodies from other suppliers could be tested.
Alternatively, integrin av expression could be assessed using Western blotting.
Nevertheless, the data would be difficult to interpret without investigating the effects
on phagocytosis by RGD on ES derived DCs that were expressing a normal integrin
av gene. While wild type E14 ES cells could be used to generate control DCs, the
ideal experiment would be to differentiate ES cells carrying a floxed integrin av
gene. The floxed DCs could then be treated with adenovirus expressing Cre in a
similar manner to the BMDM allowing both control and integrin av deficient DCs to
be generated simultaneously.
The capacity to generate integrin av null macrophages by treating floxed
macrophages cultured from targeted mice with adenoviral Cre has opened up new
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avenues for investigating the role of this integrin in apoptotic cell phagocytosis.
Integrin av is thought to bind TSP 1 alongwith CD36 to form a "molecular bridge" to
apoptotic cells. Macrophages cultured from CD36"A mice, similar to integrin av~'~
macrophages show no defect in phagocytosis (Dr Adam Lacy-Hulbert, personal
communication) and this may be due to compensation by the other receptor. A
previous report using p3_/~ mice has shown that in the absence of this integrin, CD36
becomes upregulated on smooth muscle cells indicating a close link between these
receptors (Weng et ah, 2003). Crossing integrin av targeted mice with CD36"7" mice
and treating the macrophages with adenoviral Cre to generate integrin av ~7CD36_/"
macrophages may provide greater insight into the compensatory pathways involved
in maintaining phagocytosis in the absence of these receptors. Real-time PCR could
also be a useful method for investigating which phagocytic receptors are upregulated
in macrophages deficient in integrin av. This would help to determine which receptor
knockout mice could be crossed with integrin av targeted mice or which
combinations of blocking antibodies could be used to help delineate the pathways
involved in phagocytosis in the absence of integrin av. It would also be of interest to
generate integrin av deficient DCs from the integrin av targeted mice to investigate
the effects of RGD on apoptotic cell phagocytosis by DCs and this may help
elucidate ifmacrophages and DCs use different integrins for this process.
In summary, this thesis has presented two alternative methods for generating
genetically modified myeloid cells. Both methods, combined with the ability to
deliver Cre to these cells has provided a powerful system in which to assess the role
of genes that have a lethal phenotype in vivo. Moreover, delivery of Cre to
genetically modified cells derived from ES cells allows the investigation of genes in
specific cell types without necessarily generating a conditionally targeted mouse.
Importantly, macrophages and DCs generated by either of these methods could be re¬
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Appendix I: Materials and Solutions.
All tissue culture reagents were purchased from Invitrogen (Life technologies,
Paisley, UK) unless otherwise stated. All chemicals were of analytical reagent grade
and purchased from Sigma (Poole, UK) unless otherwise stated. Tissue culture
plastics were purchased from Costar excluding the ES differentiation culture plates.
Routinely used reagents Cat.No
Collagenase-Sigma C-0130
Culture dishes for differentiation- Stem Cell Technologies 27150
ES cell differentiation serum: Labtech serum-Labtech International, Sussex, UK
ES cell serum-Sigma F2442
FBS (pre-tested for differentiation)- Stem Cell Technologies 06900
Gelatin-Sigma G1890
GRADSP-Calbiochem, 03-34-0052
GRGDSP-Calbiochem, Nottingham, UK 03-34-0035
Insulin-Sigma 1882
Leishmans's stain -BDH Poole, Dorset 350224L
LPS-Sigma L3129
Methylcellulose -Stem Cell Technologies, Canada M3120
Mitomycin C-Sigma M0503
Monothioglycerol -Sigma M6145
RmIL-3-R&D -Oxon, UK 403-ML-010
Serum for batch testing:
Batch 1-Cat.No. F2442, Batch 101K8401 (Sigma)
Batch 2-Cat.No. PET 10270098, Batch 40G2027K (Invitrogen)
Batch 3-Cat.No. PET 10270098, Batch 40F9224K (Invitrogen)
Batch 4-Cat.No. PET 10106151, Batch 40Q8124F (Invitrogen)
Batch 5-Labtech serum, Batch 2539 (Labtech International)
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Solutions for bacterial work




Make up to 1L with distilled water and autoclaved














PH 8.0 and make up to 100ml distilled water
DNA loading buffer
















Proteinase K (add fresh) lOOpg/ml
Protein Buffers
SDS-PAGE- 12% separating gel
Distilled water 5.25ml
4x Tris-HCL.SDS, pH8.0 3.75ml
acrylamide/Bis acrylamide (37:5:1) 6.0ml




4x Tris-HCL.SDS, pH 6.8 1.25ml
acrylamide/Bis acrylamide (37:5:1) 0.65ml
10% (0.lmg/ml) ammonium persulphate 25pi
TEMED (Sigma) 5pl
4X Tris.Cl/SDS pH 8.8
Tris base 91 g
SDS 2g
Dissolve Tris in 300ml distilled water, pH to 8.8 with IN HCL and filtered through
0.45pm filter before adding SDS.
Make up to 500 ml
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4X Tris.Cl/SDS pH 6.8
Tris base 6.05g
SDS 0.4g
Dissolve Tris in 40ml distilled water, pH to 6.8 with IN HCL and filtered through
0.45pm filter before adding SDS.
Make up to 100 ml
4X SDS-reducing Buffer







Tris base 15. lg
Glycine 72g
SDS 5g


























Potassium ferrocyanate (0.4M Final) lOOgil
Potassium ferricyanate (0.4M Final) 1OOjul
X-gal (40mg/ml stock) 250jul
MgCl2(2M) 10|al





Make up to 1L with distilled water and autoclave.
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Appendix II Plasmid Maps



































pET-1 Id 5.7kb (Stratagene)
loc&q
GAAGGAGATATAAC ATG OCT AOC ATO ACT OCT OGA CAG CAA ATG GGT cAo ATC COG C
A S M TGGQQMG, R I RJ














511 911 SI I S3! 531 HI SI «1 STI £yfp
GCTAGCGCTACCGGAGTCAGAT CTCGAGCTC AAGCTTCGA ATTCTGCAGTCGACGGTACCGCGGGCCCGGGATGCACCGGTCGCCACCATGGT&
flfiel Ecs471 fit.'II Xtio I X, tfmd IIISad
fc/U6ll




; I f Zo.it
I71SI \ fiscuiI \ fiscUO I lfni.il5.if IT 5m.i I
4 OH I
189
















pnLacZLoxP LoxP 2 |
iEGFP
SV40 ori
PSV40f
SV40
fi poiyA
\
Afl II
201
